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Auditory processing disorder is a common developmental disorder affecting about 10% of 
children. It is characterised by poor perception of speech sounds, especially in background noise 
environments, despite normal hearing sensitivity, which can lead to poor performance in school 
with a negative impact on education and everyday life. Previous studies have shown that auditory 
processing skills have a substantial genetic component, however, it is not clear which genes or 
molecular mechanisms are involved. In this thesis three different genetic approaches are applied 
(monogenic, common disease-common variant and common disease-rare variant) to assess the 
effect of candidate genes on neurodevelopmental measures, including hearing and language 
phenotypes, in a population cohort (ALSPAC) of more than 14,000 children. To complement these 
analyses, a reverse phenotype to genotype approach is used, focussing on a surrogate measure of 
auditory processing difficulties in ALSPAC children, to identify potential high impact coding 
variants that may explain these difficulties. 
Given previous work, these genetic investigations focus upon candidate genes related to Usher 
syndrome, a recessive disorder leading to hearing and vision loss resulting from dysfunctional 
neurosensory cells in the inner ear and retina (hair cells and photoreceptor cells respectively). 
Analyses indicate that there is no one single risk variant, but a complex mix of variation across 
Usher genes (such as USH2A, PCDH15, CLRN1, and ADGRV1) might explain some of the APD risk. 
The phenotype to genotype analysis across coding regions further shows that rare pathogenic 
variants with large effect in other genes (such as GRHL3, DIAPH1, FAT4 and IFT88) can contribute 
to risk of APD in simplex cases.  
These results provide insights into the genetic landscape underlying APD and offer candidate 
genes and variants for further investigation and validation. Furthermore, the results highlight 
allelic heterogeneity where multiple variants present in the same Usher gene (USH2A) can display 
different, but related hearing phenotypes. In a wider context, this study also highlights the 
viability of using related/surrogate phenotypes for genetic discovery in a large sample when deep 
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Our understanding of auditory perception can be informed by the investigation of individuals in 
whom this process is disrupted. For example, in auditory processing disorder (APD). This term 
describes a deficit in the perception of speech sounds, especially in background noise, despite 
normal hearing and auditory function (Section 1.2).  
The work described in this thesis was based on preliminary findings in a discovery family affected 
by an apparently autosomal dominant form of APD. The discovery family is briefly described in 
Section 2.1.1 and further described by Perrino et al. (Perrino et al., 2020). The preliminary findings 
resulted from whole genome sequencing analysis (completed before the start of this work), which 
identified a stop-gain heterozygous variant in USH2A, which co-segregated with the disorder in 
the family (Perrino et al., 2020). Perrino et al., further showed that heterozygous Ush2a knockout 
mice (Ush2a+/-) had a distinctive low-frequency (15Hz) hearing loss while their hearing at high-
frequency (40Hz) remained intact (Perrino et al., 2020). Even after allowance for this hearing loss, 
Ush2a+/- mice were impaired on complex pitch discrimination tasks, which involved the detection 
of a deviant target sound embedded in background distractors (Perrino et al., 2020). Furthermore, 
analysis of ultrasonic vocalisations showed that Ush2a+/- mice vocalised at a significantly higher 
pitch and produced calls that were shorter and louder than wildtype mice (Perrino et al., 2020). In 
contrast, the complete knockout mice (Ush2a-/-) had high-frequency hearing loss (as expected) 
but showed superior performance on pitch discrimination tasks and did not have altered 
vocalisations (Perrino et al., 2020). These animal studies provided a direct link between 
heterozygous Ush2a knockout and auditory perception and warranted further analyses. 
This thesis therefore investigates the wider effects of USH2A variation (and the variation in other 
Usher syndrome genes) upon hearing, auditory processing and language in a large human 
population cohort. The sections that follow introduce the background concepts that later link to 
the presented data. 
1.1. The human auditory system 
1.1.1. Central auditory anatomy for information processing 
The human auditory system includes the ear (peripheral auditory organ) and regions within the 
brainstem, midbrain, the thalamus and auditory cortex (forming the central auditory system), that 
receive signals propagated from the inner ear (Figure 1.1). The sound waves picked up by the ear 
are transduced into electrical signals and transmitted via the cochlear (auditory) nerve to the 
cochlear nucleus within the brainstem, where different sound cues are detected (Figure 1.1). 
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Most of the information is then transmitted through crossing fibres into the superior olivary 
complex (important in sound localisation) and from there up through the contralateral side of the 
brainstem and the inferior colliculus within the midbrain (important in integrating auditory input 
with other sensory inputs) (Figure 1.1). The information then passes through the medial 
geniculate nucleus in the thalamus (important in primary auditory information transmission) and 
reaches the auditory cortex where processing takes place. Processing includes complex tasks such 
as resolving multiple concurrent sound sources, attending to sounds in noisy environments, 
recognising auditory objects or contexts and performing higher-order auditory tasks such as 
language (Figure 1.1). This ascending pathway of auditory information is also known as the 
bottom-up or afferent route. Reciprocal connections from the cortex to subcortical structures all 
the way to the cochlea also exist, forming the top-down (descending or efferent) route (Figure 
1.1). Independent tracks from the auditory cortex to the thalamus (medial geniculate nucleus), 
midbrain (inferior colliculus) and brainstem (superior olive) have been identified (Winer, 2006) 
(Figure 1.1). The efferent networks have been proposed to fine-tune afferent signal encoding and 
control gain in the system so important information can be extracted easily (Robinson and 
McAlpine, 2009). While the processing of auditory information is thought to take place along the 




Figure 1.1. Diagram of the bilateral ascending auditory pathway from the cochlea and descending pathway 
from the auditory cortex (adapted from Hall, 2011).  
The ascending pathway includes structures in the brainstem (1), midbrain (2) and auditory cortex (3). 
Unilateral auditory pathway involves: cochlear nerve (A), ventral cochlear nucleus to contralateral and 
ipsilateral superior olivary complex (B1), superior olivary complex to inferior colliculus (B2), dorsal 
cochlear nucleus to contralateral inferior colliculus (C), inferior colliculus to medial geniculate nucleus (D) 
within thalamus, and medial geniculate nucleus to auditory cortex (E). Descending pathway is illustrated in 




1.1.2. Peripheral auditory system and the process of hearing 
The process of hearing starts with sound waves entering the outer (external) ear and travelling 
through the ear canal until they reach the ear drum, causing it to vibrate (Figure 1.2a). These 
vibrations are amplified within the middle ear and transmitted to the cochlea within the inner ear. 
The cochlea is a snail-like structure, filled with fluid with each turn consisting of three sections: 
scala vestibuli, scala tympani and scala media (Figure 1.2a). The middle section, scala media, 
contains the sensory auditory organ, the organ of Corti (Figure 1.2b-c). The organ of Corti 
comprises of a single row of inner hair cells (IHC) and three rows of outer hair cells (OHC) (Figure 
1.2c-d). The hair cells form tight connections with supporting cells, which are in turn connected at 
their basal surface to an extracellular matrix, called the basilar membrane (Figure 1.2c). The apical 
surface of each hair cell contains the mechanically sensitive organelle, the hair bundle, which 
consists of dozens of “hairs”, called stereocilia (Figure 1.2c-d). Another extracellular matrix, called 
the tectorial membrane, is attached to the stereociliary bundles of OHCs and covers the apical 
surface of the organ of Corti (Figure 1.2c). In contrast to the OHC bundle, the IHC bundle is free 
standing in the subtectorial space (Figure 1.2c). As the sound vibrations reach the organ of Corti, 
they form a travelling wave which causes displacement of the basilar membrane. This in turn 
leads to deflection (bending) of the stereocilia bundle and opening of mechanically gated cation 
channels (Figure 1.2d). The influx of calcium and potassium ions into the hair cell induces 
depolarisation and release of neurotransmitter glutamate at the basal end of the hair cell 
(Hudspeth, 2014). Glutamate stimulates the cochlear (auditory) nerve, which transmits the signal 




Figure 1.2. The mammalian ear and the structures involved in sound processing (adapted from (Frolenkov et al., 2004).  
a) External ear with the inner ear auditory organ; b) sections of the cochlea; c) the sensory cells of the organ of Corti: inner (IHC) and outer (OHC) hair 
cells with afferent terminals (in green) that form the ascending pathway and efferent terminals (in yellow) which exit the descending pathway ; d) a 
scanning electron microscopy picture of hairs cells with three rows of OHCs (left) and one row of IHCs (right); e) the mechanosensitive organelle of 
IHCs, the hair bundle, with Ca2+ and K+ influx through the mechanoelectrical transduction channels of the stereocilia upon hair bundle deflection.  
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There are approximately 16,000 sensory hair cells in the human cochlea (Schwander, Kachar and 
Müller, 2010). Due to variation in width and thickness of the basilar membrane and variation in 
height of the stereocilia, hair cells at different positions along the cochlear duct are tuned to 
different frequencies, described as tonotopic organisation (Mann and Kelley, 2011) (Figure 1.3a). 
Hair cells at the base of the duct (nearest to the tympanic middle ear) are sensitive to high 
frequencies, while those at the apical end of the coiled cochlea are sensitive to low-frequencies 
(Hudspeth, 1997) (Figure 1.3a). The same orderly map of sound frequency is functionally 
represented throughout the auditory system all the way to the auditory cortex (Figure 1.3b).  
The IHC and OHC are specialised to do different things. The IHC (approximately 3,500 in the 
human cochlea) are the primary receptor cells, innervated by dendrites of the auditory nerve and 
so they form the majority of the afferent links to the central auditory system (from the ear to the 
brain). As such they are responsible for the transduction of sound waves into electrical signals and 
so can be perceived as the cells that do the “hearing” process. The OHC (11,000 in human 
cochlea) are the target of efferent neural pathway from the brainstem through the superior 
olivary complex’s olivocochlear bundle (OCB). The OCB contacts OHCs directly and the IHCs 
indirectly via the afferent fibres beneath them (type I afferent fibres) (Figure 1.2c). Therefore, the 
OCB exerts fine-tuning right at the periphery. The OHCs are primarily involved in sound 
amplification and are considered as “amplifiers”, interpreting auditory feedback to balance input 
between ears and facilitate auditory perception (Murakoshi, Suzuki and Wada, 2015). Both types 
of hair cells are exposed to a variety of external and internal ototoxic factors, such as loud noise, 
ototoxic drugs, ageing and genetic defects, which can cause damage. As mammalian hair cells do 
not regenerate, the damage can build up over time and lead to decreased hearing ability and even 
hearing loss, known as peripheral (sensorineural) hearing loss. If the IHC are damaged, that is 
expected to directly disrupt hearing through the afferent pathway. If the OHC are damaged, that 
will affect the ability to amplify important signals, controlled through the efferent pathway, which 
is essential for understanding complex information such as speech in noisy environments. Yet, the 
afferent and efferent pathways are connected and processes in one can influence the output in 
the other. For example, a study where IHCs in chinchillas were preferentially damaged with 
carboplatin (an anti-cancerous drug), showed that in spite of the fact that the chemical damage 
was purely peripheral (mainly as a result of >80% IHCs loss), a cascade of neuroplastic changes in 
the central auditory pathway could compensate for the reduced neural output from a damaged 
cochlea (Salvi et al., 2016). Salvi et al. reported that the chinchilla’s hearing in noise was affected, 
but it was largely preserved in quiet. This was because the activity from the few remaining intact 
IHCs was progressively amplified through the central auditory system so weak signals become 
comfortably loud (Salvi et al., 2016). The difficulty hearing in noise was proposed to arise from the 
central auditory system not being able to compensate for the reduced neural output in the 
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cochlea (by turning up its gain and decreasing its inhibitory effect which worked for weak sounds 
in quiet, but not in adverse conditions with competing noise) (Salvi et al., 2016). Indeed, the 
efferent control of OHCs has been shown to be important in speech discrimination in noise 
(Winslow and Sachs, 1987; Kawase and Liberman, 1993) and sound localisation (Andeol et al., 
2011) and as such is an important pathway studied in disorders of auditory processing (Reynard, 
Veuillet and Thai-Van, 2020; Boothalingam et al., 2015). Furthermore, the function of OHCs is 
thought to also directly contribute to hearing in noise by fine tuning the motion of the basilar 
membrane (Parker, 2020). As such OHCs dysfunction has been shown to correlate with better 
performance in quiet, but poor performance in noise and is regarded as an important cause for 
hidden hearing loss (HHL- explained in Section 1.2) (Hoben et al., 2017; Parker, 2020).  
Auditory nerve (AN) fibers transmit signals from IHCs to the brainstem targets in the cochlear 
nucleus. The multiple innervation of single IHCs, whereby each IHC is contacted by 10-30 AN 
fibers, is important in auditory processing and understanding speech in noise because the AN 
fibers differ in spontaneous discharge rate (SR) and threshold to acoustic stimuli (Liberman, 
1978). The low-SR fibers (<20 sp/s) have higher thresholds and increased dynamic range of the 
auditory periphery compared the high-SR fibers (>20 sp/s) (Liberman, 1978). The low-SR fibers are 
thought to be important for hearing in noisy environments because of their resistance to masking 
by continuous background noise (or because of their ability to follow the quick change of the 
amplitude of acoustic signals) (Costalupes, Young and Gibson, 1984). In contrast, the high-SR 
fibers are responsible for the sensitivity to quiet sounds and are saturated by high-level 
background noise. Kujawa and Liberman showed that acoustic overexposure to intense sound (8 
to 16 kHz octave band at 100 dB SPL for 2h) can cause a permanent damage of auditory nerve 
fibers in mice, but without damaging cochlear hair cells and despite a complete recovery of 
cochlear thresholds (Kujawa and Liberman, 2009), as measured by ABR. It was further confirmed 
this was likely due to the selective loss of low-SR fibers following exposure to neuropathic noise (4 
to 8 kHz octave band at 106 dB SPL for 2h) in guinea pigs, which could explain the recovery of ABR 
thresholds despite significant noise-induced neuropathy (Furman, Kujawa and Liberman, 2013). It 
was therefore suggested that selective loss of low-SR high threshold AN fibers may be another 
contributor to problems of hearing in noise in humans and therefore hidden hearing loss 






Figure 1.3. Tonotopic organisation in the auditory system from cochlea to auditory cortex (adapted from Purves et al., 2001). 
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1.1.3. Evaluating hearing 
Amongst the tests used to assess hearing and diagnose hearing loss, the ones I will review and 
later refer to in this thesis are pure tone audiometry, Otoacoustic Emissions (OAE) and Auditory 
Brainstem Response (ABR).  
Pure tone audiometry (also referred to as threshold audiometry) determines the quietest (softest) 
sound that a person can hear at different frequencies from 250 to 8000Hz, which span most of 
the human audible range. It is also called air conduction testing as the sound goes through the 
outer and middle ear to reach the inner ear. This is usually the first-line test to evaluate hearing 
deficits. The results are recorded on an audiogram (Figure 1.4). Sound frequency (ranging from 
low to high pitch) is measured in Hertz (Hz) and is recorded on the audiogram’s horizontal axis 
(Figure 1.4). Sound intensity (hearing level) is measured in decibels hearing level (dB HL) and is 
recorded on the vertical axis (Figure 1.4). The quietest sound at each tested frequency is called air 
conduction threshold and is recorded as a point on the audiogram for the left and right ear 
separately. Any points that are heard at 20dB or quieter are considered to be within the normal 
range. Pure tone audiometry is a key measure in the evaluation of hearing disorders as it is able to 
provide information regarding the type, degree and configuration of hearing loss, however, it is 
considered to offer limited insight into auditory function and auditory processing in real world 
settings (such as speech, music, noisy environments) (Musiek et al., 2017). 
 
 
Additional electrophysiological tests, such as OAE and ABR, are used to test the cochlea and the 
brain pathways (such as auditory nerve and brainstem pathways) and therefore provide 
quiet sounds 
Figure 1.4. Audiogram showing hearing with normal hearing thresholds for both right and left ear 
(ANSI- American National Standards Institute). 




diagnostic insight into specific disorders of the auditory system. Both tests are particularly useful 
for assessment of infants and young children (Stanton et al., 2005). The otoacoustic emissions are 
generated in the cochlea and are measurable in the ear canal, so they are an objective measure of 
the cochlea functioning. Distortion Product Otoacoustic Emissions (DPOAE) are distorted sounds 
generated by the OHCs in the cochlea in response to two tones that are close in frequency. The 
presence of a DPOAE response is typically an indication that the OHCs specifically are functioning 
properly, while the IHCs abnormal function does not seem to affect the DPOAE input/output (Salvi 
et al., 2016). DPOAE is a common hearing test used in mouse models to provide additional 
information about OHCs function. 
ABR measures the electrical activity of the auditory nerve pathway from the inner ear to the 
brainstem that is recorded by electrodes. The ABR response is displayed as a waveform with five 
major peaks used to assess brainstem function at different levels of the auditory pathway. 
Through the different peaks ABR shows the activity of the auditory nerve and the activity of 
neurons in successive nuclei of the auditory hindbrain within the brainstem. The time between 
the peaks (latencies) and the amplitude of the peaks are measured and compared to normative 
data. The reliability, sensitivity, non-invasive nature and ease of application has made ABR a 
method of first choice to assess hearing impairment in mouse models (Zheng, Johnson and Erway, 
1999). 
1.2. Disorders of the auditory system: Hidden Hearing Loss and 
Auditory Processing Disorder 
The audiogram as the standard method to evaluate hearing (Figure 1.4) is sensitive at identifying 
hearing loss but is unable to detect “hidden” cochlear impairments such as cochlear synaptopathy 
(loss of synaptic contact between auditory nerve and IHCs) or hair cell dysfunction (Liberman et 
al., 2016; Chen, 2018). Cochlear impairment with normal audiometric thresholds is defined as 
hidden hearing loss (HHL) (Schaette and McAlpine, 2011) and is thought to result from noise-
induced synaptopathy, cochlear demyelination or possibly hair cell dysfunction (Kujawa and 
Liberman, 2009; Wan and Corfas, 2017; Hoben et al., 2017). These forms of hidden cochlear 
impairment do not result in overt hearing loss (Chen, 2018), but they may increase the 
susceptibility of the cochlea to further damage and weaken or disturb central auditory processing 
such as sound discrimination (D et al., 2020). Due to this secondary impact of HHL on central 
auditory pathway functioning, the term auditory processing disorder is sometimes preferred in 
order to include those individuals with peripheral auditory impairment (Iliadou et al., 2017). 
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1.2.1. APD definition and prevalence 
Auditory Processing Disorder (APD) is a highly heterogeneous neurodevelopmental disorder. It is 
included in the International Classification of Diseases by the World Health Organization, 10th 
edition (ICD-10) as H93.25: “a disorder characterised by impairment of the auditory processing, 
resulting in deficiencies in the recognition and interpretation of sounds by the brain”. According 
to the British Society of Audiology (BSA), APD is considered as “poor perception of speech and 
non-speech sounds” (BSA, 2018). Affected individuals report listening difficulties, despite in most 
cases having a normal hearing sensitivity (as detected on an audiogram- Figure 1.4) (Bamiou, 
Musiek and Luxon, 2001). The BSA proposes three types of APD: developmental, acquired and 
secondary (BSA, 2018) (Table 1.1), and highlights the international focus towards developmental 
APD, because of its unknown aetiology and its potential impact on learning difficulties, which can 
in turn affect school performance.  
Table 1.1. APD types as recommended by the British Society of Audiology 
Developmental APD 
There is usually no known cause other than a family history of developmental 
communication and related disorders, it is present in childhood and may 
continue into adulthood. 
Acquired APD 
Associated with ageing or a known neurological event (brain lesion, trauma, 
stroke, infection). 
Secondary APD 
Occurs together with, or as a result of either short term (for example glue ear) 
or permanent hearing impairment. 
The hallmark of APD is difficulty understanding speech when in noisy environments. Affected 
individuals require frequent repetition of information, they are easily distracted and struggle to 
follow instructions, and they find it difficult to interact in noisy group activities (Moore et al., 
2013; Jerger and Musiek, 2000). These difficulties can consequently impact on school 
achievements and social skills (Moore et al., 2013). This collection of symptoms can be traced 
back to a different auditory deficit (Table 1.2), but they are also present in co-occurring 
neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD), language 
impairment, autism spectrum disorder (ASD) and dyslexia (Witton, 2010; Ferguson et al., 2011; 
Moore and Hunter, 2013; Dawes et al., 2008; Dawes and Bishop, 2010). Effective processing of 
sounds is important for the development of language and this together with the likely cognitive 
elements of APD may explain some of the developmental overlaps. Several causal models have 
been proposed to explain the co-occurrence between APD and language disorders. The earliest 
theory was developed by Tallal and supports the idea that language disorders are caused by APD 
due to a deficit in rapid auditory temporal processing (processing sounds when closely spaced in 
time) (Tallal, 2004). Later studies concluded the opposite relationship: deficits in auditory 
processing are a consequence of language impairment with processing of sounds within the brain 
being affected by poor language skills (Shafer, Schwartz and Martin, 2011; Bishop, Hardiman and 
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Barry, 2012). An alternative model argues that a number of genetic and environmental factors 
interact with other risk factors to determine whether an individual will develop a language 
disorder (Bishop, 2006). According to this theory, auditory processing deficits may constitute one 
of these risk factors and thus contribute to language difficulties in the absence of a one-to-one 
relationship between the two. Most recently, data from a correlation study investigating the links 
between language and auditory processing tasks in children with mild to moderate sensorineural 
hearing loss, ruled out the extreme models of direct relationships (Halliday, Tuomainen and 
Rosen, 2017). Instead, the results suggested that deficits on auditory processing tasks which 
required higher level cognitive ability were associated with language difficulties, but were not 
sufficient for causality, implying that the relationships were not as straight-forward as 
hypothesised before and were likely influenced by other factors (genetic and environment). 
APD is relatively common with estimates ranging from between 0.5%-1% in the general 
population to 10% when APD occurs in combination with other neurodevelopmental disorders 
(Brewer et al., 2016; Hind et al., 2011). APD impacts on both school performance and everyday 
life, predominantly through a reduced ability to listen and respond to speech and sounds 
appropriately (Moore et al., 2013). 
Table 1.2. Auditory deficits and their implications on day-to-day performance and behaviour, characteristic 
of APD (adapted from (Bamiou, Musiek and Luxon, 2001). 
1.2.2. Diagnosis of APD and hypotheses about its origin 
There is no single test that can diagnose APD. Instead, the diagnosis is typically based on evidence 
from a multi- and inter-disciplinary team. These include concerns from parents and teachers, 
reports from medical professionals (such as GPs, speech and language therapists, audiologists, 
psychologists), medical and family history, observation of speech quality, examination of 
Auditory deficits in: Resulting symptoms and behaviours: 
Sound localisation 
 (ability to pinpoint the source and location of a sound) 
Poor performance in confusing environments 
with competing speech and noise 
Auditory pattern recognition 
 (ability to determine similarities and differences in 
patterns on sounds) 
Difficulties following oral instructions 
Auditory discrimination  
(ability to distinguish between different sounds) 
Language, reading, and spelling difficulties Temporal processing  
(the ability to process multiple auditory stimuli in their 
order of occurrence)  
Processing degraded auditory signals  
(ability to perceive a signal in which some of the 
information is missing) 
Difficulties with rapid speech and with filling in 
missing portion of the auditory signal to 
recognise the whole message  
Processing the auditory signal when embedded in 
competing acoustic signals  
(ability to perceive speech and other sounds when 
another signal is present) 






peripheral auditory function and cochlear feedback pathway, and results from auditory 
processing (AP) specific tests (forming an APD test battery). Although individual elements of the 
APD battery are standardised, no agreement has been reached on the exact tests or the number 
of tests that should comprise the battery, resulting in no “gold standard” (Moore et al., 2013; 
Dillon et al., 2012). APD evaluation is described as a dynamic assessment, where specific AP tests 
are selected based on the individual’s age, observational data, medical history and their problems 
and presentations, including any other issues and co-occurring conditions (Campbell et al., 2019). 
Four broad areas of auditory processing are generally measured in the APD battery, including 
dichotic processing, temporal processing, perception of monoaural low redundancy speech and 
binaural interaction (Campbell et al., 2019) (Table 1.3).  
Table 1.3. Main auditory processing areas tested through the APD battery with examples of tests used. 
Concerns have been expressed regarding the suitability of the tests included in the APD battery 
(Dillon et al., 2012; Moore, 2018), as the tests were initially developed in the 1970s and 1980s for 
the detection of brain tumours and cortical lesions in adults (Berlin, 1976; Musiek and Geurkink, 
1980). These AP tests typically carry a high cognitive load and therefore also measure language, 
attention and memory skills indirectly. As a result, a child with a language development problem 
might score poorly on the AP tests because of their poor language skills and not because of their 
poor auditory processing skills. Furthermore, the recommendations regarding what threshold to 
use to interpret APD-battery tests to reach a diagnosis also differ between the three auditory 
bodies: American Speech-Language and Hearing Association (ASHA), American Academy of 
Audiology (AAA) and BSA. The most commonly used diagnostic criteria is performance at or below 
2 standard deviations of the mean on at least two tests from the APD battery, or 3 standard 
deviations below the mean on one AP test (ASHA, 2005). The AAA recommends that these are 
met for at least one ear (AAA, 2010), while BSA suggests that at least one of the diagnostic tests 
should be non-speech stimuli so it does not depend on language skills (BSA, 2013). The lack of 
consensus has been highlighted by Wilson and Arnott (2013), who compared the diagnostic rates 
of APD in 150 children by using recommendations from BSA, AAA and ASHA and selected 
Main auditory processing areas tested: Examples of tests 
Dichotic processing 
(measures the ability to process information when a 
different stimulus is presented to each ear 
simultaneously) 
Dichotic Digit Test (DDT) 
Competing Sentence Test 
Temporal processing 
(assesses the ability to process nonverbal auditory 
signals and to recognise order or patterns) 
Frequency Pattern Test (FPT) 
Duration Pattern test (DPT) 
Perception of monoaural low redundancy speech 
(tests whether each ear can independently recognise 
distorted words) 
Filtered Speech Test 
Binaural interaction 
(tests integration of information using both ears) 
Masking Level Difference (MLD) 
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researchers in the APD field (Wilson and Arnott, 2013). The authors found that 7.3% of the 
children studied were diagnosed with APD under the strictest criteria compared to 96% using the 
most lenient criteria (when using the same traditional APD tests) (Wilson and Arnott, 2013). This 
further emphasised the heterogeneity of the disorder and the need for any diagnosis to be 
qualified by an explicit statement of the criteria used. 
The conventional hypothesis about the origin of APD is that it results from impaired bottom-up 
sensory processing within the central auditory system, which may involve lesions in CANS or 
functional impairment of basic auditory processing (Cacace and McFarland, 2005). The cochlea at 
the periphery is usually not included in this hypothesis, however, it should not be overlooked as 
considerable encoding of sound stimuli is carried out in the cochlea and transmitted via the 
auditory nerve and so synaptic damage preferentially involving low-SR auditory neurons after 
noise damage, is thought to explain problems with understanding speech in background noise 
(Furman, Kujawa and Liberman, 2013). Moreover, impaired hair cell function and resulting 
changes in cochlear compression can influence spectral and temporal tuning to some extent 
independently of pure tone sensitivity (Oxenham and Bacon, 2003). Other researchers argue that 
APD is a multi-modal deficit or even entirely cognitive, incorporating higher order functions, such 
as cognition, attention and language, exerting non-specific effect on perception (Musiek, Bellis 
and Chermak, 2005; Moore et al., 2010).  
1.2.3. Genetic studies 
Twin studies have shown that both speech and non-speech based auditory processing skills have a 
substantial genetic component (Morell et al., 2007; Brewer et al., 2016). Identifying candidate 
genes specific to APD has proven difficult not only due to the diagnostic controversies (highlighted 
in Section 1.2.2), but also due to its frequent co-occurrence with other neurodevelopmental 
conditions, making it challenging to disentangle genetic relationships. Nevertheless, mouse 
models of disrupted genes, known to play a role in other neurodevelopmental disorders such as 
dyslexia, Developmental Language Disorders (DLD) and ASD, have given an insight into candidate 
genes for auditory processing deficits. For example, Guidi et al. identified an impairment in 
behavioural gap-in-noise detection task in double knock-out of the dyslexia susceptibility mouse 
gene Kiaa0319 and its homologous gene Kiaa0319L, indicating a deficit in the auditory system 
(Guidi et al., 2017). Felix et al., studied the contribution of Chrna7 to auditory processing in knock-
out α7-nAChR mice, showing delays of evoked ABR responses, impaired forward masking and 
impaired gap detection (Felix et al., 2019). Human CHRNA7 has been further associated with 
reading and language skills and SLI in genome-wide association studies (GWAS) (Pettigrew et al., 
2015; Simpson et al., 2015; Gialluisi et al., 2016).  
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In two studies Cntnap2 mutant mice showed reduced vocalisations and an impaired temporal 
auditory processing (Peñagarikano et al., 2011; Truong et al., 2015). In humans homozygous 
mutations of CNTNAP2 lead to severe disease, characterised by profound intellectual disability, 
epilepsy, language difficulties and autistic traits (Strauss et al., 2006; Rodenas-Cuadrado et al., 
2016), while multiple studies have identified other variants to be associated with increased risk 
for ASD and language-related disorders (Vernes et al., 2008; Alarcón et al., 2008; Arking et al., 
2008). Scott et al. showed that a new Cntnap2 knock-out rat model had typical hearing thresholds 
but reduced auditory evoked neural responsivity and slowed signal transmission in juvenile 
animals (Scott et al., 2018). By adulthood the disruptions in auditory signal processing mostly 
disappeared, indicating a delayed maturation of auditory processing pathways (Scott et al., 2018). 
However, disruptions in brainstem-mediated auditory evoked behaviour persisted in adulthood, 
suggested that early developmental disruptions in sensory processing can cause permanent 
defects in circuitries responsible for auditory reactivity (Scott et al., 2018). 
A further insight into potential genetic regions and candidates for APD can also be gained from 
family genetic studies, with only one study in the literature and no GWAS or sequencing studies of 
APD available. Addis et al. investigated auditory processing as a core deficit of language 
impairment by performing genome-wide linkage analysis on a three-generation German family 
(NE family) (Addis et al., 2010). The results suggested that a gene within the central region of 
chromosome 12 is likely linked to the auditory processing difficulties (Addis et al., 2010). Although 
a potential “causal” variant was not identified with the techniques available at the time, the study 
proposed that APD could follow a simple inheritance pattern, where a damaging variation within 
one gene can have a direct influence on auditory processing difficulties. 
1.3. Disorders of syndromic hearing loss and the example of 
Usher Syndrome 
1.3.1. Definition and prevalence 
Usher syndrome (USH) is an autosomal recessive genetic disorder that causes hearing and vision 
loss and occasional balance problems (Keats and Corey, 1999). Although considered collectively 
rare with an estimated prevalence of between 4 and 17 in 100,000 people worldwide (Kimberling 
et al., 2010; Boughman, Vernon and Shaver, 1983), it is the most common cause of combined 
hearing and vision loss, accounting for approximately 50% of all deaf-blindness cases (Keats and 
Corey, 1999).  
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1.3.2. Usher Syndrome Types 
Based on the clinical symptoms, relating to severity and age of onset, and the presence or 
absence of balance problems, USH patients are classified into clinical types. Types I to III are the 
more well described ones, with both a newer type IV and atypical cases also reported (Table 1.4). 
1.3.2.1. Usher Syndrome Type I 
Usher syndrome type I (USH1) is the most severe of the three USH types. It is characterised by 
severe to profound deafness from birth affecting both ears, known as congenital bilateral 
sensorineural hearing loss (SNHL- affecting the inner ear) (Lentz and Keats, 1993b) (Table 1.4). 
Affected children who receive cochlear implants at an early age (within the first 2 years of life) can 
usually communicate using speech and lip-reading (Lentz and Keats, 1993b). Poor balance from 
birth, known as vestibular areflexia, is associated with the deafness and causes delays in sitting 
and walking (Lentz and Keats, 1993b) (Table 1.4). Loss of side vision and night blindness are early 
signs of retinitis pigmentosa (RP) which can manifest before the age of 10 (Lentz and Keats, 
1993b) (Table 1.4). RP is a progressive, symmetric degeneration of the retina, affecting both eyes, 
which starts at the periphery, mainly disturbing the function of the photoreceptive cells active in 
dark-adapted state (rod cells). 
1.3.2.2. Usher Syndrome Type II 
Usher syndrome type II (USH2) is the most common form of the disorder, representing around 
half of all cases (Reiners et al., 2006). It is less severe than type I and causes a moderate bilateral 
SNHL from birth and RP that may not become apparent until adulthood (Lentz and Keats, 1993a) 
(Table 1.4). The hearing loss is mild to moderate in the low frequencies (for the sounds that are 
low-pitched) and severe to profound in the higher frequencies (sounds that are high pitched) 
(Lentz and Keats, 1993a) (Table 1.4). The rate and degree of hearing loss is variable among and 
within families with progressive PR and visual symptoms diagnosed around the third decade of 
life (Blanco-Kelly et al., 2015) (Table 1.4). Balance is not affected and so walking and sitting is 
developed at typical age (Table 1.4). Children affected by USH2 benefit from conventional hearing 
aids and often have close to normal speech acquisition. With progression of hearing loss, cochlear 
implants have shown to increase speech intelligibility, quality of life and communication in later 
life (Hartel et al., 2017). 
1.3.2.3. Usher Syndrome Type III 
Usher syndrome type III (USH3) is the mildest and rarest form in the UK, but is particularly 
prevalent in Finland and among Ashkenazi Jewish people (Pakarinen et al., 1995; Ness et al., 
2003). Children usually have normal hearing and vision at birth and develop SNHL after 
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development of speech (usually detected in the first decade of life) and RP in adulthood (Keats 
and Corey, 1999) (Table 1.4). Hearing loss is of progressive nature with high frequencies affected 
first and more severely around the first decade of life and patients still showing some residual 
hearing at the lower frequencies at 40 years or older (Sadeghi et al., 2005). Balance problems are 
experienced by some with most patients reporting a normal age of independent walking (Sadeghi 
et al., 2005). Hearing aids can be of benefit early in the course of disease while cochlear implants 
have been found beneficial later on in life as hearing loss progresses (Pietola et al., 2012) 
1.3.2.4. Usher Syndrome Type IV and atypical Usher Syndrome 
Although clinically divided into three types, atypical cases having incompatible phenotypes with 
the three established types are also described in the literature. For example, Khateb et al. 
described a family with an atypical form of USH (later designated as USH4), inherited in the typical 
autosomal recessive manner, but presenting with a distinctive retinal degeneration phenotype 
(resulting in ring scotoma) and moderate to severe SNHL, both with a late onset (around the age 
of 40), without vestibular involvement (Khateb et al., 2018) (Table 1.4). The cause was a 
homozygous mutation in ARSG (Table 1.4) (further described in Section 1.3.3.2), not previously 
associated with Usher Syndrome or any other disorder.  
Variants in well characterised USH genes (MYO7A, USH2A, CDH23 and SARS) have also been 
associated with atypical clinical presentations of milder symptoms. In two consecutive studies Liu 
et al. described two siblings with bilateral progressive hearing loss and mild RP and another four 
unrelated individuals with progressive SNHL, RP, and variable vestibular function (vestibular 
dysfunction was in one individual only), symptoms most closely related to USH3 (Liu et al., 1998; 
Liu et al., 1999). The siblings in the first study were compound heterozygous for pathogenic 
variants in MYO7A, typically related to syndromic USH1B (Liu et al., 1998). The four individuals in 
the second study had a pathogenic variant in USH2A (homozygous in three individuals and 
heterozygous in one individual), typically associated with USH2 (Liu et al., 1999) and not USH3 as 
was expected by the mild symptoms in the two studies. Atypically milder phenotypes have also 
been described in cases with pathogenic variants in CDH23 (homozygous or compound 
heterozygous splice-site) and SANS (homozygous deletion and homozygous missense), expected 
to cause severe USH1 symptoms, but presenting with no obvious vestibular dysfunction, mild 
retinal symptoms and moderate to severe hearing loss, resembling an USH2 diagnosis (Bashir, 
Fatima and Naz, 2010; Kalay et al., 2005; Bork et al., 2001; Valero et al., 2019). These atypical 
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(# 276900) USH1B MYO7A (* 276903) myosin VIIa actin-based motor protein 
Congenital, severe to 
profound 
Prepubertal onset; 
average age of 








(Weil et al., 1995) 
(# 276904) USH1C USH1C (* 605242) harmonin PDZ scaffold protein (Verpy et al., 2000) 
(# 601067) USH1D CDH23 (* 605516) cadherin 23 cell adhesion (Bolz et al., 2001) 
(# 602083) USH1F PCDH15 (* 605514) protocadherin 15 cell adhesion (Ahmed et al., 2001) 
(# 606943) USH1G 
USH1G/SANS  
(* 606943) 
SANS scaffold protein (Weil et al., 2003) 





(# 276901) USH2A USH2A (* 608400) usherin Cell adhesion & signalling 
Congenital moderate 
to severe; high 
frequencies most 
affected 
Onset in second 
decade; average age of 




(Eudy et al., 1998) 
(# 605472) USH2C 
ADGRV1/GPR98 
 (* 602851) 
GPR98/VLGR1 
adhesion G-protein coupled 
receptor VI, signalling 
(Weston et al., 2004) 
(# 601067) USH2D 
WHRN/ DFNB31  
(* 607928) 





(# 276902) USH3A CLRN1 (* 606397) clarin-1 




Variable onset, typically 
in second decade 




HARS (* 142810) 
histidyl tRNA 
synthetase 
synthesis of histidyl-transfer 
RNA 




ABHD12 (* 613599) 
alpha/beta hydrolase 
domain containing 12 
catalyses the hydrolysis of 2-
arachidonoyl glycerol 





(# 618144) -  ARSG (* 610008) Arylsulfatase G hydrolyse sulfatase esters, 
located in lysosome 
Progressive moderate 
to severe 
Late onset retinal 
degeneration 
Normal 
(Khateb et al., 2018; Abad-
Morales et al., 2020) 
Digenic cases 




PDZD7 (* 612971) 
PDZ domain-
containing protein 7 
ciliary protein Typical for USH2 Earlier onset of RP Normal (Ebermann et al., 2010) 
Atypical -  CEP250 (* 609689) CEP2 centrosome cohesion during 
interphase 
Progressive Mild RP Normal 
(Khateb et al., 2014; Fuster-
Garcia et al., 2018) 





maintenance and vision 
Normal AR RP Normal (Khateb et al., 2014) 
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1.3.3. Implicated genes 
Usher Syndrome is a not only clinically, but also genetically heterogeneous and to date 16 genes 
have been associated with it (Table 1.4). The numbering system in the Usher Syndrome 
classification (USH1, USH2 and USH3) corresponds to the associated severity of the clinical 
presentation. Each type is split into subtypes, labelled with letters, which indicate the molecular 
subtype (Table 1.4). 
Ten of the USH genes are classed as causative of typical Usher syndrome: MYO7A, USH1C, CDH23, 
PCDH15, USH1G, CIB2 causing USH1; USH2A, ADGRV1, WHRN causing USH2 and CLRN1 causing 
USH3 (Table 1.4). The remaining genes can be classed as USH-related or atypical as the symptoms 
of affected individuals do not fully match the three typical clinical types of USH (explained in 
Section 1.3.2) or the genes have only been detected in a very small number of individuals: PDZD7, 
CEP250, C2orf72, ARSG, HARS and ABHD12 (Table 1.4). To date all pathogenic variants within the 
causative genes of typical USH have been reported as homozygous or compound heterozygous 
(inherited in an autosomal recessive model). 
1.3.3.1. Usher Syndrome causative genes  
1.3.3.1.1. USH1 causative genes 
USH1B (# 276900), caused by mutations in MYO7A, is the most common type of USH1, accounting 
for 55-75% of USH1 cases and about 21% of all USH cases (Le Quesne Stabej et al., 2012; Roux et 
al., 2006) (Figure 1.5). MYO7A also harbours mutations causing both recessive (DFNB2) and 
dominant (DFNA11) nonsyndromic deafness and atypical USH (as discussed in Section 1.3.2.4) (Liu 
et al., 1998; Liu et al., 1997c; Liu et al., 1997a; Weil et al., 1997). Pathogenic MYO7A variants 
appear to be spread across the whole gene sequence, with a cluster forming at the motor head 
protein domain and another cluster in the tail (Liu et al., 1998). With the exception of the 
DFNA11-causing mutation c.2662_2670del (p.Lys888_Lys890del), affecting the coiled-coil region, 
there appears to be no obvious correlation between mutations and the resulting phenotype. 
Heterozygous mutations in the coiled-coil region, responsible for the dimerisation of the protein, 
have been proposed to result in dominant hearing loss because of a dominant-negative effect (Liu 
et al., 1998), with affected individuals showing less severe post-lingual hearing loss compared to 
USH2B and DFNB2 (Liu et al., 1997b). The pathogenic variants c.93C>A (p.Cys31Ter) is a major 
recurring MYO7A variant causing USH1B, which has been described as a founder mutation, 
accounting for 33% of all USH1 cases in Denmark (Dad et al., 2016).  
Pathogenic variants in CDH23, PCDH15 and USH1C are responsible for USH1D (# 601067), USH1F 
(# 602083) and USH1C (# 276904) respectively (Oshima et al., 2008; Jouret et al., 2019; Roux et 
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al., 2006) (Figure 1.5). Mutations within the three genes are also implicated in nonsyndromic 
autosomal recessive deafness (DFNB12 for CDH23, DFNB23 for PCDH15 and DFNB18A for USH1C) 
(Bolz et al., 2001; Bork et al., 2001; Ahmed et al., 2001; Ahmed et al., 2003; Verpy et al., 2000). A 
genotype-phenotype correlation has been shown for CDH23 and PCDH15: null variants (stop-gain, 
some splice site and frameshift) which result in truncating USH1 proteins are responsible for the 
occurrence of USH1, whereas missense and some splice site mutations that do not truncate the 
protein lead to milder phenotypes associated with DFNB (Doucette et al., 2009; Astuto et al., 
2002; Schultz et al., 2011). This has led to the hypothesis that the residual function of USH1 
proteins in DFNB “spares” retinal and vestibular function in patients. CDH23 pathogenic variants 
have been found across the gene, affecting all protein domains, except for the signal domain, with 
clustering in the region encoding the EC domain (Astuto et al., 2002). The most frequent CDH23 
pathogenic variant is the splice-site c.336+1G>A, which has been exclusively observed in Swedish 
USH1D individuals and has thus been suggested as a founder mutation (Astuto et al., 2002; 
Oshima et al., 2008). The most common PCDH15 variant is c.733C>T (p.Arg245Ter), which is 
specific to the Ashkenazi Jews and is the predominant cause of USH1 in that population (Ben-
Yosef et al., 2003). Pathogenic variants in USH1C are a relatively rare cause of USH, with the 
exception of the Acadian population, where USH1C mutations represent the most common cause 
of USH1 with c.238dup (p.Arg80ProfsTer69) exhibiting highest prevalence, suggesting a founder 
effect (Verpy et al., 2000; Zwaenepoel et al., 2001; Ouyang et al., 2005).  
Pathogenic variants in USH1G (also known as SANS), responsible for USH1G (# 606943), are the 
rarest cause of USH1 (Bonnet et al., 2011; Jouret et al., 2019; Le Quesne Stabej et al., 2012) 
(Figure 1.5). The nonsense variant c.113G>A (p.Trp38Ter) has been reported in six USH1G cases in 
three independent USH genetic screens, making it the most frequent USH1G mutation (Ouyang et 
al., 2005; Bonnet et al., 2011; Bujakowska et al., 2014).  
CIB2 is the causative gene of USH1J (# 614869). To date, a total number of 13 pathogenic variants 
(including a CNV, missense, frameshift and splicing variants) have been reported in CIB2. Of those, 
only one variant (c.192G>C, p.Glu64Asp) is linked to USH1J while the rest are associated with 
autosomal recessive hearing loss (DFNB48) (Booth et al., 2018; Riazuddin et al., 2012). The 
missense variant c.192G>C was identified in homozygous state in four individuals from a single 
consanguineous Pakistani family diagnosed with USH1J (Riazuddin et al., 2012). The role of CIB2 
variants as disease causing in USH1J has been challenged by Booth et al., who reported four more 
novel CIB2 pathogenic variants (three were loss of function and one was a missense) in families 
from diverse origins, all causing DFNB48 (Booth et al., 2018), providing evidence to disqualify CIB2 
as an USH-causing gene. Yet, because of the private pathogenic variant causing USH1J in the 
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Pakistani family, CIB2 is included in some genetic studies when investigating Usher syndrome’s 
molecular basis (Aparisi et al., 2014). 
1.3.3.1.2. USH2 causative genes 
Pathogenic variants within USH2A can explain the symptoms of up to 85% of USH2 patients and 
about 50% of all USH cases (Jouret et al., 2019) (Figure 1.5), making it the most common cause of 
Usher Syndrome. USH2A pathogenic variants cause USH2A (# 276901). Mutations are spread 
throughout the gene with missense variants being the most common type (Baux et al., 2014; 
Lenassi et al., 2015). The majority of disease-causing USH2A variants are extremely rare, except 
the ancestral pathogenic variant c.2299delG (p.Glu767SerfsTer21), which accounts for 15-31% of 
USH2 cases in European patients (Dreyer et al., 2008; Garcia-Garcia et al., 2011; Le Quesne Stabej 
et al., 2012). The USH2A variant c.2276 G>T, (p.Cys759Phe), also commonly found in patient 
cohorts, has been mainly associated with eye phenotypes (Rivolta et al., 2000; Bernal et al., 2003), 
proposing the existence of USH2A alleles that are retinal-disease specific. In a more recent study, 
investigating 186 individuals with recessive retinal disease and no childhood hearing complaints, 
the allelic hierarchy was evidenced by six USH2A alleles that were associated with nonsyndromic 
retinal disease only (defined as “retinal disease-specific”) and were proposed to be likely 
phenotypically dominant to USH2 alleles (so the presence of at least one retinal disease specific 
USH2A allele would likely result in preservation of hearing) (Lenassi et al., 2015). 
ADGRV1 (also known as GPR98, VLGR1 and previously- MASS1) pathogenic variants cause USH2C 
(# 605472). ADGRV1 mutations are the second most common cause of USH2, accounting for 
about 6% of USH2 cases and about 5% of all USH cases (Le Quesne Stabej et al., 2012; Jouret et 
al., 2019) (Figure 1.5). To date about 106 ADGRV1 variants are classed as presumed pathogenic 
(LOVD-USHBase, accessed 4 July 2020). It needs to be noted that from the reported pathogenic 
ADGRV1 variants, not all are causative of USH with studies suggesting association of ADGRV1 to 
febrile seizures and epilepsy (Nakayama et al., 2002; Coll et al., 2017). Reported ADGRV1 
mutations causing USH1C appear to be spread along the whole sequence with a cluster emerging 
in the terminal end and mutations predominantly resulting in a truncated protein product 
(Besnard et al., 2012). In contrast to USH2A cases, no major recurrent mutations have been 
identified for USH2C (Besnard et al., 2012). 
WHRN (also known as DFNB31) was first linked to nonsyndromic deafness in two families (Mburu 
et al., 2003) with its involvement in USH was later demonstrated by Ebermann et al. in a family 
with typical USH2 symptoms (Ebermann et al., 2007). To date only four pathogenic variants have 
been linked to USH2D, all located towards the start of the gene (between exon 1 and exon 3) 
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(Ebermann et al., 2007; Besnard et al., 2012), showing that WHRN pathogenic variants account for 
a very small proportion of USH2 cases (Figure 1.5).  
Some genotype-phenotype correlations have been suggested for USH2 genes. In a study analysing 
the audiological findings in 100 USH2 patients, Abadie et al. found that as a group the ADGRV1- 
caused USH2 cases had a higher proportion of severe hearing loss (40%), compared to USH2A 
cases (16%) (Abadie et al., 2012). Although this was not statistically significant, it suggests that 
ADGRV1 pathogenic variants are likely to result in more severe hearing symptoms than USH2A 
pathogenic variants in patients with USH2.  
1.3.3.1.3. USH3 causative genes 
CLRN1 pathogenic variants are the main cause of USH3, explaining about 2% of all USH cases 
(Figure 1.5) (Jouret et al., 2019; Joensuu et al., 2001). The missense variant c.144T>G (p.Asn48Lys) 
is relatively common and detected in Ashkenazi Jewish population (Fields et al., 2002). CLRN1 
pathogenic variants are also implicated in nonsyndromic recessive retinitis pigmentosa 61 (Khan 
et al., 2011) with less severe (missense) CLRN1 variants, representing hypomorphic mutations and 
preserving hearing. 
 
Figure 1.5. Frequency of causative mutations in patients presenting with both SNHL and RP suggesting 




1.3.3.2. Usher Syndrome atypical and rare genes 
PDZD7, encoding PDZ domain-containing 7 scaffolding protein, was first proposed as a prime 
candidate for USH syndrome due to its sequence similarity with the causative USH genes USH1C 
and WHRN (Schneider et al., 2009). Next, Ebermann et al. reported the first clinical cases 
diagnosed with USH2 to carry pathogenic variants in PDZD7 (Ebermann et al., 2010). In one family 
the authors reported a heterozygous frameshift mutation in PDZD7 detected in the presence of a 
homozygous truncating USH2A mutation in an USH2 affected individual with more severe retinal 
phenotype than their USH2 sister, suggesting that PDZD7 has a modifying effect on retinal disease 
(Ebermann et al., 2010). In another family a heterozygous truncating PDZD7 mutation was found 
in and USH2 affected individual with a heterozygous frameshift mutation in ADGRV1, indicating 
digenic inheritance (instead of the typical monogenic inheritance in USH) (Ebermann et al., 2010). 
The role of PDZD7 in USH is further supported by evidence that PDZD7, USH2A, ADGRV1 and 
WHRN interact in vivo and in vitro to form an USH2 complex (Zou et al., 2014; Zou et al., 2015; 
Chen et al., 2014).  
HARS codes for histidyl tRNA synthetase which charges tRNA molecules with histidine amino acids 
for protein translation (Antonellis and Green, 2008). The gene was proposed as a novel USH3 
player as a result of an exome sequencing study of Old Order Amish and Mennonite (Plain) 
children, descendants of Swiss immigrants (Puffenberger et al., 2012). A homozygous missense 
pathogenic HARS variant was identified in two individuals, diagnosed with USH3 and presenting 
with progressive sensorineural hearing loss, retinitis pigmentosa and episodic psychosis 
(Puffenberger et al., 2012). Different HARS compound heterozygous missense pathogenic variants 
were identified in another Swiss individual, diagnosed with Usher Syndrome (unspecified type) in 
a later study (Tiwari et al., 2016). The HARS variant identified by Puffenberger et al. was shown, in 
vitro to cause a reduction in the thermal stability of the protein (Abbott et al., 2017). The role of 
HARS in the inner ear and retina has not been elucidated, therefore, the role of HARS as a typical 
USH3 causing gene requires further investigation.  
CEP250 encodes centrosomal protein 250 (CEP250 or CNAP1), which is a member of CEP family of 
centrosome-associated proteins (Kumar et al., 2013). C2orf71, also known as PCARE, codes for 
photoreceptor cilium actin regulator protein PCARE and is a known retinitis pigmentosa causing 
gene (Collin et al., 2010; Nishimura et al., 2010). Homozygous stop-gain mutations in both CEP250 
and C2orf71 (double homozygotes) were identified in three siblings from a consanguineous family 
of Iranian Jewish origin, who had hearing loss and an early onset severe PR (Khateb et al., 2014). 
Three other siblings from the same family presented with a milder retinal phenotype and were 
found to be homozygous for the CEP250 mutation, but heterozygous for the C2orf71 mutation. It 
was thus concluded that the severe retinal involvement in the double homozygotes indicated a 
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potential additive effect on retinal burden, caused by nonsense mutations in the 2 genes 
occurring within the same cell (and possibly having an impact on the same photoreceptor region). 
In a later study Kubota et al. identified compound heterozygous mutations in CEP250 in a 
Japanese family with cone-rod dystrophy and SNHL while Fuster-Garcia et al. detected two novel 
stop-gain CEP250 mutations in a compound heterozygous state in an individual with symptoms 
similar to the Japanese family (Fuster-Garcia et al., 2018; Kubota et al., 2018). Interactions with 
other USH proteins and how CEP250 and PCARE function in the inner ear and eye are areas still 
open to investigation. 
ABHD12 (α/β-hydrolase domain containing 12) is a membrane-embedded serine hydrolase, which 
catalyses the hydrolysis of 2-arachidonoyl glycerol and is a known causal gene for 
polyneuropathy, hearing loss, ataxia, retinitis pigmentosa and early onset cataract (PHARC). Stop-
gain homozygous ABHD12 mutations were identified in two siblings from a consanguineous 
Lebanese family and later in two siblings from a Chinese family, all clinically diagnosed with USH3 
(Eisenberger et al., 2012; Li et al., 2019). A homozygous splice site mutation was detected in two 
other cases, where the individuals were originally thought to be affected by Usher Syndrome, but 
associated PHARC symptoms of dysfunctional central and peripheral nervous system made a 
PHARC diagnosis more plausible (Yoshimura et al., 2015). All three authors emphasised that Usher 
Syndrome and PHARC have overlapping symptoms and phenotypic variability. ABHD12 is known 
to be expressed in the retina but its expression in the inner ear would need to be investigated to 
support the role of ABHD12 in USH3.  
ARSG (arylsulfatase G) encodes a member of a class of enzymes called sulfatases, responsible for 
hydrolysing ester- sulphate bonds, and playing a role in a variety of biochemical processes 
(Ferrante et al., 2002). Khateb et al. described 5 patients from three Yemenite Jewish Families 
with an atypical form of Usher syndrome, later designated as USH4 and characterised by 
distinctive retinal degeneration (involving a ring scotoma) and usually late-onset of progressive 
sensorineural hearing loss without vestibular involvement (Khateb et al., 2018). The authors 
reported a homozygous ARSG missense mutation which segregated with the disorder in the 
families (Khateb et al., 2018). A different homozygous ARSG missense mutation, a homozygous 
frameshift deletion and two compound heterozygous missense mutations, were recently 
described in three further cases, presenting with clinical features closely resembling the USH4 
phenotype described by Khateb et al. (Abad-Morales et al., 2020; Peter et al., 2020). Khateb et al. 
and Peter et al. further demonstrated that the ARSG mutations in their studies abolished enzyme 
function and the gene was expressed in the human retina (Khateb et al., 2018), while Girotto et al. 
showed Arsg expression at the top of hair cells in mouse cochlea (Girotto et al., 2014). Knock-out 
homozygous Arsg mice show retinal degeneration and behavioural dysfunction suggesting 
systematic effects (Kruszewski et al., 2016). Ingham et al. showed that knockdown of Arsg in mice 
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did not cause any detectable auditory dysfunction (Ingham et al., 2020). However, that could be 
because hearing was tested in mice aged 14 weeks old (Ingham et al., 2020) while Khateb et al. 
found that the onset of hearing loss was relatively late in the reported patients (Khateb et al., 
2018). Possible interactions with the other USH proteins have not been yet explored.  
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1.3.4. Role of Usher proteins in the inner ear 
The ten USH causative genes code for proteins with a wide range of functions: actin-binding 
molecular motors (myosin VIIa encoded by MYO7A), cell adhesion proteins (cadherin 23, 
protocadherin 15 and usherin encoded by CDH23, PCDH15 and USH2A respectively), scaffolding 
proteins (harmonin, SANS and whirlin encoded by USH1C, USH1G and WHRN respectively), an 
adhesion G-coupled receptor (ADGRV1/GPR98 encoded by ADGRV1), calcium and integrin binding 
protein (CIB2 encoded by CIB2) and transmembrane protein involved in scaffolding and cellular 
trafficking (clarin-1 encoded by CLRN1). These proteins form complexes and function 
cooperatively in both the inner ear hair cells and retinal photoreceptor cells. As this thesis focuses 
on hearing and audition, only the role of Usher proteins within the cochlea will be discussed.  
Their role in the retina is reviewed elsewhere (Kremer et al., 2006; Cosgrove and Zallocchi, 2014). 
Most of the USH proteins (except CIB2 and clarin-1) are directly involved in the formation of links 
that hold stereocilia together and therefore play key roles in the morphogenesis of the hair 
bundle as summarised in the following sections. 
1.3.4.1. Morphogenesis of the hair bundle within the inner ear 
The inner ear stereocilia on the IHC and OHCs are organised in bundles, called stereociliary 
bundles which are important for transducing mechanical sound stimuli into electrical signals and 
essentially for sound perception. At the onset of hair bundle formation (as defined in the chick by 
Tilney et al.), the apical surface of each hair cell is covered with microvilli, which consist of parallel 
actin filaments held together by a set of actin-bundling proteins (Figure 1.6a) (Tilney, Tilney and 
DeRosier, 1992). The microvilli grow in length and form stereocilia of similar length, while one 
single kinocilium (primary cilium) is in the centre of the surface (Figure 1.6b). The kinocilium then 
moves to the periphery (lateral edge) of the hair cell, dictating the orientation of the hair bundle 
(i.e. its planar polarity) (Figure 1.6c). Next, the stereocilia closest to the kinocilium start to grow 
longer (Figure 1.6c), which is followed by elongation of stereocilia in adjacent rows, forming a 
staircase pattern of height-ranked rows (Figure 1.6d). The stereocilia then stop growing in length 
but grow in width and then again in length until they reach their final length (Figure 1.6d). The 
processes of elongation and widening of stereocilia are separated in chick but occur in parallel in 
mammals. Finally, excess microvilli on the apical surface are reabsorbed (Figure 1.6e). Upon 
maturation the stereocilia in each bundle are arranged into three rows of increasing length and 
the kinocilium (which during early development is positioned next to the longest stereocilia), is 
lost during the early stages of postnatal development and before the onset of hearing in 
mammalian cochlea (Figure 1.6f). The graded height across the rows of stereocilia (Figure 1.6e) is 
central to their transduction ability. This is because tension on the sloping tip links connecting the 
tops of stereocilia (discussed below) controls the opening probability of the mechanoelectrical 
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transducer (MET) channels which are located at the tips of the short- and middle-row stereocilia 
(Figure 1.6g) (Gillespie and Müller, 2009; Beurg et al., 2009). Bending of the bundle towards the 
tallest row increases tension on tip links and channel conductance whereas deflection the 
opposite way (away from the tallest row) decreases channel conductance (Figure 1.6g), which is 
known as directional sensitivity (Shotwell, Jacobs and Hudspeth, 1981). This directional sensitivity 
is established along the epithelial plane and as a result the apical cytoskeleton in individual hair 
cells is planar polarised leading to the typical V-shaped stereocilia bundle and the off-centre 
position of the kinocilium (Figure 1.6h). Neighbouring hair cells also orient their hair bundles in 
the same direction, to presumably respond in a coherent manner to shared local stimuli (Figure 
1.6h). This cell-to cell communication property is known as planar cell-polarity (PCP). Planar 
polarity mechanisms thus act at two levels (single-cell and intercellular) to provide the specific 




Figure 1.6. Hair bundle development, mechanotransduction and planar polarity (adapted from (Schwander, Kachar and Müller, 2010; Frolenkov et al., 2004) and 
https://www.tarchini-lab.org/ 
a) at the onset of stereocilia formation the apical hair cell surface contains microvilli and one kinocilium; b) the microvilli grow in length; c) the kinocilium moves to 
the lateral edge of the hair cell; d) microvilli grow in width and reach their final length; e) excess microvilli are reabsorbed; f) scanning electron microscopy of mature 
OHC bundle that shows the staircase organisation of the  three stereocilia rows (scale bar: 1µm); g) deflection of hair bundles in the direction of the longest 





1.3.4.2. Stereocilia links and Usher proteins in development 
During the stereocilia morphogenesis and growth and in adulthood, the stereocilia stay together 
through fibrous inter-stereociliar links and links with the kinocilium. By keeping the stereocilia and 
kinocilium together in a bundle, these links maintain the stereociliary cohesion, which is essential 
for bundle development, maintenance and function (Goodyear et al., 2005; Michalski et al., 
2007). Developing cochlear hair cells in mice show kinociliary links, transient lateral links and 
ankle links (during embryonic and early postnatal development), whereas functionally mature 
cochlear cells contain tip links and horizontal top connectors (Goodyear et al., 2005) (Figure 1.7). 
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Figure 1.7. Stereociliary links in the hair bundle through development (a), molecular components of the tip links and mechanotransduction complex (b) and components of the 
ankle link complex (c) (adapted from (Mathur and Yang, 2015; Schwander, Kachar and Müller, 2010; Michalski et al., 2007; Richardson and Petit, 2019; El-Amraoui and Petit, 2014). 
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1.3.4.2.1. Kinociliary and transient lateral links 
The kinociliary links connect the longest row of stereocilia to the kinocilium (Figure 1.7a) and are 
present only transiently in mammal cochlea, disappearing with the kinocilium shortly after birth. 
As the kinocilium is crucial for establishing the hair bundle polarity, the kinociliary links are 
thought to be essential for ensuring the kinocilium and the stereociliary bundle are coordinated 
within the hair bundle during early development. Transient lateral links also form during the early 
stages of development, recorded as early as embryonic day (E) 17.5 (Goodyear et al., 2005), and 
are the first links to interconnect the stereocilia along their entire length (Figure 1.7a). These 
lateral links become progressively restricted towards the distal end of the stereocilia forming 
apical lateral links in postnatal development (Figure 1.7a). The apical lateral links are also thought 
to become integrated into the links at the very tip of the stereocilia (tip links) in mature bundles 
(Goodyear et al., 2005; Richardson and Petit, 2019) (Figure 1.7a). The USH1 proteins CDH23 and 
PCDH15 have been shown to be expressed in developing stereocilia and are both localised to 
kinociliary and transient links (Goodyear et al., 2010; Michel et al., 2005) (Figure 1.7a). 
1.3.4.2.2. Ankle links 
At postnatal day (P) 2, thin filaments called ankle links become concentrated at the bottom of the 
stereocilia (where they insert into the cuticular plate) (Goodyear et al., 2005) (Figure 1.7a). In the 
mouse these links are transient and are only detected until P12, disappearing before the onset of 
hearing (Goodyear et al., 2005). The USH2 proteins ADGRV1, usherin, and whirlin are all 
expressed at the base of the inner ear hair cells, detected in embryonic development (as early as 
E17 for ADGRV1 and E18 for usherin) and just after birth (as early as P1 for whirlin) (Michalski et 
al., 2007; Zou et al., 2014; Delprat et al., 2005). Because of the localisation of ADGRV1 and usherin 
and because they both have long extracellular regions, both proteins were suggested as 
components of the ankle link filaments (Figure 1.7c) (Adato et al., 2005a; McGee et al., 2006). 
Together with whirlin and PDZD7 (USH2 modifier), all USH2 proteins have been shown to interact 
with one another to form a multiprotein complex, known as USH2 or ankle link complex (ALC) 
(Figure 1.7c), which is located at the cytoplasmic region of the ankle links (Michalski et al., 2007; 
Zou et al., 2015). Another protein, vezatin (VZT), known to interact with myosin VIIa and usherin 
(Michalski et al., 2007), is also expressed around the base of mouse stereocilia and colocalises 
with ankle links (Figure 1.7c) (Küssel-Andermann et al., 2000). 
1.3.4.2.3. Horizontal top connectors 
Horizontal top connectors, also known as top links or side-to-side links first appear at P9 and 
continue to develop at P12 (when the ankle links disappear), attaining their mature appearance 
between P12 and P14 and becoming highly organised by P19 (Goodyear et al., 2005). In their 
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mature state, the horizontal connectors are zipper-like structures (due to the presence of a 
central density region), located near the tops of the stereocilia (Figure 1.7a) and connecting them 
within and across rows. The central density region has been observed in top connectors within 
cochlear OHCs, but not in IHCs (Goodyear et al., 2005; Tsuprun et al., 2003), showing that the 
structure of the links varies according to type of hair cells which is likely linked to their different 
function. In mice, a protein called stereocilin (STRC) has been shown to be associated with these 
links within OHCs, but has not been detected in IHCs (Verpy et al., 2011), and is thus thought to 
play a key role in the central density region. STRC is also linked to the tectorial membrane 
attachment crowns (Verpy et al., 2011), present at the tips of the tallest stereocilia of OHCs to 
couple them to the tectorial membrane above. 
1.3.4.2.4. Tip links 
Tip links, which connect the tips of the stereocilia between adjacent rows appear on the hair 
bundles of both OHCs and IHCs at the same time as ankle links (around P2), together with the 
tectorial membrane attachment crown and are still present in the mature OHC bundle at 
postnatal day P19 (Figure 1.7a) (Goodyear et al., 2005). The tip links play a major role in 
transmitting force to the MET channels (Figure 1.7b), which convert sound waves into an 
electrical signal (Kazmierczak et al., 2007; Michalski and Petit, 2015). Although the IHCs and OHCs 
have distinct roles (signal transmission for IHCs and frequency dependent amplification for OHCs), 
they both perform mechano-electrical transduction. Increasing evidence has shown that cadherin 
23 and protocadherin 15 make up the upper and lower part of the tip link respectively (Figure 
1.7b) (Siemens et al., 2004; Ahmed et al., 2006). Cadherin 23 binds to the upper tip link density 
region (UTLD) while protocadherin 15 binds to the lower tip link density (LTLD) region (Figure 
1.7b), which are protein-dense plaques that underlie the stereocilia membrane at each end of the 
tip link (Kachar et al., 2000). Protocadherin 15 has also been suggested to interact with TMC1 and 
TMC2, which are core components of the MET complex (Maeda et al., 2014; Pan et al., 2013). The 
three USH1 proteins myosin VIIA, SANS and harmonin localise to the UTLD of mature cochlear 
cells (Figure 1.7b) and form a complex responsible for anchoring cadherin23 to the actin 
cytoskeleton of stereocilia (Yan et al., 2010; Boeda et al., 2002). Out of the three proteins, it is 
harmonin which binds to cadherin 23 within the upper part of the tip links (Figure 1.7b) (Boeda et 
al., 2002), bridging cadherin 23 to the cytoskeletal actin core. Myosin VIIA is expressed along the 
stereocilia and the cuticular plate (Weil et al., 1995; Hasson et al., 1995) and as a motor protein is 
known to transport components of the actin assembling machinery to the tips of the stereocilia to 
regulate length, so it is also likely involved in the transport of other USH molecules (Rhodes et al., 
2004). SANS is highly concentrated below the cuticular plate (Adato et al., 2005b) and has been 
shown to bind harmonin and myosin VIIA (Figure 1.7b), and is required for localisation of 
harmonin to stereocilia tips (Lefèvre et al., 2008). The molecular composition of the LTLD region is 
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much less well characterised, however, it is thought that the region contains elastin filaments, 
important in adaptation to occur following the mechanical deflection of stereocilia in the 
direction of the tallest stereocilia (Figure 1.7b) (Eatock, 2000). Other proteins such as whirlin, 
myosin XVa (essential for stereocilia elongation), actin regulatory protein epsin8 and myosin IIIa 
might also take part in anchoring protocadherin 15 (Delprat et al., 2005; Manor et al., 2011; 
Schneider et al., 2006). 
1.3.4.2.5. Other USH proteins that may interact with stereocilia link proteins 
and are important hair bundle proteins 
The USH1 player calcium and integrin-binding protein-2 (CIB2) is a newly discovered member of 
the USH protein family. It has been shown to bind to the components of the hair cell 
mechanotransduction complex, TMC1 and TMC2 (Giese et al., 2017b). It has thus been suggested 
to play an essential role in mechanotransduction (Wang et al., 2017b) by being involved in limiting 
the growth of transducing shorter row stereocilia in mammalian auditory hair cells (Giese et al., 
2017b). Regulation of stereocilia length is likely to occur at their tips where CIB2 may bind to 
whirlin and be part of the myosin XVa/whirlin stereocilia elongation complex (Belyantseva et al., 
2005). The above findings together with results from Michel et al., propose that unlike the other 
five known USH1 proteins, functional CIB2 is not required to ensure the early cohesion and 
shaping of the growing auditory hair bundle but is necessary for the terminal differentiation and 
maturation stages (Michel et al., 2017).  
Similar to CIB2, the USH3 protein clarin-1 has not been detected to play a direct role in stereocilia 
link formation. However, there is compelling evidence of a link between CLRN1, actin and other 
USH proteins (such as myosin VIIa), supporting the role of clarin-1 as an essential hair bundle 
protein (Tian et al., 2009; Adato et al., 1999), required for the development or maintenance of the 
normal shape of the bundle (Geng et al., 2012). Similarly to the USH2 proteins, clarin-1 is detected 
at the base of both IHCs and OHCs during embryonic development (Zallocchi et al., 2009; Geng et 
al., 2009). Postnatally clarin-1 shows expression at the apical regions of hair cells, which 
disappears from the OHCs at P10, while a weak signal remains at the base of IHCs (Zallocchi et al., 
2009). Contrary to previous reports suggesting a possible role for clarin-1 in the sensory synapses 
of inner hair cells (Adato et al., 2002; Geng et al., 2009), mutant mice findings from Geng et al. 
demonstrate that Clrn1 is not required for the development or maintenance of ribbon synapse 
and is not essential in the hair cell presynaptic function (Geng et al., 2012). 
1.3.4.3. Usher proteins isoforms 
Many of the USH proteins are expressed as multiple isoforms (Figure 1.8) (as reviewed in (El-
Amraoui and Petit, 2005; Kremer et al., 2006). The protein isoforms are often expressed in specific 
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tissues and sub-cellular compartments and even in a tonotopic manner along the cochlea (as 
recently suggested for myosin VIIa) (Adato et al., 2005a; Li et al., 2020), which adds to the 
complexity of deciphering the function of the USH proteins. Harmonin is expressed in at least 
three isoform subclasses (a,b and c) that differ by the number of the PDZ domains and the 
presence or absence of a second coiled-coil domain (Figure 1.8) (Verpy et al., 2000; Boeda et al., 
2002). Cadherin 23 has at least three isoforms that all contain a cytoplasmic domain, but differ at 
the opposite C-terminus (Figure 1.8) (Lagziel et al., 2005). Three protocadherin 15 splice isoform 
classes (Pcdh15-CD1, Pcdh15-CD2 and Pcdh15-CD3), which differ in the C-terminal part of their 
cytoplasmic domain (Figure 1.8) have been shown to be present in the hair bundles of developing 
cochlear hair cells (Ahmed et al., 2006). Two whirlin isoforms (a longer-FL-whirlin and a shorter- C-
whirlin depending on the presence or absence of the PDZ domains 1 and 2 in the N-terminus of 
the protein) are detected in the inner ear (Figure 1.8) (Ebrahim et al., 2016) . The mouse Clrn1 is 
known to give rise to three protein isoform, of which isoform 1 and isoform 2 both contain four 





1.3.5. Pathological insights from mouse models of Usher syndrome 
1.3.5.1. Stereocilia defects resulting from dysfunctional Usher proteins 
USH1 mouse models of disrupted Myo7a, Ush1g, Chd23, Pcdh15 and Ush1c genes share hair 
bundle morphological defects including fragmentation and misorientation in embryonic 
development and abnormal staircase architecture postnatally (Lefèvre et al., 2008), whereas 
mouse models for Cib2 show similar bundle disruptions only postnatally (Table 1.5 & Figure 1.9) 
(Wang et al., 2017b; Giese et al., 2017b). The kinocilium in Myo7a, Cdh23, Pcdh15, Ush1g and 
Ush1c mutated mice appears mispositioned and often misplaced (Lefèvre et al., 2008; Di Palma et 
al., 2001). While the mutated USH1 stereocilia in OHCs form clumps and display abnormal length 
leading to loss of staircase architecture (Table 1.5 & Figure 1.9b), the IHCs stereocilia show to be 
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Figure 1.8. USH protein isoforms with predicted domain structures. Many of the proteins exist in multiple 
isoforms: three sub-classes of harmonin isoforms (a,b and c), three sub-classes of cadherin-23 (a,b and c), 
three main classes of protocadherin-15 (CD1-CD3), a secreted and a transmembrane form of usherin and two 




(Lefèvre et al., 2008; Alagramam et al., 2011). The stereocilia defects appear to be more severe as 
the mice grow older with loss of stereocilia observed by P15-P20 in Ush1c, Myo7a and Pcdh15 
mutated mice and at P30 for some Cib2-/ mice, which show loss of OHCs and fusion of IHCs 
stereocilia (Figure 1.9a) (Lefèvre et al., 2008; Self et al., 1998; Washington et al., 2005; Wang et 
al., 2017b). It is important to also note that the severity of the mutations for some USH1 models 
corresponds to the severity of cochlear pathology and hair cell development. For example, mice 
with in-frame deletions and missense mutations (as in Pcdh15avJ, Pcdh15av2J and Myo7ash1, 
Myo7a6j) have shown less disorganised stereocilia within the organ of Corti compared to same 
gene presumptive null alleles (Pcdh15av3J  and Myo7a4626SB) (Mburu et al., 1997; Kros et al., 2002; 
Pawlowski et al., 2006), suggesting a genotype-phenotype correlation. 
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Figure 1.9. SEM images of cochlear hair bundles from USH1 mice of different genotypes and ages (images adapted from (Kros et al., 2002; Tian et al., 2010; Holme 
and Steel, 2002; Washington et al., 2005; Wang et al., 2017b; Lefèvre et al., 2008) 
a) low-magnification SEM images of OHCs and IHCs of USH1 knock-out mice in bottom row (except Cdh23v/v where only OHCs bundles imaged), showing disordered 
arrangement of stereocilia on OHCs and only moderate disorganisation of IHCs stereocilia compared to controls; b) high magnification SEM images of OHC bundles of 
P5 USH1 mutant mice (view from the end of the apical cochlear turn) showing abnormal height of many stereocilia of the medium row and frequent absence of small 
stereocilia in mutant hair bundles compared to controls (Scale bar = 1µm) 
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While the disrupted function of USH1 proteins affects stereocilia early in embryonic development 
along the whole of the cochlea, knock-out mouse models of the USH2 genes show structural 
defects affecting the hair cell bundles in post-natal development, preferentially at the basal half 
of the cochlea (sensitive to high frequencies) (Table 1.6 & Figure 1.10b). Adgrv1 knock-out mice 
show the most severe USH2 stereociliary defects, that are also detected the earliest: disorganised 
OHC stereocilia bundles, stereocilia tilted at their base and forming U-shape (instead of a V-shape) 
plus significant loss of OHCs by 2 months of age (Table 1.6 & Figure 1.10a) (McGee et al., 2006; 
Michalski et al., 2007; Zou et al., 2015). Ush2a -/- mice show an intermediate phenotype of 
severity with distorted OHC bundle shape and loss of OHCs by 4 months of age (Table 1.6 & Figure 
1.10a-b) (Liu et al., 2007; Zou et al., 2017) and Whrn (also known as Dfnb31) mutated mice have 
least severely affected stereociliary bundle with various U-shaped OHC hair bundles observed at 
P15, leading to degeneration by P99-P102 (Table 1.6 & Figure 1.10a). The IHCs dysmorphology, on 
the other hand, shows to be less evident and only visible at high magnification (Zou et al., 2015). 
While according to Lui et al. the IHCs in Ush2a ¯/¯ mice were present throughout the cochlear 
spiral and appeared to be normal (Figure 1.10b) (Liu et al., 2007), Zou et al. showed that at high 
scanning electron microscope (SEM) magnification the IHCs bundle showed an additional ectopic 
(outside the bundle) stereocilia at the neural edge of the IHC apex (Figure 1.10a) (Zou et al., 
2015). This ectopic stereociliary phenotype was also present in Adgrv1-/- but not in Dfnb31neo/neo 
mice (Figure 1.10a). Both Adgrv1-/- and Dfnb31neo/neo mice had thicker IHC stereocilia than what 
was observed in wild-type mice, with IHCs lost by 2 months for Vlgr1/del7TM and by P99-P102 for 
Dfnb31wi/wi (Figure 1.10a) . The presence of ankle links in mutated USH2 mice has also been 
investigated, showing missing ankle links in Adgrv1-/-(McGee et al., 2006; Michalski et al., 2007) 
while they were present in Dfnb31neo/neo (Zou et al., 2015) and not studied in Ush2a -/-mice, 
suggesting that ADGRV1 is essential for the formation of the ankle links while whirlin is not and 
usherin is unknown.  
Consistent with the expression of clarin-1, Clrn1-/- knock-out mice also show bundle morphology 
defects in cochlear hair cells, that become more obvious by P2 and primarily affect OHCs along all 
turns of the cochlea while IHCs appear normal or mildly affected (Geng et al., 2009) (Table 1.6 & 
Figure 1.10c). Profound hearing loss is detected at P21 by which time a loss of OHCs is also 
observed, while IHCs appear to be missing at both basal and apical turn of the cochlea around P30 
(Geng et al., 2009). SEM in Clrn1-/- at P3-P4 shows that the disruption of hair bundle integrity is 
characterised by splits in the V-shaped bundle and loss of some of the tall stereocilia (Geng et al., 
2012) (Figure 1.10c). As tip links, the bundle orientation and the graded heights of the stereocilia 
in the hair bundles of Clrn1-/- mice are not affected (Geng et al., 2012), it was concluded that Clrn1 
is not required for the formation of tip links or the polarised orientation of the hair bundle or the 
development of graded heights of stereocilia. Instead, the disruption of the hair bundle structure 
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and loss of stereocilia in Clrn1-/- mice suggests that Clrn1 might be required to maintain the 
structure of the bundle after it is formed (Geng et al., 2012).
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Figure 1.10. SEM images of cochlear hair bundles from USH2 and USH3 mice of different genotypes and ages (adapted from (Zou et al., 2015; Liu et al., 2007; Geng et al., 2009; Geng et 
al., 2012) 
a) Low and high magnification SEM images of USH2 knock-out mice, showing abnormal hair cell bundles (top row); USH2 knock-out mice OHC bundles show: stereocilia tilted at 
stereociliary bases and missing stereocilia in the shortest stereociliary row (Adgrv1−/−), distorted shapes and mislocalised kinocilia (Ush2a) and a blunt U-rather than a sharp V-shape 
(Dfnb31) (middle row); USH2 knock-out mice IHC bundles show thicker and ectopic stereocilia (Adgrv1), ectopic stereocilia, but no difference in thickness (Ush2a) and thick stereocilia 
(Dfnb31) (Zou et al., 2015).  
b) Low magnification SEM showing Ush2a stereocilia affected only in the basal cochlear turn (top) compared to the middle-apical turn (bottom) 
c)Low and high magnification SEM images of Clrn1 mouse mutants at different stages at both the basal and apical cochlear turn showing disorganised stereocilia bundles in OHCs (with 
splits in the bundles and loss of some of the tallest stereocilia and normal looking bundles in IHCs (top two rows). 
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1.3.5.2. Cochlear dysfunction and hearing impairment resulting from 
dysfunctional Usher proteins in knock-out mice 
As a result of the severe stereocilia defects in USH1 knock-out mice, affecting both IHCs and OHCs 
throughout the cochlear turns, the USH1 mutant mice show severe cochlear dysfunction and 
severe hearing impairment. Absence of ABR response to click stimuli at 8, 16, 24 or 32 kHz tone 
bursts demonstrated that the cochlea in Ush1g, Chd23, Pcdh15 and Ush1c and Cib2 knock-out 
mice was non-functional and the mice were profoundly deaf at all frequencies at all time points 
(Raphael et al., 2001; Washington et al., 2005; Haywood-Watson et al., 2006; Di Palma et al., 
2001; Tian et al., 2010; Kikkawa et al., 2003; Caberlotto et al., 2011; Wang et al., 2017b). It has 
also been suggested that no ABR response at the maximum intensity of above 90dB SPL indicates 
that both OHCs and IHCs were impaired as even a complete loss of OHCs function cannot account 
for more than a 60bB threshold elevation (Dallos and Harris, 1978). 
DPOAE measurements further demonstrated that OHC function of Ush1g-/- mice was defective at 
high frequencies, but was partly preserved at low frequencies in mature mutant mice before the 
complete loss of OHCs at P15 (Caberlotto et al., 2011). DPOAE measurements are also available 
for Cib2-/- mice, indicating significant threshold elevation compared to controls, suggesting OHC 
function deficits in the Cib2 knock-out mice (Wang et al., 2017b). Additional electrophysiology 
experiments, testing MET currents in Cib2 knock-outs, indicated a complete lack of MET current in 
OHCs and in the more intact IHCs at P7 compared to controls, suggesting that disrupted Cib2 
function abolishes MET currents in auditory hair cells (Wang et al., 2017b; Giese et al., 2017b).  
Compared to the hair cell defects along the whole cochlea in the USH1 knock-out mice, the USH2 
mutated mice are preferentially affected at the basal half of the cochlea, which consequently 
leads to elevated thresholds at high frequency. ABR thresholds of all three knock-out USH2 mouse 
models at P30 (when the mouse cochlea has matured) showed to be elevated in the frequency 
range 4-45.2 kHz relative to wild type controls (Zou et al., 2015), with Ush2a thresholds being 
consistently elevated at high frequencies (Liu et al., 2007). Adgrv1-/- mice were most severely 
affected, while Dfnb31neo/neo showed the mildest hearing loss and Ush2a -/- mice were in-between, 
correlating with the degree of ALC disruptions and stereociliary bundle defects. DPOAE signal 
testing of Ush2a -/- mice showed conflicting results between the two studies (Liu et al., 2007; Zou 
et al., 2015). While Lui et al. showed elevated thresholds for f2 frequencies only above 15 KHz, 
but not at low frequencies, Zou et al. showed that the thresholds were elevated for all 
frequencies. This discrepancy might be a result of different genetic backgrounds of the Ush2a -/- 
mice used where potential modifier genes (such as Cdh23ahl allele) could rescue the Ush2a -/- inner 
ear phenotype and thus result in more variable and less severe phenotype reported by Liu et al.  
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By P21, when OHCs are lost from the cochlea, ABR thresholds in Clrn1-/- mice are significantly 
elevated (85-95 dB peSPL), with a delay in latency for all four peaks (at 8, 16 and 32 kHz) 
compared to wild type mice (Geng et al., 2009). In addition, the interpeak latencies P1-P2 and P1-
P3 show to be prolonged in mutant mice compared to controls and by P30 no hearing function is 
detected (Geng et al., 2009), indicating that the mice are deaf around that age, coinciding with 
the loss of IHCs. These results suggest that Clrn1-/- mice have some auditory function at young age, 
which deteriorates rapidly after P21 and demonstrates hair cell function deficiency, and a neural 
deficit, necessary for normal sensory transduction. At P21 the mutant mice produced no 
detectable DPOAE above the noise floor, indicating lack of OHC function (Geng et al., 2009). 
1.4. Current genetic strategies to study complex phenotypes 
1.4.1. Monogenic disorders and gene identification methods 
Monogenic disorders are traditionally defined as resulting from a pathogenic variant/s within a 
single gene where the variants are both necessary and sufficient to produce the clinical 
phenotype and to cause the disease (Peltonen and McKusick, 2001) (Figure 1.11a). Large families 
represent a particularly useful tool for gene identification, because they have multiple affected 
and unaffected members whose clinical symptoms could be related to a single variant in their 
genome. Many hearing disorders such as nonsyndromic and syndromic hearing loss are inherited 
under a monogenic model following a dominant (DFNA loci), recessive (DFNB loci) or X-linked 
inheritance pattern. 
Linkage mapping is a method to identify genetic regions underlying monogenic diseases, relying 
upon linkage disequilibrium (LD) of genetic markers through large pedigrees (Dawn Teare and 
Barrett, 2005). Two genetic features are said to be in LD when they are located close enough to 
not be separated by the recombination process and to always be inherited together. By using 
genetic markers spaced across the genome and studying their segregation through pedigrees, it is 
possible to identify chromosome regions that are linked to the disease (where the affected 
individuals are more similar than expected by chance). The biggest limitation of family linkage is 
the low level of resolution that it offers. Since linkage studies only narrow down the chromosome 
location of contributory variants, they usually result in the identification of a large chromosome 
region rather than a specific variant. Current gene mapping and variant identification methods 
rely on whole exome and whole genome sequencing techniques (WES and WGS), which offer 
better resolution and therefore allow detection of near complete variation. These sequencing 
methods have become relatively cheap and have the advantage of being unbiased regarding the 
set of genes analysed, allowing parallel examination of most/all of the genes in the human 
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genome. They also allow identification at the level of novel and very rare variants, which was not 
possible before.  
The biggest challenge of WES/WGS has been interpreting the data and ranking the large number 
of variants in a systematic way to identify potentially causal variants. To aid variant interpretation 
now available are population datasets, such as the Genome Aggregation Dataset (gnomAD) which 
provides summary statistics of large scale sequencing data (such as population specific variant 
frequency) and prediction tools that assess the potential damaging effect on protein level 
(summarised in Section 2.5.2). 
Guidelines for interpretation of variants in molecular genetic testing have also been developed by 
professional genetic associations such as the American College of Medical Genetics and Genomics 
(ACMG) (Richards et al., 2015). The recommended criteria for classifying pathogenic variants 
involve collecting multiple lines of evidence from publicly available databases on allele frequency, 
functional effect, disease presentation and expected inheritance pattern, computational and 
predictive data and aligning it to the specifics of the investigated disorder and segregation with 
the phenotype (Richards et al., 2015). Although challenges remain in classifying non-coding and 
missense variants (due to limited functional evidence), approaches learnt from monogenic 




1.4.2. Complex disorders and the role of common variants through GWAS 
(common disease-common variant hypothesis) 
Complex genetic disorders are influenced by the combination of risk variants within many genes 
and environmental factors that can modify that risk (Mitchell, 2012) (Figure 1.11b). For example, 
complex common disorders such as ARHL, ASD, dyslexia and DLD have an inherited component, 
described by the term heritability. Heritability shows how much of the variation in a given trait or 
disorder can be attributed to genetic variation (0% is entirely environmental and 100% - entirely 
genetic). The heritability estimates for complex disorders typically range from 30% to well over 
a) Monogenic disorder        b) Complex disorder 
Figure 1.11. Monogenic and complex inheritance patterns and risks (adapted from (Peltonen and 
McKusick, 2001). 
a) In monogenic disorders pathogenic variants in a single gene (within the coding region of the 
gene) are typically necessary and enough to cause a disease. Pedigrees show Mendelian inheritance 
patterns. The impact of the pathogenic variant on disease risk is typically 100% (it has a direct effect 
on disease phenotype) and the risk is the same in different families and within populations.  
b) In complex disorders, variants in different genes (within coding or non-coding regions) increase 
the risk and are typically neither sufficient, nor necessary to explain the disease by themselves. 
Family trees do not show Mendelian pattern of inheritance and environmental factors act to modify 
the risk. The effect size of a given variant can differ between individuals and across a population 





50%, for example ARHL giving estimates between 35% and 55% and DLD -between 18% and 45% 
(Gates, Couropmitree and Myers, 1999; Karlsson, Harris and Svartengren, 1997; Wolber et al., 
2012; Bishop and Hayiou-Thomas, 2008). 
Because of the small effect size of each variant on complex disease, in order to capture risk 
genome-wide association studies (GWAS) compare frequencies of SNPs between cases and 
controls in large populations. Higher frequencies in cases compared to controls usually indicate a 
higher risk for the alleles involved. GWAS are based on the common disease-common variant 
(CDCV) hypothesis which proposes that if a disease that is heritable is common in the population 
(a prevalence greater than 1–5%), then the genetic contributors will also be common in the 
population (Wang et al., 2005). Although for complex diseases such as ARHL and DLD, GWAS have 
identified variants reaching statistical significance within new candidate genes (NOP9 and ROBO2 
for DLD and GRM7, PCDH20 and SLC28A3, IGS20 or ACAN and TRIOBP, and CLRN2 and NID2 for 
ARHL) (Nudel et al., 2014; St Pourcain et al., 2014; Friedman et al., 2009; Vuckovic et al., 2015; 
Hoffmann et al., 2016; Wells et al., 2019) in the majority of cases findings from GWAS fail to 
replicate between studies (Tam et al., 2019). Moreover, the variants identified through GWAS are 
not necessarily functional. This is because they are proxies, which mark the approximate position 
of the aetiological variant within a small segment of DNA. Therefore, while GWAS provide an 
informative starting point for functional studies, even high-density SNP association screens will 
require follow-up studies to enable proof of robust effect (McCarthy and Hirschhorn, 2008).  
Table 1.7. Possible frequencies of gene variants in complex traits (adapted from (Cirulli and Goldstein, 2010) 
Variant class Minor allele frequency (MAF) Implications for analysis 
Common Between 5% and 50% 
Detectable in association analysis using GWAS 
methods 
Less common Between 1% and 5% 
Detectable in association analysis using GWAS 
methods in larger association studies 
Rare but not 
private 
Less than 1% but sill polymorphic in 
one or more major human 
populations 
Detectable in exome/whole genome sequencing 
studies and co-segregation in families 
Very rare and 
private 
Restricted to single families 
Difficult to analyse even in co-segregation and whole 
genome sequencing in affected families 
1.4.3. The role of rare coding variants through genome sequencing 
(common disease-rare variant hypothesis)  
Association studies assume the presense of major shared genetic effect, meaning that very rare 
and private SNPs are overlooked (Table 1.7). Such rare (low-frequency) variants have been 
proposed as players in susceptibility to complex disease even before the GWAS field was 
established to capture common risk variants (Pritchard, 2001). This view was based on the 
theoretical explanation for the importance of rare variants where variants that strongly 
predispose to disease are likely to be deleterious and therefore kept at low frequencies by 
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purifying selection (Pritchard, 2001). These rare, usually coding, variants differ from the rare 
causal variants implicated in Monogenic disorders (described in Section 1.4.1) as they are usually 
not sufficient to cause disease leading to genetic heterogeneity between individuals, but instead 
can contribute to risk in complex disorders (with some exceptions like rare variants in FOXP2 (Lai 
et al., 2001). While common variants, which have high frequency in the general population (MAF≥ 
5%) are expected to have low relative risk, rare highly penetrant variants may confer high risk (as 
shown in neurodevelopmental disorders- ASD, ADHD, schizophrenia) (Henriksen, Nordgaard and 
Jansson, 2017; Anney et al., 2012; Yang et al., 2013; Faraone and Larsson, 2019). Therefore, rare 
risk variants have been considered an important source of variation, leading to the common 
disease-rare variant hypothesis (Iyengar and Elston, 2007). Within this hypothesis the rare 
variants are all considered together in a single analysis rather than being restricted to highly 
penetrant variants. Several statistical methods have been developed to increase statistical power 
in rare variant association studies by combining information across multiple rare variants within a 
specified genomic functional unit such as within a gene (gene-based methods that provide 
multivariate analysis such as burden tests) or across many genes (such as polygenic risk scores) 
(for review of methods see (Lin et al., 2018). 
The role of rare risk variants in neurodevelopmental disoders is now well-recognised. A rare 
variant burden for protein-truncating variants was reported in a WES study in individuals with 
complex neurodevelopmental disorders (such as ASD, ADHD, bipolar disorder or intellectual 
disability) (Ganna et al., 2018), suggesting a widespread genetic effect among those disorders. 
Another recent large scale exome sequencing study of ASD reported 102 genes in ASD risk (of 
which 30 were novel) and a greater burden for de novo protein-truncating varians over de novo 
missense variants, with all exome de novo variants in the autosomes in total explaining 1.92% of 
the variance in ASD (Satterstrom et al., 2020). 
1.4.4. Alternative mechanisms and combinations  
It is becoming apparent that rare and common variants at single bases of DNA sequence (SNPs) 
are unlikely to fully account for the heritability of complex genetic disorders. An alternative 
mechanism such as copy number variants (CNVs representing deletions and duplications ranging 
from 50bp to 5Mb in size) has been identified in many neurodevelopmental disorders such as 
ASD, ADHD, schizophrenia and DLDs (Simpson et al., 2015; Kalnak et al., 2018; Zarrei et al., 2019; 
Shearer et al., 2014).  
Increasing evidence also points to a complex interplay between genes and the environment in 
neurodevelopmental disorders (Tran and Miyake, 2017). Epigenetic mechanisms (affecting gene 
expression, without changing the DNA sequence) such as DNA methylation and histone 
modification can act at this interface (Banik et al., 2017). We need to keep in mind, that although 
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each environmental risk factor (being driven through epigenetic or other mechanisms) might have 
a very small effect, when it occurs in the context of genetic background with specific risk variants, 
the overall combination may result in what’s referred to as a “perfect storm”, leading to 
disruption of normal neurodevelopment. 
The emerging picture of complex genetic neurodevelopmental disorders, including ASD, ADHD, 
dyslexia, schizophrenia and DLDs, is that they can arise for many different reasons, each involving 
different combination of underlying risk. In most cases, we now expect risk models to involve 
many factors that act together: hundreds of genetic variants together with CNVs, gene x gene 
interactions, epigenetic modifications and environmental influences. The application of diverse 
technologies and multi-national collaborative effort is thus required to explore the role of each 
factor when studying a complex disease in order to better explain not only the genetic 
contributions, but also our understanding of the biological mechanisms and interactions involved 
in its aetiology.  
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1.5. Aims of thesis 
The overall aim of this thesis is to comprehensively identify and examine the overlapping genetic 
mechanisms between hearing, auditory processing, and emergent language.  
The specific aims are: 
1. To examine the effect of heterozygous pathogenic variants in USH causative genes (as 
candidate APD susceptibility genes) on hearing, auditory processing, and language under a 
Mendelian model. 
2. To examine the effect of common and rare risk USH variants on hearing, auditory processing, 
and language abilities under a complex model. 
3. To discover new pathways implicated in APD by identifying pathogenic variants with big effect 
on a genome-wide level in individuals that show difficulties discriminating words in noise. 
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2. Subjects and Methods 
2.1. Subjects and ALSPAC population cohort 
2.1.1. Discovery Family 
This thesis came about because of a large family affected by APD. The discovery family consisted 
of 12 members; eight of which (including I.1 and all his seven descendants) (Figure 2.1) were 
affected by expressive language disorder with acute auditory processing difficulties and disfluent 
speech (dysarthria), indicating an autosomal dominant inheritance pattern. The affected 
individuals showed difficulties characteristic of APD such as processing speech and following 
instructions particularly in presence of background noise. The discovery family is further 
described by Perrino et al (Perrino et al., 2020).
 
 
2.1.2. ALSPAC population Cohort 
Following candidate gene identification in the discovery family (Perrino et al., 2020), genetic 
investigations were performed in the Avon Longitudinal Study of Parents and Children (ALSPAC). 
ALSPAC is a population-based birth study of the children born to 14,541 mothers in the Avon area 
(Boyd et al., 2013). Three datasets generated from the ALSPAC study were used in this thesis. 
They will be referred to as ALSPAC phenotype dataset, ALSPAC genotype dataset and ALSPAC 
UK10K dataset. The ALSPAC phenotype dataset provides a wide range of neurodevelopment 
phenotype measures of all participating children including language, memory, hearing and 
neuropsychiatric measures (Table S1). The ALSPAC genotype dataset contains genetic data of 
Figure 2.1. Pedigree of the four-generational APD family 
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common variation, providing 500,527 SNPs genotyped in 8,365 children. The ALSPAC UK10K 
dataset contains low read depth whole genome sequence data for 1,867 children as part of the 
UK10K project, which aimed to study the contribution of genes to phenotype traits and disease 
(Walter et al., 2015) (https://www.uk10k.org/studies/cohorts.html). The ALSPAC cohort profile 
and study protocol have been described elsewhere (Boyd et al., 2013; Golding, Pembrey and 
Jones, 2001) and further information is available on the ALSPAC website 
(http://www.bris.ac.uk/alspac). 
2.1.3. Ethical approval 
Ethical approval for the discovery family was provided by University of London & St George’s 
University Hospitals. All members gave informed consent/assent of investigation. Access to the 
ALSPAC and UK10K data for the use of this study was agreed as part of project B2341 by the 
ALSPAC Ethics and Law Committee and an ethical approval for secondary data analysis was 
granted by Oxford Brookes University (DREC Reference: 1216_29).  
2.2. ALSPAC phenotype dataset 
The ALSPAC phenotype dataset contained 684 measures available for this this study (413 
qualitative and 271 quantitative) (Table S1), for full list of measures see 
http://www.bristol.ac.uk/alspac/researchers/our-data/). Performance on all these measures was 
considered for rare Mendelian analyses utilising the ALSPAC UK10K dataset in Results Chapters 1 
and 4. Subsets of the ALSPAC phenotype dataset were also created and are detailed below. 
2.2.1. Core phenotypes for complex analyses 
Eight core phenotypes were selected from the ALSPAC phenotype dataset for association analyses 
of common variants on the ALSPAC genotype dataset (Results Chapter 2) and gene-based 
association analyses on the ALSPAC UK10K dataset (Results Chapter 3). These core measures 
consisted of three measures of hearing and five measures of language development and are 
summarised below.  
2.2.1.1. Hearing measures 
Otitis Media with Effusion status (OME @ 7 years) (ALSPAC variable f7hs062) 
Bilateral otitis media with effusion (OME) status (“glue ear”) was chosen for analysis because it is 
a known risk factor for secondary APD (Khavarghazalani et al., 2016) and as such is expected to 
show some associations with signs and symptoms of APD. OME status was documented on the 
basis of tympanometry results which were obtained by audiologists and trained staff as part of 
the ALSPAC study when children were 7 years old. In short, the two ears were tested one by one, 
with the right ear tested first. A Kamplex AT2 tympanometer was used and the probe was placed 
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at the entrance of the ear canal, measuring the eardrum mobility and middle ear pressure. A 
graph, called tympanogram, was produced, indicating how effectively sound is transmitted into 
the middle ear and thus how well the middle ear functions. Tympanogram tracings were classed 
as type AA (indicating bilateral normal middle ear function with middle ear pressure of +100 to -
100 daPa), Type C1 (indicating bilateral slight eustachian tube dysfunction but no OME with 
middle ear pressure of -101 to  -200 daPa), Type C2/B (indicating unilateral eustachian tube 
dysfunction with middle ear pressure < 200 daPa (Type C2) or unilateral OME with flat trace (Type 
B); Type BB (indicating bilateral OME with flat trace). Data for this measure were available for 
5,410 genotyped children, with a distribution of 74% of children having Type AA, 11.9%- Type C1, 




Low-frequency hearing thresholds at 0.5 kHz frequency (LowFreq_min) 
Hearing thresholds at low frequencies (0.5 kHz) were chosen for analysis based on the deficits 
shown by Ush2a heterozygous knock-out mice by Perrino et al. (Perrino et al., 2020). Audiometry 
was performed as per British Society of Audiologists (BSA) standards. Air conduction was 
performed using either a GSI 61 clinical audiometer or a Kamplex AD12 audiometer. All hearing 
tests were carried out by audiologists and trained staff in a room with minimal external noise (not 
exceeding 35 dB) as part of the ALSPAC study. Low frequency hearing thresholds were not directly 
available as a separate score within ALSPAC and so scores at 0.5kHz were derived through 
calculations (see Calculations Box 2.1). In short, lowFreq_min hearing thresholds were defined as 
the minimum air conduction threshold in the better performing ear at 0.5kHz. The measure was 
Figure 2.2. Distribution of OME status across the ALSPAC genotype core cohort 
(N= 5,410 genotyped children).  
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derived from ALSPAC variables f7hs017, f7hs018, f7hs027 and f7hs028 (Calculations Box 2.1), 
which indicate average thresholds across different frequencies (0.5 kHz, 1kHz, 2kHz, 4kHz, 8kHz 
and 16kHz in each ear. This measure was available for 4,440 genotyped children with thresholds 
ranging from -10 dB HL (better performance) to +40 dB HL (poorer performance), with a mean= 
10.36 dB HL and SD= 5.7 (Figure 2.3). 
 
 
Calculations Box 2.1. 
f7hs017 and f7hs018 are composites for Right ear: 
f7hs017 = (f7hs010+f7hs011+f7hs012+f7hs013)/4 
f7hs018 = (f7hs011+f7hs012+f7hs013)/3 
where f7hs010 is air cond hearing threshold level (dB HL) r ear 500 Hz: hearing F @ 7 
where f7hs011 is air cond hearing threshold level (dB HL) r ear 1 kHz: hearing F @ 7 
where f7hs012 is air cond hearing threshold level (dB HL) r ear 2 kHz: hearing F @ 7 
where f7hs013 is air cond hearing threshold level (dB HL) r ear 4 kHz: hearing F @ 7 
f7hs027 and f7hs028 are composites for Left ear: 
f7hs027 = (f7hs020+f7hs021+f7hs022+f7hs023)/4 
f7hs028 = (f7hs021+f7hs022+f7hs023)/3 
where f7hs020 is air cond hearing threshold level (dB HL) l ear 500 Hz: hearing F @ 7 
where f7hs021 is air cond hearing threshold level (dB HL) l ear 1 kHz: hearing F @ 7 
where f7hs022 is air cond hearing threshold level (dB HL) l ear 2 kHz: hearing F @ 7 
where f7hs023 is air cond hearing threshold level (dB HL) l ear 4 kHz: hearing F @ 7 
from these, measures of low frequency thresholds were derived: 
lowfreqR = (f7hs017*4) -(f7hs018*3) 




Figure 2.3. Distribution of Low frequency_min hearing scores across the ALSPAC 
genotype core cohort (N= 4,440 genotyped children).  
LowFreq_min sores (dB HL) 
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Mid-frequency hearing thresholds (MidFreq_min) 
Mid-frequency hearing thresholds measure was chosen for analysis to cover frequencies in the 
middle ranges between low and high. The thresholds were defined as the minimum air 
conduction thresholds in the better performing ear at mid-range hearing frequencies, which were 
averaged across 1, 2 and 4 kHz (ALSPAC variables f7hs018 and f7hs028 for right and left ear 
respectively). This measure was available for 4,520 genotyped children with scores ranging from 0 
dB HL (better performance) to +40 dB HL (poorer performance), with a mean of 5.55 dB HL and SD 
of 4.4 (Figure 2.4). 
 
 
2.2.1.2. Language measures 
Early communication score (comm @ 18 months) (ALSPAC variable kd654) 
The communication score at 18 months (1.5 years of age) was chosen for analysis as a marker of 
very early language as it starts to develop through signs of communication. It represents a sum of 
items from a list of 14 tasks, which incorporate measures of hearing (child reacts to ringing bells 
and people speaking), vocabulary (child copies what you say, child understands and says words 
and can name colours) and grammar (child combines words and makes negative statements). 
Data were available for 6,344 genotyped children with scores ranging from 1 (child has done the 
task 1-2 times) to 28 (child can do well all the tasks) (mean= 15.96, SD= 4.6) (Figure 2.5).  
Figure 2.4. Distribution of Mid frequency_min hearing scores across the ALSPAC genotype 
core cohort (N= 4,520 genotyped children). 





Early vocabulary (vocab @ 38 months) (ALSPAC variable kg865) 
The vocabulary score taken at 38 months (3 years of age) was chosen for analysis as it represents 
an early marker of expressive language. The measure represents a sum of items that a child could 
use and/or understand, from a list of 123 words (ALSPAC variable kg865). The scores are derived 
from a parental questionnaire. Data were available for 6,165 genotyped children with scores 
ranging from 0 (child did not understand or use any of the 123 words) to 246 (child could use and 
understand all of the 123 words) (mean= 229.8, SD= 29.4) (Figure 2.6). The ceiling effect observed 
shows that at 3 years of age, most children can use and understand all the words tested. 
 
Figure 2.5. Distribution of early communication scores across the ALSPAC genotype core 
cohort (N= 6,344 genotyped children). 
Figure 2.6. Distribution of early vocabulary scores across the ALSPAC genotype core 
cohort (N= 6,165 genotyped children) 
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Verbal Intelligence Quotient (VIQ @ 8 years) (ALSAC variable f8ws110) 
Verbal IQ was chosen for analysis as a cognitive ability marker of verbal comprehension at school 
age (8Y). It was measured using the Wechsler Intelligence Scale for Children Version III (WISC III), 
which is the most widely used individual ability test worldwide for children between the ages of 6 
and 16 (Wechsler et al., 1992). For the ALSPAC study, a short form of the measure was employed 
to reduce the length of the session. Tests were administered by psychology professionals. The 
Verbal IQ scores were finally derived from the sum of five verbal subtests: information (assessing 
child’s knowledge), similarities (where similarities between things must be explained), arithmetic 
(mental arithmetic questions), vocabulary (ascertaining child’s understanding of the meaning of 
different words) and comprehension (questions about different situations), which were scaled for 
age, using look-up tables in the WISC manual. Data were available for 5,218 children and scores 
ranged from 50 (very low scores classed as mild intellectual disability) to 155 (high scores classed 
as “gifted”) with a mean of 108.25 and SD of 16.5 (Figure 2.7). 
 
 
Nonword repetition (NWR @ 8 years) (ALSPAC variable f8sl105) 
Nonword repetition (NWR) was chosen for analysis as it has been shown to be an accurate 
biomarker of speech and language difficulties (Bishop, Adams and Norbury, 2006) (Newbury et al., 
2009). For the ALSPAC study, an adaptation of the Nonword Repetition Test by (Gathercole et al., 
1994) was used to assess short term memory. The ALSPAC test was completed in clinic and 
consisted of 12 nonsense words, split into four of 3, 4 and 5 syllables and conforming to English 
Figure 2.7. Distribution of Verbal IQ scores across the ALSPAC genotype core cohort (N= 
5,218 genotyped children) 
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rules for sound combinations.  The child had to listen to each word via an audio cassette recorder 
and repeat each item. The repetition attempt was correct if there was no phonological deviation 
from the target form. The total number of correctly repeated items (including 3, 4 and 5 syllables) 
was used for analysis. The test was completed at 8 years of age and data were available for 5,229 
children, who scored from 0 (no nonsense words repeated correctly) to 12 (all nonsense words 
repeated correctly) (mean= 7.3, SD= 2.5) (Figure 2.8) 
 
 
Developmental Language Disorder Status (DLD) 
DLD status was assigned to children based on their performance on language tests, covering 
comprehension, verbal fluency and syntax as defined in previous publications (Newbury et al., 
2009). In short, “case” status was assigned to children who performed at least 1SD below mean 
on WOLD comprehension (ALSPAC variable f8sl040) OR had CCC verbal fluency AND syntax 
(ALSPAC variables ku503b and ku504b respectively) ≥ 1SD below mean with no evidence for ASD 
or hearing impairment. Typically developing “controls” were selected to perform above expected 
levels across all three selected measures (WOLD comprehension, CCC verbal fluency and CCC 
syntax) and had nonverbal (performance) IQ > 80 with no documented neurodevelopmental 
disorders or special education needs. The ALSPAC genotype core cohort included 2,114 controls 
and 731 cases from a total of 2,845 genotyped individuals (Figure 2.9).  
Figure 2.8. Distribution of Nonword repetition scores across the ALSPAC genotype core 





2.2.2. Core phenotypes for selecting a suspected APD group  
The performance of ALSPAC UK10K individuals on two further measures was compared to select a 
group of children with features of APD (Results Chapter 4). As the most frequently reported 
characteristic of individuals with APD is problems with understanding speech in challenging 
listening conditions, despite normal hearing sensitivity (Bamiou, Musiek and Luxon, 2001; 
Chermak, 2002; Keith, 1999; Vanniasegaram, Cohen and Rosen, 2004), the ALSPAC phenotype 
database was scanned for hearing measures that captured speech identification in quiet and in 
noise as they together, can reveal potential auditory deficits with understanding words only when 
in noisy environments, but not in quiet. The only hearing measure available in quiet and in noise 
conditions was the word discrimination threshold (cf573 in quiet and cf577 in noise), obtained as 
part of the Institute of Hearing Research (IHR)- McCormick Automated Toy Test (ATT) hearing 
measures taken at 61 months (5 years old). The ATT is the most commonly used test of speech 
recognition in preschool children within the UK and it measures the minimum sound level at 
which a child can identify words presented in quiet (Ousey et al., 1989; Palmer, Sheppard and 
Marshall, 1991; Summerfield et al., 1994).  
2.2.2.1. Word discrimination threshold in Quiet (ALSPAC variable cf573) and word 
discrimination threshold in Noise (ALSPAC variable cf577) @ 61 months  
The word discrimination threshold provides a direct measure of the ease with which a child can 
identify speech in quiet versus noise and is a surrogate measure of auditory sensitivity (Ousey et 
al., 1989). The test involves children attempting to identify which of 7 pairs of toys is requested by 
a pre-recorded message from an audio speaker at varying volume levels. The objects are in pairs 
with similar sounds (cup/duck, tree/key, man/lam, fork/horse, spoon/shoe, cow/house and 




plate/plane), so that an error most commonly arises when a toy is confused with its pair member 
(Summerfield et al., 1994). For the word discrimination in noise an output of a pink noise 
generator is mixed with the stimulus word (Summerfield et al., 1994). An effort is made to ensure 
that children are familiar with all of the objects before the test is started and, in the event, that 
some were unknown, the pairs were removed, and the remaining pairs included. The volume of 
the instructions increased and decreased 6 times in order to find the level at which the child could 
hear. The two measures were available for 180 ALSPAC children with scores ranging from 15 
(better performance) to 34 (poorer performance) with a mean of 24.37 and SD of 4.48 for word 
discrimination in quiet (Figure 2.10) and scores from 53 (better performance) to 68 (poorer 












Figure 2.10. Distribution of Word discrimination threshold (Quiet) at 61 months across 
180 ALSPAC children with available scores (Mean= 24.37, SD= 4.483) 
Figure 2.11. Distribution of Word discrimination threshold (Noise) at 61 months across 
180 ALSPAC children with available scores (Mean= 58.03, SD= 2.318) 
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2.3. ALSPAC genetic datasets and core cohorts 
2.3.1. ALSPAC genotype dataset generation 
The ALSPAC children had been genotyped previous to this work, using the Illumina Human Hap 
550-quad chip (Illumina Inc., San Diego, CA), following an already described protocol (Boyd et al., 
2013). After quality control based on gender mismatches; minimal or excessive heterozygosity; 
disproportionate level of individual missingness (> 3%); evidence of cryptic relatedness (> 10% 
IBD) and selection for European descent, 8,365 children were kept within the study. Quality 
control measures removed all rare SNPs with a minor allele frequency of < 1% (because rare SNPs 
are not informative in a gene association study), a call rate of < 95% and the ones which violated 
the Hardy-Weinberg equilibrium (p< 5x10-7), resulting in 500,527 SNPs. These quality control steps 
were performed by ALSPAC prior to data release.  
2.3.2. ALSPAC genotype core cohort selection 
As this thesis focuses upon auditory processing and speech and language difficulties, the ALSPAC 
genotype dataset (N=8,365) was filtered to exclude confounding factors (Table 2.1). Children were 
excluded if they were a twin, not of British ethnicity, who were bilingual, born earlier than 32 
weeks gestation, and having a birth weight < 1500g, who were missing a large amount of data and 
had an overt pathology that could confound language development (non-verbal IQ <65) and 
hearing loss (hearing thresholds above 40dB) (Table 2.1). These filtering criteria resulted in a 
selected cohort of 7,141 children (3,615M and 3,526F), which will be referred to as ALSPAC 
genotype core cohort and is used in Results Chapter 2. The number of individuals provides 80% 
power to detect a variant that explains at least 0.38% of the traits’ variance at a Bonferroni-




Table 2.1. Exclusion criteria to generate ALSPAC genotype core cohort of 7,141 individuals 
 
Exclusion criteria used 
ALSPAC code 






    15,444 
no gtyp data Not informative 7,165 46.39% 8,279 
Twins MZ010>1 (kept A if genotyped) ¹ The genetic effect is falsely over-represented 51 0.62% 8,228 
English not main language² f8sl200 not=1 
May confound language assessment scores as 
bilingual children can be slower to develop language (Hoff et al., 2012) 
7 0.09% 8,221 
child uses other language regularly² f8sl201=1 May confound language assessment scores (same as above) 104 1.27% 8,117 
English not mother tongue² cf442=2 May confound language assessment scores (same as above) 9 0.11% 8,108 
more than one language spoken at home² cf443>1 May confound language assessment scores (same as above)  17 0.21% 8,091 
English not first language² plascc24=2 May confound language assessment scores (same as above) 7 0.09% 8,084 
ethnicity not British³ plasca20 not=1 Confounding ethnic factor 4 0.05% 8,080 
Premature bestgest⁴ < 32 
May confound overall development as premature children are at risk 
of reduced cognitive scores (Bhutta et al., 2002) (Zimmerman, 2018) 
SLI to DLD criteria development references to add 
39 0.48% 8,041 
low birth weight⁴ KZ030<1500 May confound overall development  (Zimmerman, 2018) 6 0.07% 8,035 
premature AND low birth weight⁴ KZ030<2000 AND bestgest < 34 May confound overall development  (Zimmerman, 2018) 22 0.27% 8,013 
no phenotypes 
more than 114 of 116 core phenotypes data missing 
Missing data above acceptable threshold, does not allow informative 
conclusion 
67 0.84% 7,946 
Missing data from 16 essential hearing & language phenotypes⁵ 
Missing data above acceptable threshold, does not allow informative 
conclusion 
663 8.34% 7,283 
PIQ (performance IQ)⁶ <65 F8ws111<65 May confound language assessment scores-add reference 78 1.07% 7,205 
Individuals presenting with moderate to severe hearing loss⁷ (hearing 
thresholds >40 dB HL) 
May confound auditory processes- add reference 64 0.89% 7,141 
Total  8,303 60.79% 7,141 
1. In multiple pregnancies only 1 genotyped baby was kept in core cohort; 2. Children, whose main language at home was different from English and whose mother tongue 
and/or first language was not English, who used other languages regularly  and spoke more than one language at home, were all excluded; 3. Children who were not of white 
ethnicity were excluded; 4. Children who were born before 32 weeks were excluded, together with children born weighing less than 1.5kg and children born before 34 weeks 
with birth weight less than 2kg were all  excluded; 5. Hearing & language phenotypes included: six developmental problems that required special arrangement at school, 
reading and spelling @ 7Y, WOLD comprehension, nonword rep, Verbal IQ and Performance IQ @ 8Y, Vocab score @ 38 mths, high frequency hearing loss, bilateral OME, low 
and mid-frequency derived scores; 6. Children with Performance IQ scoring less than 65 were excluded; 7. Children with hearing thresholds >40 dB HL, representing moderate 
to severe hearing loss were excluded.  
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2.3.3. ALSPAC UK10K dataset generation 
The ALSPAC UK10K sequence dataset was generated previous to this study and full details are 
available within the supplementary data of other studies (Taylor et al., 2015; Timpson et al., 
2014). In short, low-read-depth whole genome sequencing was performed on 2,040 individuals 
using Illumina HiSeq platform (low read depth at an average 7x depth). Sequencing reads that 
passed quality control were aligned to the GRCh37 human reference, using BWA (v0.5.9- r16) (Li 
and Durbin, 2010). This resulted in 1,976 sequenced samples that went through the variant calling 
procedure, generated using samtools/bcftools (version 0.1.18-r579) (Danecek et al., 2011). 
Following a standard filtering pipeline and quality control steps, 1,867 samples remained for 
analysis. 
2.3.4. ALSPAC UK10K core cohort selection 
The ALSPAC UK10K dataset was filtered on the same criteria as ALSPAC genotype dataset (Section 
2.3.2), but individuals with hearing loss and neurodevelopmental difficulties (last two filtering 
steps in Table 2.1) were left in. This produced a selected cohort of 1,681 individuals (806M: 875F), 
which will be referred to as ALSPAC UK10K core cohort and is used in Results Chapters 1 and 3. 
2.3.5. ALSPAC suspected APD cohort selection 
This ALSPAC UK10K core cohort was further filtered to produce the suspected APD (sAPD) cohort: 
individuals who were not subjected to the word discrimination hearing tests and those who had 
missing data for the two core phenotypes of word discrimination threshold in quiet (cf573) and in 
noise (cf577) (Section 2.2.2) were excluded. Because the two word discrimination thresholds 
(cf573 and cf577) were tested only in a sub-cohort of the ALSPAC UK10K cohort, called Children in 
Focus, the number of available children dropped significantly, resulting in 180 individuals 
remaining (Table 2.2). To exclude the confounding effect of hearing loss, all individuals who 
presented with moderate to severe hearing loss were excluded (those who had hearing 
thresholds f7hs017, f7hs018, f7hs028, f7hs028 >40 Db), resulting in 177 individuals remaining 
(Table 2.2). Lastly, only children whose word discrimination thresholds in quiet were considered 
typical within a normative range (cf573 ≤29 which excludes individuals with scores 1SD above the 
mean) and whose word discrimination thresholds in noise were elevated (cf577 ≥61 which 
includes individuals with scores 1SD above the mean) were included, resulting in 13 individuals in 
the sAPD cohort (7%) (Table 2.2). The sAPD cohort is used in Result Chapter 4. 
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Table 2.2. Exclusion criteria to generate APD suspected core cohort 
2.4. Genetic analyses 
The genetic investigations on the discovery family (2.4.1) were completed prior to the current PhD 
project and therefore the PhD candidate was not involved in the analyses. All the follow-up 
analyses, including the ALSPAC association analyses of common variants (2.4.2), the ALSPAC 
UK10K gene-based association analyses (2.4.3) and the sAPD cohort coding variant analysis (2.4.4) 
were completed by the PhD candidate herself and are further explained below. 
2.4.1. Discovery family genetic investigations 
All genetic analyses on the discovery family were performed by the Newbury group at the 
Wellcome Centre for Human Genetics, Oxford and formed the basis of the current PhD project. 
Full details are provided by Perrino et al. (Perrino et al., 2020). In short, seven members of the 
discovery family (five affected individuals: II.1, II.2, III.3, IV.1 and IV.2, and two unaffected 
individuals, II.4, III.4, Figure 2.1) were genotyped to allow identification of shared chromosome 
segments between affected individuals and to identify copy number variants (CNVs). Two 
individuals (II.2 and IV.1, Figure 2.1) underwent whole genome sequencing, enabling the 
identification of possibly pathogenic variants. Candidate variants were further validated by Sanger 
sequencing using BigDye (v3.1). Data from these analyses enabled the identification of a set of 
candidate genes that set the foundation of this thesis. 
2.4.2. ALSPAC association analyses of common variants 
The ALSPAC genotype data were filtered for the purpose of Results Chapter 2 to include variants 
with a minor allele frequency > 5% within the 11 Usher genes of interest , which were pruned 
within PLINK (Section 2.5.1) to obtain a pairwise tagging SNP set with R2< 0.8. (Table 2.3). The 
UCSC genome browser was used to position the Usher genes to the human genome based on the 
NCBI RefSeq genes track (GRCh37 assembly).  
Exclusion criteria used 
ALSPAC code 
N children remaining 
 
ALSPAC UK10K core cohort 1681 
Individuals with available cf573 and cf577 scores 180 
Individuals presenting with moderate to severe hearing loss (hearing 
thresholds f7hs017, f7hs018, f7hs028, f7hs028 >40 Db) 
177 
cf577 ≥61 and cf573 ≤29 13 
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Table 2.3. Usher genes of interest- chromosome positions and length of studied regions 
 
The eight core phenotypes of hearing and language (Section 2.2.1) were tested for association 
with the pruned common variants within the USH genes (Table 2.3) using a linear model of 
regression for quantitative traits and a logistic model for discrete traits within PLINK (additive 
model). Bonferroni correction for multiple testing was used to calculate the significance threshold 
using the formula: 0.05/number of tested traits/number of tested pruned SNPs. Regional 
association plots were generated with LocusZoom (http://locuszoom.org). 
Gene-environment (GxE) interactions were modelled within PLINK at the gene level to further 
investigate the relationships between Usher genes and speech and language outcomes. Within 
this model, the ALSPAC genotype core cohort was analysed by adding low frequency hearing as an 
interaction factor within a linear regression model (Y= b0 + b1.ADD + b2COV1 + b3.ADD.COV1 + e) 
(interaction model)(Purcell et al., 2007). As an output, p-values were reported for each term. 
ADDxCOV p-values were used to detect interaction as they represent the interaction between the 
SNP and covariate factor and show if together they exert a stronger effect on the phenotype than 
expected through the linear addition of their individual effect. These analyses were performed on 
the five language outcome measures (early communication, early vocabulary, VIQ, NWR and DLD 
status). 
2.4.3. ALSPAC UK10K gene-based association analyses 
The sequence data from ALSPAC UK10K includes all variants across the genome. This data was 
filtered to include only the 11 genes of interest and only SNPs, resulting in 33,452 variants for 
analysis (Figure 2.12). The resulting variants had an allele count of at least 1 in the sample set 
(meaning each variant was carried by at least 1 individual), with a minimum base quality of 20, a 
minimum mean depth of 3 across samples and Hardy Weinberg equilibrium p value of > 1x10-5.  
The transition-transversion ratio of the variants was 2.3.  
chr gene transcript -/+ 10Kb length of 
region 
covered (bp) 
No SNPs after pruning 
1 USH2A  chr1:215,786,236-216,606,738 820,502 129 
3 CLRN1 chr3:150,633,950-150,700,786 66,836 8 
5 ADGRV1 chr5:89,844,617-90,470,033 625,416 66 
5 HARS chr5: 140,043,490- 140,081,312 37,822 Gene too small-0 SNPs* 
9 WHRN chr9:117,154,360-117,277,736  123,376 21 
10 PCDH15 chr10:55,552,533-56,571,051 1,018,518 135 
10 CDH23 chr10:73,146,691-73,585,704 439,013 127 
11 MYO7A chr11:76,829,310-76,936,286 106,976 22 
11 USH1C chr11:17,505,442-17,575,963 70,521 34 
15 CIB2 chr15:78,386,948-78,433,877 46,929 11 
17 USH1G chr17:72,902,176-72,929,351 27,175 Gene too small- 0 SNPs* 
0 SNPs* as genes are too small and not spanned by any common SNPs (MAF>0.05) after pruning using 





The eight core phenotypes of hearing and language (Section 2.2.1) were tested for association 
with rare variants (MAF≤1%) within the 11 Usher genes of interest (Figure 2.12) under Burden-
Zeggini model for gene-based associations within RVTESTS (Section 2.5.1). Analysing the eight 
core phenotypes for all rare variants yielded a Bonferroni significance threshold of P= 0.05/8 
phenotypes/11 Usher genes= 5.68x10-4 at an alpha level of 0.05. 
As gene-based association analyses collapse the effects of many variants into one, it is difficult to 
distinguish the group of variants that are most strongly contributing to any observed association. 
Further in-depth analyses were therefore performed to isolate possible groups of rare driver 
variants in genes with evidence of association. The in-depth analyses included grouping rare 
Figure 2.12. A flow diagram showing the filtering steps of ALSPAC UK10K core cohort data. Purple boxes 
show each filter step and red boxes describe the inclusion/exclusion criteria involved in each step. 
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variants by function (1) (into rare intronic, regulatory and exonic and if applicable further sub-
grouping the exonic variants into missense, stop-gained, splice-site and synonymous) and by 
location (2) (Figure. 2.13). For grouping variants by function (1), gene variant annotations and 
functional effect predictions were performed through SnpEff (Section 2.5.1.) and were based on 
the canonical gene transcript. Gene variants were grouped into exonic (located within exons), 
intronic (located within introns) and regulatory (located within 5- and 3-prime untranslated 
regions). Variants within the former two groups could be further divided into variant type such as 
missense, stop, frameshift, splice-site, synonymous for exonic (which were not filtered out 
because of their possible effect on splicing), and introns towards the 5-prime end and towards the 
3-prime end for intronic variants. Finally, to group gene variants by position (2), the Haploview 
programme was used (Barrett et al., 2005), which generates LD information and haplotype blocks, 
so variants within the same LD block were grouped together. Due to the memory limitation of 
Haploview to analyse genes that contain more than 1,000 variants, larger genes (USH2A and 
ADGRV1) were manually grouped into 5’ and 3’ -ends. 
Figure 2.13. A flow diagram for gene-based associations in the investigated Usher genes, divided into 
baseline and in-depth analyses.  
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2.4.4. ALSPAC UK10K data- sAPD cohort coding variant analysis 
The ALSPAC UK10K sequence data included all variants across the 13 sAPD individuals. In order to 
identify whether this set of data included potentially pathogenic variants in individuals with sAPD, 
the following pipeline was used: all variants which were homozygous for the reference allele were 
removed (using VCFtools- Section 2.5.1) and the potential functional relevance of the remaining 
variants was annotated using SnpEff (v.4.3) (Section 2.5.1) (Figure 2.14). The variants were then 
filtered to only include sites within exons or potential splicing site regions (coding variants) (Figure 
2.14). These coding variants included missense, splice, frameshift, stop loss/gain, start loss, exon 
loss and transcription factor ablation site. To identify novel/very rare variants that were most 
likely to be deleterious, very stringent criteria were used where variants were excluded if they 
were reported in the gnomAD Non-Finnish European population (Figure 2.14) (including 55,860 
individuals which allows for the detection of variants with an expected population frequency of 
8.95x10-6). The pathogenicity of the novel remaining variants (Table S7) was then ranked 
according to ACMG guidelines (Richards et al., 2015; Abou Tayoun et al., 2018) and only 
pathogenic or likely pathogenic variants were prioritised for follow-up (Figure 2.14). As an 
addition to supporting evidence PP4 (gene involved in a disorder with affected hearing), a list of 
known deafness genes in humans and/or mice was used as compiled by Lewis et al. (Table S8) 










2.5. Tools for data analysis and interpretation 
2.5.1. Bioinformatics packages 
PLINK is an open-source package, developed to facilitate the analysis of genome-wide association 
studies and can effectively analyse very large datasets for hundreds of thousands of SNPs across 
large sample sizes (Purcell et al., 2007). Therefore, PLINK (v1.90) was selected for association 
analyses of common variants in this work and all analyses were run within a Linux environment. 
RVTESTS is a software package which allows gene-based collapsing analysis to be performed (Zhan 
et al., 2016), in this way identifying whether qualifying rare variants across the 11 candidate Usher 
genes were, in aggregate, associated with a hearing and/or language phenotype. The Burden-
Zeggini (BZ) model was employed upon all variants with MAF≤1% to test for increased burden 
(MAF was based on the frequency of each variant in the 1,681 ALSPAC UK10K core cohort). BZ 
works by aggregating counts of rare variants into 1 variable for each individual and tests whether 
the variable is associated with phenotype variation on a single phenotype basis (Morris and 
Zeggini, 2010). As this approach works under the assumption that a large proportion of the 
variants are causal and have the same direction of effect, it is a powerful method to detect a 
group of rare variants with a deleterious effect.  
VCFtools is a programme package designed for working with variant call format (vcf) files 
(Danecek et al., 2011), generated from sequencing studies, such as the ALSPAC UK10K datasets. A 
range of VCFtools commands were used to summarise and filter out data, to compare and merge 
files, to run calculations and summarise variants.  
SnpEff (v.4.3) is a genetic variant annotation and functional prediction toolbox, designed to work 
with vcf files (Cingolani et al., 2012). It was used for simple annotations of variants within ALSPAC 
genotype and ALSPAC UK10K datasets in order to locate each variant within the human genome 
and to predict its effect.  
wAnnovar is a web-based rapid and efficient tool that uses the ANNOVAR software to annotate 
functional consequences of genetic variation (http://wannovar.wglab.org/) (Chang and Wang, 
2012). It was used to link population allele frequency information for investigated variants and to 
predict functional effect to the protein.  
2.5.2. In Silico tools  
2.5.2.1. ClinVar and gnomAD 
Pathogenicity in Results Chapter 1 was defined by a clinical significance of 4 or 5 of reported 
variants in ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/). Each identified Usher 
pathogenic mutation from the ALSPAC UK10K cohort was annotated with genome information 
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retrieved from the UCSC Genome Browser (http://genome.ucsc.edu/), which included genome 
position, identification number, transcript details, reference and alternative allele, functional 
effect, DNA and protein change. ClinVar database was used to interpret the clinical significance of 
each mutation and gnomAD (v2.1) browser (http://gnomad.broadinstitute.org/) was used to 
retrieve information on the allele frequency of each mutation.  
2.5.2.2. Constraint scores  
For loss of function gene classification in Results Chapter 4, the following constraint scores were 
taken into account: pLI, pRec and o/e ratios (all accessed through the gnomAD browser at 
http://gnomad.broadinstitute.org/). The probability of being loss-of-function (LoF) intolerant (pLI) 
separates genes of sufficient length into LoF intolerant (pLI ≥ 0.9) or LoF tolerant (pLI ≤ 0.1) 
categories. pRec shows the probability of being intolerant to two loss of function variants within 
the same gene (recessive inheritance). pRec≥ 0.9 is the cut-off for highly intolerant genes. The o/e 
LoF ratio is a score showing a ratio of observed/expected individuals with that particular variant. 
The scale of o/e is the opposite of pLI, where low o/e values are indicative of strong intolerance. A 
gene with LoF o/e score of 0.1 will be interpreted as a gene where only 10% of the expected LoF 
variants were observed and therefore is likely under selection against LoF variants.  
2.5.2.3. Putative functional effect, splicing defect prediction and evolutionary 
conservation 
Putative functional effects of associated variants in Results Chapter 4 were evaluated using 
Sorting Intolerant From Tolerant (SIFT), Polymorphism Phenotyping v2 (PolyPhen2), Combined 
Annotation Dependent Depletion (CADD) score and Genomic Evolutionary Rate Profiling (GERP) 
score, while splicing-altering single nucleotide variants were predicted using ada- and rf-scores, 
and evolutionary conservation of the affected nucleotide was assessed across 100 vertebrate 
species using the phastCons and phyloP conservation scores from wAnnovar.  
To assign pathogenicity, SIFT and PolyPhen-2 algorithms consider protein sequences, motifs and 
structures and thus can only be used for coding changes and missense mutations in particular (Ng 
and Henikoff, 2001; Adzhubei et al., 2010). SIFT scores range between 0 and 1, where amino acid 
substitutions are classified as “deleterious” for scores ≤ 0.05 and “tolerated” when > 0.05. 
PolyPhen-2 provides scores for two models: HumDiv, more appropriate for identification of rare 
alleles at loci involved in complex phenotypes, and HumVar, more appropriate for distinguishing 
mutations with drastic effect in Mendelian disorders. For both models, PolyPhen-2 scores range 
between 0 and 1, where scores ≥ 0.95 predict a “deleterious” effect. Functional effects are 
evaluated as “benign”, “possibly damaging” and “probably damaging”, based on pairs of false 
positive rate thresholds.  
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The CADD score integrates many diverse annotations into a single, quantitative score by 
contrasting variants that survived natural selection with simulated mutations (Kircher et al., 
2014). CADD measures deleteriousness of single nucleotide variants, as well as 
insertions/deletions variants in the human genome. CADD scores strongly correlate with allelic 
diversity, pathogenicity of both coding and non-coding variants, and experimentally measured 
regulatory effects, and also highly rank causal variants within individual genome sequences. 
PHRED-like (-10*log10(rank/total)) scaled CADD score ranks a variant relative to all possible 
substitutions of the human genome (8.6x109). A scaled CADD score of greater of equal 10 
indicates that these are predicted to be the 10% most deleterious substitutions that you can do to 
the human genome, whereas scores of greater or equal 30 are predicted to be the 0.1% most 
deleterious possible substitutions in the human genome. 
The GERP score is defined as the reduction in the number of substitutions in the multi-species 
sequence alignment compared to the neutral expectation (Davydov et al., 2010). For example, a 
GERP score of 4 would mean there are 4 fewer substitutions at a particular site than what is 
expected based on the neutral rate of evolution across the phylogeny. As such, the GERP score is 
a measure of sequence conservation across multiple species. Thus, positive scores represent a 
substitution deficit (which would be expected for sites under selective constraint), while negative 
scores represent a substitution surplus. 
Splicing ada and rf scores are splicing-change predictions for splicing consensus SNPs (scSNVs)  
across the human genome, based on adaptive boosting and random forest ensemble learning 
methods, respectively (Jian, Boerwinkle and Liu, 2014). A variant is considered to be splice altering 
when both predictions are taken into account and both are higher than the optimum cut off value 
of 0.6 (Jian, Boerwinkle and Liu, 2014). 
PhastCons is based on a hidden Markov model (a statistical model of sequence evolution) which 
shows the probability of each nucleotide belonging to a conserved element, considering flanking 
alignment columns (Siepel et al., 2005). Scores range between 0 and 1, where 0 shows divergent 
bases and 1 conserved. PhyloP measures conservation at individual alignment columns and 
disregards the effect of their neighbours (Pollard et al., 2010). Scores range between -14 and +6, 
where negative values represent nucleotide bases that have undergone accelerated evolution and 
positive values represent conserved bases.  
2.5.3. Statistical analyses tools 
The performance of Usher pathogenic carriers (N= 17 individuals) (Section 3.2.1 for description) 
and sAPD group (N= 13 individuals) on neurodevelopmental measures (including language, 
reading, cognition, educational support, neurodevelopmental disorders and hearing) was 
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compared to control groups. Those included individuals that were known non-carriers of Usher 
heterozygous pathogenic variants (N= 1,664 non-carriers not found to carry a heterozygous 
pathogenic variant in the 11 USH genes) and individuals not suspected for APD according to the 
same selection criteria as the sAPD group (N= 163 unsuspected individuals). Descriptive statistics 
to show score distributions of quantitative and discrete measures for the two groups (Usher 
carriers vs non-carriers and sAPD group vs unsuspected group) was performed in IBM SPSS, 
version 25. The expected normal range between 5th and 95th percentile was computed for each 
tested quantitative measure in the control groups so individuals from the Usher carriers and the 
sAPD groups performing outside the normal range could be identified. Effect sizes were computed 
as standardised mean difference (Cohen’s d) with 95% confidence interval in SPSS (Cohen, 1998). 
The effect size for the tested discrete measures was calculated as Relative Risk (RR) with 95% 









3. Results Chapter 1: Genotype-driven rare 
Mendelian analysis 
3.1. Rationale 
Preliminary genetic investigations of a discovery family affected by a severe language disorder 
with AP difficulties (Figure 2.1) showed a stop-gain heterozygous pathogenic variant in the USH2A 
gene as further described by (Perrino et al., 2020). The apparent AD inheritance pattern in the 
family (Figure 2.1) matched with the observed stop-gain heterozygous USH2A pathogenic variant, 
which co-segregated in the family (Perrino et al., 2020). At a population level, Perrino et al. 
showed that these USH2A variants increased the risk of delayed language milestones, but they 
alone did not result in a discernible carrier phenotype (Perrino et al., 2020). Given these findings, 
and the known role of usherin in stereocilia development in Usher syndrome (Section 1.3.4.), we 
hypothesised that pathogenic heterozygous variants in other USH causing genes (MYO7A, CDH23, 
PCDH15, USH1C, USH1G, CIB2, USH2A, ADGRV1, WHRN and CLRN1) have a similar subtle effect on 
developmental profiles in other carrier individuals (Hypothesis 1: H1). The atypical USH gene 
HARS was added to the hypothesis as a novel USH3B player. 
To test H1, a genotype-driven Mendelian approach was utilised where individuals who carried 
variants previously identified as pathogenic in Usher syndrome were identified from the ALSPAC 
UK10K core cohort (N= 1,681) (Section 2.3.4). Individuals found to carry a pathogenic USH variant 
were compared to non-carrier controls on a range of neurodevelopmental measures to identify 




3.2.1. Pathogenic Usher carriers 
Seventeen UK10K individuals (14 M: 3F, from 1,681 individuals with sequence and phenotypic 
data available, 1.01% detection rate) were identified as carriers of known USH gene variants that 
were designated as “pathogenic” in ClinVar. These consisted of eight distinct variants which were 
always detected in a heterozygous form in USH2A (relating to USH2 syndrome) and MYO7A, 
USH1C or CDH23 (relating to USH1 syndrome) (Table 3.1). No second hit was observed in either 
USH2A, MYO7A, USH1C or CDH23, indicating that all 17 individuals were carriers. None of the 17 
individuals had a genetic diagnosis of Usher syndrome. This is not surprising as the number of 
individuals tested here (1,681) is not large enough to detect USH cases with reported population 
frequency of 4- 17 in 100,000 individuals (meaning that 1 case will be detected in a population of 
5,882 individuals) (Kimberling et al., 2010). The variant found in the discovery family 
(rs765476745) was not present in the UK10K samples (Table 3.1). No pathogenic variants were 
found in the rest of the USH genes tested (ADGRV1, WHRN, CLRN1, PCDH15, USH1G, CIB2 and 
HARS) across the UK10K sample. It needs to be noted that the 1,681 individuals in the ALSPAC 
UK10K core cohort were not excluded on basis of hearing or neurodevelopmental impairment 
(Section 2.3.4) and as such they represent an entire population spectrum that will include 




 Table 3.1. Heterozygous pathogenic mutations identified across USH2A, MYO7A, USH1C and CDH23 in individuals from ALSPAC UK10K core cohort























 1 chr1:215956104 rs111033264 NM_206933.2 A G 24.8 pathogenic: USH2A 0.0000003 missense c.10561T>C p.Trp3521Arg 
 5 chr1:215963510 rs148660051 NM_206933.2 C T 247 
pathogenic: USH2A 
and AR retinitis pigmentosa 
0.000004 missense c.10073G>A p.Cys3358Tyr 
 1 chr1:216019240 rs397518041 NM_206933.2 C T 46.4 pathogenic: USH2A 0.00002 stop-gained c.8981G>A p.Trp2994* 
 6 chr1:216420436 rs80338903 NM_206933.2 C (-) 967 
pathogenic: USH2A 
and AR retinitis pigmentosa 
0.0007 frameshift c.2299delG p.Glu767Serfs 
 1 chr1:216497582 rs121912600 NM_206933.2 C A 171 pathogenic: USH2A 0.00004 missense c.1256G>T p.Cys419Phe 
MYO7A  1 chr11:76867949 rs121965080 NM_000260.3 C T 114 pathogenic: USH1B 
Not 
reported 
missense c.634C>T p.Arg212Cys 
USH1C  1 chr11:17552955 rs397515359 NM_005709.3 C CG 15.5 pathogenic: USH1C 0.0003 frameshift c.238dupC p.Arg80fs 
CDH23  1 chr10:73492049 rs121908351 NM_022124.5 G A 84.2 
pathogenic/likely 
pathogenic: USH1 and AR 
non-syndromic deafness 
0.000 missense c.4036G>A p.Asp1346Asn 
1- Genome location according to GRCh37/hg19 assembly. 
2- Single nucleotide polymorphism identification number. 
3- Transcript variant identification number according to NCBI RNA reference sequence collection (RefSeq). 
4- Reference allele on forward (+ strand) of the human genome. 
5- Alternative allele on forward (+ strand) of the human genome; (-) represents a deleted base. 
6- Phred-scaled quality score: assertion made in Alt i.e. give -10log_10 prob (call in Alt is wrong). High QUAL scores indicate high confidence calls. QUAL> 15 is acceptable. 
7- Clinical significance value as recommended by the American College of Medical Genetics and Genomics for variants interpreted for Mendelian disorders. 
8- Minor allele frequency: frequency of the second most common allele as reported on gnomAD browser (http://gnomad.broadinstitute.org/). 
9- Predicted functional effect of variant on RefSeq transcript. 
10- Coding DNA position where the alteration has taken place; (>) represents substitution, (del)- deletion and (dup)- duplication.  
11- Protein consequence showing the exact amino acid where the change has occurred; (*) represents a stop codon and (fs)- frameshift. 
MAF=0.000 (rs121908351) = variant not reported 
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3.2.2. Cohort characteristics as a group 
Performance on 684 individual measures of neurodevelopment (including measures of hearing 
and language) (Table S1) was compared between the 17 USH carriers and 1,664 non-carriers in 
order to characterise the carrier individuals at a broad neurodevelopmental level and to find 
areas where they showed difficulties (performed below expected).  
Characterising the USH carriers at a broad neurodevelopmental level showed that, as a group, the 
USH carriers performed below expected on a measure of early vocabulary at 3 years (ALSPAC 
code kg865) (Cohen’s d= 0.52, 95% CI= 0.03- 1.01) and word combination at 3 years (ALSPAC code 
kg868) (Cohen’s d= 0.84, 95% CI= 0.34- 1.33) compared to non-carriers (Table 3.2a) (Figure 3.1a 
and 3.1b). Although the effect size of the difference between the means of the USH carrier group 
and the non-carrier group is considered as medium to large for vocabulary and word 
discrimination scores respectively, the 95% CI for both measures spans the value of 0 (95% CI= 
0.03- 1.01 and 95% CI= 0.34- 1.33 respectively), which indicates lower confidence (<95%) in the 
effect sizes, possibly a result of the small sample size available.  
Analysis of available discrete measures showed that parents/carers of USH carriers were three 
times more likely to be concerned about their child’s speech at 2.5 years of age (RR= 3.34, 95% 
CI= 1.41- 7.95) and reported higher incidence of stuttering for carrier children at 8 years (RR= 
2.31, 95% CI= 0.82- 6.54) (Table 3.3) (Figure 3.1c and 3.1f). Children who were USH carriers were 
also twice as likely to have problems with talking at 3 years of age, compared to non-carriers (RR= 
2.02, 95% CI= 0.98- 4.17) (Table 3.3) (Figure 3.1d). Teachers expressed complaints towards the 






Table 3.2a. Quantitative measures of language, reading and cognition in carriers of USH pathogenic variants compared to non-carriers in ALSPAC UK10K core cohort (lower scores 
represent poor performance) 
 
Table 3.2b. Quantitative measures of language, reading and cognition in carriers of USH pathogenic variants compared to non-carriers in ALSPAC UK10K core cohort (higher scores 
represent poor performance) 
 













5th percentile N carriers 
below 5th 
percentile 
Vocabulary score 3 years 64 - 246 219.31 1598 0 - 246 232.40 24.83 186 2 of 16 
Plurals score 3 years 7 - 12 10.47 1591 1 - 12 10.32 2.02 6 0 of 15 
Past tense score 3 years 11 - 42 35.47 1581 0 - 42 34.23 9.44 13 1 of 16 
Word combination score 3 years 0 - 26 19.13 1590 0 - 26 22.79 4.31 15 4 of 16 
Language score 3 years 223 - 324 296.00 1568 94 - 326 300.90 31.49 236.9 2 of 15 
Reading score 7 years 14 - 45 28.59 1555 0 - 50 30.10 8.74 15 1 of 17 
Spelling score 7 years 3 - 15 7.29 1544 0 - 15 8.36 4.27 2 0 of 17 
Nonword Repetition (NWR) 8 years 4 - 10 6.76 1555 0 - 12 7.48 2.46 3 0 of 17 
WOLD comprehension 8 years 5 - 13 8.18 1554 2 - 14 7.76 1.90 5 0 of 17 
WISC - Verbal IQ 8 years 93 - 130 115.18 1548 54 - 155 112.02 16.75 86 0 of 17 
WISC - Performance IQ 8 years 82 - 139 103.29 1547 46 - 145 103.56 16.85 76 0 of 17 
WISC - Total IQ 8 years 90 - 135 111.06 1542 46 - 148 109.22 16.21 82 0 of 17 


















Air conduction Right average 0.5, 1, 2, 4 kHz 7 years 1.25 - 12.5 7.43 1444 -3.75 - 78.75 8.82 6.75 18.75 0 of 17 
Air conduction Left average 0.5, 1, 2, 4 kHz 7 years 0 - 16.25 7.35 1443 -8.75 - 66.25 8.64 7.03 20 0 of 17 
Low_frequency_min 7 years 5 - 15 10.88 1444 -10 - 50 10.53 6.62 20 0 of 17 
Mid_frequency_min 7 years -1.67 - 11.67 4.12 1489 -8.33 - 71.67 5.41 5.84 15 0 of 17 
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Table 3.3. Discrete measures of educational support, neurodevelopmental disorders and hearing in carriers of USH pathogenic variants compared to non-carriers in ALSPAC UK10K core 
cohort 
Measure Age N affected 
carriers 




Carer worried about child’s speech 2.5 years 4 of 16 0.25 118 of 1577 0.075 
Child has problems with talking 3 years 5 of 15 0.33 262 of 1589 0.16 
OME/abnormal middle ear pressure (< -100 daPa)  7 years 6 of 17 0.35 421 of 1507 0.278 
Hearing Impairment 7 years 0 of 17 0 114 of 1489 0.076 
Teacher's rating of child is average/below average 7 years 2 of 10 0.2 307 of 857 0.35 
Child received complaints from the teacher*  7.5 years 8 of 17 0.47 297 of 1559 0.19 
Child currently has uncontrollable tics or twitches 7.5 years 1 of 16 0.63 34 of 1543 0.02 
Child has learning difficulties requiring special arrangements at school 7.5 years 0 of 16 0 55 of 1545 0.036 
Child has speech problems requiring special arrangements at school 7.5 years 0 of 16 0 13 of 1545 0.008 
Child has hearing problems requiring special arrangements at school 7.5 years 0 of 16 0 30 of 1545 0.019 
Child has eyesight problems requiring special arrangements at school 7.5 years 0 of 16 0 13 of 1545 0.008 
 Child has physical problems requiring special arrangements at school 7.5 years 1 of 17 0.059 11 of 1545 0.007 
Child has reading difficulties requiring special arrangements at school 7.5 years 0 of 17 0 70 of 1545 0.045 
Child has emotional/behavioural problems requiring special arrangements at school 7.5 years 1 of 17 0.059 21 of 1545 0.014 
DAWBA DSM-IV clinical diagnosis - Any ADHD disorder 7.5 years 0 of 17 0 20 of 1566 0.013 
Child has ever had speech/language therapy 7.5 years 3 of 14 0.214 156 of 1523 0.102 
Child stutters/stumbles when speaks 8 years 3 of 17 0.176 119 of 1557 0.07 
 Mother told child has Dyslexia 9 years 1 of 14 0.07 71 of 1538 0.05 
B6b: Mother told child has Dyspraxia 9 years 1 of 14 0.07 28 of 1510 0.02 




Figure 3.1. Differences in the performance for carriers of USH pathogenic variants compared to non-carriers on a range of language 
and neurodevelopmental measures.  
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3.2.3. Individual Usher carriers’ characteristics 
In order to further characterise and compare the 17 USH carriers on an individual, rather than 
group level, neurodevelopmental ALSPAC measures where at least 1/17 carriers showed deficits 
were combined into composite scores across different time points allowing any trends of a 
recurrent difficulty to be revealed (Table S2-S3). This analysis showed that 11/17 USH carriers 
(65%) had recurrent ear problems that included earache, ear discharge, red and sore ears, pulling 
on ears, ear infections and use of ear drops between 6 months and 7.5 years of age (Table 3.4). 
Furthermore, 10/17 carriers (59%) showed a recurrent hearing problem/concern which could be 
attributed to an early sign of difficulties processing sounds, concerns over hearing abilities from 
carers/health professionals, to a referral for a hearing assessment and abnormal middle ear 
pressure measurements between 15 months and 9 years of age (Table 3.4). It needs to be noted, 
however, that none of the 17 individuals suffered from overt hearing loss or had a hearing 
impairment. Six of sixteen carriers (38%) indicated a recurrent problem with speech/talking based 
on carers expressing concerns about speech development, stuttering/stumbling, use of babbling 
noise, wrong order of words or had attended speech therapy (Table 3.4). Moreover, 6/17 carriers 
(35%) showed recurrent signs of speech and language difficulties, defined by vocabulary size, use 
of grammar, combination of words and intelligibility between the age of 1.5 and 3 years (early 
scores), reading, spelling and NWR between the age of 7 and 9 years and pragmatic skills at 9.5 
years (measured by Children’s Communication Checklist- CCC) (Table 3.4). Finally, 11/17 carriers 
(65%) showed persistent poor scores in a composite measure designated as general development 
(Table 3.4). The general development measure included early fine and gross motor coordination 
skills, understanding and communication skills (between 6 months and 1.5 years), IQ scores at 8 
years (as defined by Wechsler Intelligence Scale for Children- WISC), problems at school between 
7.5 and 13 years (defined by teacher’s reports on child’s ability, medical diagnosis and special 
education needs requiring school action) and friendship score at 8 years old. Three of the 
seventeen USH carriers (17%), of which one had dyslexia and one dyspraxia, were classed as 
children with special education needs or had received school action (Table 3.4). None of the 
carriers showed deficits on verbal and non-verbal intelligence (minimum score was low average), 
with total IQ scores ranging from average to exceptional (Table 3.4 and S2).  
To further investigate any genotype-phenotype correlations resulting from the type of USH 
variant carried by each of the 17 individuals, the USH carriers were grouped into two groups: LoF 
group (one carrier of USH2A stop-gain, six carriers of USH2A frameshift and one carrier of USH1C 
frameshift variant) and missense group (seven carriers of USH2A, 1 carrier of MYO7A and 1 carrier 
of CDH23 variant) (Table 3.4). This revealed that 5/8 (55%) LoF USH variant carriers had recurrent 
problems leading to both ear-related and hearing problems, compared to 3/9 (33%) missense USH 
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variant carriers (Table 3.4). Further 2/8 (25%) LoF USH variant carriers showed recurrent problems 
in both areas of talking abilities (reported by parent/carer) and speech and language skills 
(clinically recorded), while none of the missense USH carriers showed recurrent deficits in both 
areas (Table 3.4). In contrast 4/8 (50%) LoF USH variant carriers showed recurrent deficits in 
overall development compared to 7/9 (77%) missense carriers (Table 3.4). 
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Table 3.4. Heat map of individual deficits (in stop-gain and frameshift- USH pathogenic carriers) across 
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red cells= persistent problem, reported on two or more time points OR two different problems reported at one or 
more timepoints; orange cells= isolated problem reported at one time point OR two problems that are 
related/happen at the same time point; green cells= no problems reported. 
Speech and language composite score includes early scores (15m-3Y)| reading/ spelling/ NWR (7Y-9Y) & pragmatic 
skills (CCC 9.5Y); Development composite score includes early scores (6m-1.5Y) | IQ (WISC 8Y) | teacher reports & 
SEN (7.5-13Y) | Friendship score (8Y). 
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3.3. Discussion  
Identifying USH pathogenic carriers from the ALSPAC UK10K core cohort resulted in detecting 14 
individuals carrying USH2A pathogenic variants, and a further 3 individuals carrying pathogenic 
MYO7A, USH1C and CDH23 variants (Table 3.1). Comparing developmental profiles between USH 
carriers and non-carriers showed that as a group the 17 USH carriers had expressive language 
delays at an early age (3 years) and a higher incidence of stuttering plus increased complaints 
from teachers in the classroom at the age of 7.5- 8 years (Figure 3.1). Further analysis of individual 
profiles of USH carriers across different ages indicated common trends amongst the carriers 
towards recurring subtle difficulties with hearing, language and overall development which in the 
majority of cases did not lead to a recognised clinical problem (Table 3.4). 
3.3.1. Carriers of pathogenic USH gene variants show poor early 
expressive language as a sign of a delay rather than a deficit 
The vocabulary and word combination scores at 3 years of age are early markers of expressive 
language. The vocabulary measure is a sum of items that a child could use and/or understand, 
from a list of 123 words (ALSPAC variable kg865) while the word combination measure is a sum of 
13 sets of items that a child could combine correctly (ALSPAC variable kg868). The scores for both 
measures were derived from a parental questionnaire and range from 0 (child did not understand 
or use any of the 123 words) to 246 (child could use and understand all of the 123 words) for 
vocabulary, and from 0 (child did not combine correctly any of the 13 items) to 26 (child could 
combine all 13 items correctly) for word combination. Although as a group the USH pathogenic 
carriers showed slightly smaller vocabulary size and fewer word combinations than expected, 
later language measures (Verbal IQ and NWR) were found to be comparable with the non-carrier 
group (Table 3.2a), suggesting a trend towards a delay in early expressive language. 
The measures “carer worried about child’s speech” and “child has problems with talking” (ALSPAC 
variables kf550 and kg904) are subjective scores that examine signs of speech development in 
children aged 3 from the perspective of the parent/carer. A greater proportion of the 
parents/carers looking after children who were pathogenic USH carriers answered “yes, worried 
about speech” and “yes, has problems with talking” to the two questions, indicating a possible 
problem with speech/talking at age of 3. However, by 7 years of age, those USH carrier children 
who had shown a speech/talking difficulty at the age of 3, were reported clear of it and none of 
them had speech problems requiring special arrangements at school (Table 3.3). This 
demonstrates that, although there is a trend, the early detected talking and speech problems are 
likely to represent a speech delay rather than a deficit.  
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The questionnaires on the “child’s speech including stuttering/stumbling” are also aimed at 
identifying speech problems, but at a later age, at 8 years old, and so can be predictive of speech 
disorders at school age. Although USH carriers showed a higher risk of stuttering/stammering, the 
children showing these risks were different individuals from those who showed concerns over 
speech and talking at 3 years of age. Nevertheless, if we consider the USH carriers as a group, 
rather than as individuals, the group results show an increased overall risk for speech difficulties. 
The higher frequency of USH carriers exhibiting this problem could therefore be an additional 
indicator of a correlation between heterozygous changes and possible speech difficulties, in this 
case- at school age.  
3.3.2. High teacher complaints as a sign of classroom difficulties for USH 
carriers 
The teacher complaint score (kr468b) is a derived sum of complaints from teachers toward 
students at the age of 7.5 years including reasons such as restlessness or overactivity; poor 
concentration or being easily distracted; acting without thinking, frequently butting in, or not 
waiting their turn. A score of 0 denotes no complaints at all and a score of 6- maximum 
complaints (the higher the score, the higher the number and severity of teacher complaints). 
Because this is an overall score that could result from one or more reasons, from this measure 
alone, it is not possible to conclude whether the child received a high complaint score because 
they were overactive and restless in class, because they showed poor concentration or because 
they showed impatience (or maybe all three together), which could be signs of 
neurodevelopmental difficulties in ASD, ADHD, APD, DLD. Therefore, the higher likelihood of 
higher teacher complaints score for children carriers of USH pathogenic variants can be 
interpreted as a sign of classroom difficulties for carriers, but is not a phenotype showing a deficit 
in a specific area of development. It needs to be noted that the USH carriers all had typical 
hearing sensitivity (as measured by pure tone audiometry- Table 3.2b).  
3.3.3. USH carriers show trends for subtle problems with hearing  
The identification of subtle difficulties in hearing amongst USH carriers, revealed through analysis 
of composite neurodevelopmental scores, is not surprising because of the role of Usher related 
genes in inner ear hair cell development. In fact, it has been long recognised that carriers of genes 
for deafness exhibit some subclinical abnormalities in pure-tone sensitivity (Anderson and 
Wedenberg, 1968), which has later been shown to be the case for USH1 and USH2 subtype 
carriers (Wagenaar et al., 1995; van Aarem et al., 1995). While homozygous pathogenic variants in 
Usher genes are in general expected to cause Usher syndrome with overt hearing loss (Le Quesne 
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Stabej et al., 2012), pathogenic heterozygous variants in the same genes can lead to subtle, but 
persistent changes in auditory processes which over time can build up and result in an increased 
risk to APD. For example, a heterozygous Cdh23 mouse knock-out (heterozygous for a presumed 
null allele of Cdh23) showed hearing loss at both low and high frequencies at 5-6 weeks of age, 
with high frequency component worsening with age (Holme and Steel, 2004). This suggests that 
Cdh23 heterozygous pathogenic changes, and not only homozygous, can lead to an auditory 
phenotype that persists and gets worse over time. A similar model of effect that builds up has 
been proposed for chronic otitis media with effusion, which is a known risk factor for secondary 
APD (Khavarghazalani et al., 2016), likely because hearing gets disrupted during an important 
developmental period. 
Hearing and ear-related problems showed to be enriched amongst USH carriers of LoF pathogenic 
variants (such as stop-gain and frameshift, which may result in truncating the USH proteins), 
compared to carriers of missense USH variants who showed to suffer less frequently of such 
problems. While genotype-phenotype correlations have been previously described for USH genes 
in relation to severity of hearing loss (Bolz et al., 2001; Bork et al., 2001; Astuto et al., 2002; 
Doucette et al., 2009; Schultz et al., 2011), in the context of increased risk for APD, it is possible 
that the more severe heterozygous USH variants are more likely to affect hearing, which can in 
turn affect auditory processes as explained above.
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3.4. Conclusion  
Results Chapter 1 was based on the hypothesis that heterozygous variants in Usher causing genes 
have a subtle effect on developmental profiles, similar to the subtle effect of USH2A heterozygous 
pathogenic variants on early language and audition, shown by Perrino et al. (Perrino et al., 2020). 
This hypothesis is confirmed by results indicating that heterozygous USH2A, MYO7A, CDH23 and 
USH1C pathogenic variants are associated with subtle problems in hearing and delays in early 
language milestones, but there is no one measure that could be considered as a “clinical marker 
of deficit” of USH carriers. Instead, these subtle difficulties might put Usher carriers at a higher 
risk of developing APD and having delayed language development.  
The finding of no one clear phenotype resulting directly from heterozygous pathogenic Usher 
gene variants is in line with heterogeneous presentations in other disorders. For example, 
heterogeneity is seen even in cases where variants explain majority of risk (SATB1 in relation to 
neurodevelopmental disorder) (den Hoed et al., 2020) and may be due to the genetic background 
of the individual and the effect of a particular variant on the protein function. Moreover, 
heterogeneity in neurodevelopmental conditions is thought to be influenced by the small effect 
size of individual variants which act in complex genetic mechanisms leading to different 
behavioural phenotypes between individuals (Girirajan et al., 2012; Hemati et al., 2018). This 
suggests that, as with other neurodevelopmental conditions, the Usher pathogenic variants alone 
are not causative of APD and do not result in a discernible carrier phenotype as would be 
expected in a monogenic model. Instead, they might form part of a genetic risk within a complex 
genetic model. Given these findings, the effect of Usher genes variation on neurodevelopmental 
ALSPAC measures (such as common variants that form part of complex disorders) was examined 




4. Results Chapter 2: Association analyses of 
common variants 
4.1. Rationale 
Results Chapter 1 showed that rare pathogenic heterozygous variants in known Usher syndrome 
genes USH2A, MYO7A, USH1C and CDH23 increased the risk of subtle hearing problems and 
delayed language milestones in some cases but did not directly lead to a distinct carrier 
phenotype (as would be expected in a monogenic model). This led to Hypothesis 2 (H2) where 
under the present investigations of effect on hearing, auditory processing and language abilities, 
we hypothesised that common variants in Usher genes form part of a complex genetic model. 
According to H2, the effect of each individual common variant is small and not sufficient to fully 
explain a particular phenotype, but can contribute to susceptibility or altered ability (in line with 
complex genetic disorders discussed in Section 1.4.2).  
To test H2, SNPs tagging common variants within 10 typical USH genes (MYO7A, CDH23, PCDH15, 
USH1C, USH1G, CIB2, USH2A, ADGRV1, WHRN, CLRN1) and one atypical USH gene (HARS) were 
analysed for allelic association in the ALSPAC genotype core cohort (N= 7,141) (Section 2.3.2) 
using PLINK. Three measures of hearing: low-frequency hearing (low freq_min), mid-frequency 
hearing (mid freq_min) and otitis media with effusion status (OME) (Section 2.2.1.1), and five 
measures of language: early communication skills (comm), early vocabulary size (vocab), nonword 
repetition (NWR), Verbal IQ (VIQ), developmental language disorder (DLD) status (Section 2.2.1.2), 
were assessed for direct association (Section 2.4.2) (Figure 2.15).  
Results from Perrino et al. showing that heterozygous disruptions of mouse Ush2a led to altered 
low-frequency thresholds, which were further associated with disrupted mouse vocalisations 
(Perrino et al., 2020), warranted a further investigation into the relationship between low-
frequency hearing abilities and language within an interactive model on a population level. For 
this purpose, GxE interaction modelling was applied to the ALSPAC genotype core cohort (Section 
2.4.2), in which low-frequency hearing was included as an interaction factor to the complex model 





Across the eleven USH genes analysed, two genes (USH2A and CLRN1) contained at least one 
significant SNP associated with hearing or language outcomes and one further gene (PCDH15) 
contained a cluster of suggestively associated SNPs with hearing and language outcomes (see 
Table S4 for significance value for all SNPs per gene). Three more genes (CDH23, ADGRV1 and 
USH1C) indicated sporadic association to hearing and/or language outcomes, which were 
represented by single SNPs, while three other genes (CIB2, WHRN and MYO7A) showed no 
association (Table S4). USH1G and HARS common variants were not analysed as the genes were 
not covered by the genotype assay. The sections below review each of the significant genes one 
by one according to SNPs reaching the Bonferroni corrected p-value (Table 4.1). 
Table 4.1. Usher genes with P-values of significance for association analyses 
 
4.2.1. USH2A common variants are directly associated with low-
frequency hearing outcomes and indirectly associated with early 
language milestones 
A cluster of SNPs located towards the 5’end of USH2A (between intron 4 and 13 on NM_206933.2 
transcript) showed association specifically with low-frequency hearing thresholds (Table 4.2 & 
Figure 4.1). The top associated SNP (rs10864237, p= 2.92 x 10-5) explained 0.39% of variance in 
low-frequency hearing thresholds (ßSE= 0.1), representing a 0.9dB difference between risk (T/T 
genotype group with low-frequency thresholdsmean= 10.77 dB) and non-risk individuals (C/C 
genotype group with low-frequency thresholdsmean= 9.864 dB) (Table 4.2 & Figure 4.3). This 
difference in low frequency hearing thresholds was found to be statically significant, t(2466)= 3.1, 
p= 0.0018 (Figure 4.3). These analyses show that common USH2A variants exert a small effect on 
low-frequency hearing thresholds within the typical range. No association was found between 
common variants in USH2A and language outcomes (Table 4.2).  
Gene Length of region 
(Kb) 
N pruned SNPs N tested traits Corrected P-value of 
significance (Bonferroni)* 
USH2A 820 129 8 4.84E-05 
CLRN1 66 8 8 7.81E-04 
ADGRV1 625 66 8 9.47E-05 
HARS 37,8 0 8 Gene not covered 
WHRN 123 21 8 2.98E-04 
PCDH15 1,018 135 8 4.63E-05 
CDH23 439 127 8 4.92E-05 
MYO7A 106 22 8 2.84E-04 
USH1C 70 34 8 1.84E-04 
CIB2 46 11 8 5.68E-04 
USH1G 27 0  8 Gene not covered 
* Bonferroni significance calculated at an alpha level of 0.05 
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The association between USH2A variation and low-frequency hearing abilities together with the 
results from Perrino et al., showing that heterozygous Ush2a disruptions in mice affect their 
expressive communication abilities, warranted a further investigation into the relationships 
between USH2A and language. In this model, common variants in USH2A were assessed for 
association to language outcomes in ALSPAC, but this time including low-frequency hearing 
thresholds as an interaction factor (GxE interactions in Section 2.4.2). Significant association was 
now observed with early vocabulary at 3 years (kg865), represented by the top SNP rs7532570 
(Table 4.2), located towards the 5’ end of USH2A (between intron 4 and 13 on NM_206933.2 
transcript) (Figure 4.2b). Within this interactive model rs7532570 had a p-value of 1.16 x 10-4 
compared to P= 0.197 in the additive model. Together these data suggest that low frequency 






Figure 4.1. UCSC custom track of USH2A genotyped SNPs. Annotations show two protein coding USH2A RefSeq gene transcripts, 
located on the reverse DNA strand of chromosome 1. In blue (bottom of figure) are all genotyped SNPs that are of sufficient quality 





Table 4.2. Associations of 5’ USH2A common variants with hearing and language phenotypes under an additive and interactive model  
    Additive Model Interactive Model 





























rs682319 216417675 T 1.34E-01 6.88E-03 1.65E-02 3.17E-01 9.30E-02 3.62E-01 8.04E-01 7.39E-01 1.91E-02 5.87E-04 1.61E-01 5.03E-02 9.76E-01 
rs386654 216431962 A 9.25E-01 3.90E-01 4.30E-01 5.05E-01 9.38E-01 8.84E-01 8.74E-01 1.98E-01 3.88E-01 6.24E-02 8.12E-01 5.81E-01 8.44E-01 
rs11120747 216438500 G 5.36E-01 5.05E-03 5.81E-01 8.41E-01 2.38E-01 4.97E-01 9.61E-01 1.89E-01 4.79E-01 5.55E-01 2.78E-01 7.56E-02 8.66E-01 
rs2168924 216440105 A 9.98E-02 9.93E-01 4.41E-02 1.98E-01 3.49E-01 3.14E-01 5.37E-02 4.63E-01 1.60E-01 4.54E-01 7.43E-01 7.50E-02 3.75E-01 
rs1159143 216454483 T 2.50E-01 5.13E-03 6.41E-02 6.31E-01 5.38E-01 6.82E-01 7.20E-01 3.20E-01 5.94E-01 9.26E-02 3.12E-01 4.45E-01 6.79E-01 
rs10864237 216466861 C 8.03E-02 2.92E-05 1.14E-03 4.03E-01 2.44E-01 9.09E-01 9.88E-01 3.12E-01 3.47E-01 5.25E-01 1.08E-01 4.98E-02 8.79E-01 
rs17651066 216470121 C 1.29E-01 3.76E-02 2.34E-02 9.42E-01 1.22E-01 4.14E-01 3.15E-01 4.88E-01 5.03E-02 3.18E-03 3.44E-01 1.84E-01 3.28E-01 
rs11801737 216492391 G 7.48E-01 6.39E-04 2.59E-02 3.59E-01 5.39E-01 9.05E-01 7.29E-01 8.23E-01 9.20E-01 4.97E-01 3.68E-01 2.63E-01 6.30E-01 
rs7532570 216504269 G 8.09E-02 1.97E-01 1.16E-01 3.77E-01 1.50E-01 6.86E-01 8.35E-01 8.47E-01 7.64E-03 1.16E-04 2.16E-01 1.16E-01 8.15E-01 
rs17657634 216552571 G 2.14E-01 7.81E-01 7.61E-01 5.01E-01 7.28E-01 2.57E-01 3.17E-02 3.41E-01 6.56E-01 2.39E-01 2.96E-01 7.76E-01 6.69E-01 
rs4253963 216592003 T 5.94E-02 1.20E-02 4.30E-02 2.16E-01 1.60E-01 8.49E-01 6.17E-01 7.32E-01 2.47E-01 2.74E-01 1.54E-01 2.28E-01 5.46E-01 
rs10779261 216595306 C 5.60E-02 4.28E-02 1.41E-02 6.52E-01 6.76E-01 3.77E-01 8.25E-01 8.62E-01 4.44E-01 7.54E-01 4.45E-01 2.27E-01 5.30E-01 
rs12723493 216605071 A 6.39E-01 1.53E-02 5.33E-01 7.98E-01 8.27E-01 2.83E-01 6.59E-01 3.95E-01 1.73E-01 3.37E-01 7.35E-01 1.94E-01 4.36E-01 
SNPs are shown for the 5’ region of association only (chr1:216417675-216605071, hg 19). 
A1 is allele 1 (usually minor). 
Grey cells indicate p-values <0.01. Bold values indicate that p-value was significant after a Bonferroni correction for multiple testing.  




Figure 4.2. Regional USH2A plots of association. 
a) with low frequency hearing thresholds under additive model and b) with vocabulary score at 38 months under interactive model. The -log10 of p values of the 
genotyped SNPs are plotted on the y-axis against genomic positions (hg19 assembly) on the x-axis. The top associated SNPs are represented by the purple diamond: a) 
rs10864237 and b) rs7532570. The colours of all other SNPs are representative of the pairwise r2 value relative to the top SNP using patterns of Linkage Disequilibrium 
from the CEU HapMap populations. The top markers in (b) are shown to be in very high LD with each other and for both (a) and (b) they are in moderate LD with a cluster 
of markers in the 5’ end of the gene, which have moderately elevated -log (p-values). Plots were generated using Locus Zoom (http://locuszoom.org/). 
    




4.2.2. CLRN1 common variants are directly associated with early 
communication skills 
Direct associations under the additive model were observed for a cluster of CLRN1 SNPs and early 
communication skills at 1.5 years (kd654) (Table 4.3 & Figure 4.4). The top-associated SNP 
(rs10935822, p= 2.94 x 10-4) explained 0.21% of variance in early communication scores at 1.5 
years (ßSE= 0.1), representing a 0.78 item decrease in the mean communication score for the risk 
group of individuals (C/C genotype) compared to the non-risk group (T/T genotype) (Table 4.3 & 
Figure 4.5a). This result suggests that CLRN1 common variants exert only a small effect on early 
communication abilities at 1.5 years within the typical range. No associations were observed with 
the core language measures at later ages: vocabulary at 3 years, nonword repetition at 8 years 
and Verbal IQ at 8 years (Table 4.3). There were no associations to hearing outcomes tested 
(Table 4.3). 
Based on the significant associations to communication skills at 1.5 years and the lack of 
association to later language measures at 8 years, associations to other language markers were 
further explored, just before and just after the 1.5 years milestone (between 6 months and 3 
years of age). For this purpose, additional additive model associations were performed on 12 
available language phenotypes taken from 6 months to 3 years of age (Table 4.4). These 






























Figure 4.3. Low frequency hearing threshold per genotype. Risk genotype T/T increases the 
threshold for hearing noises at low-frequency, compared to C/C and C/T genotypes (difference 
between risk T/T and non-risk C/C genotype was significant (p= 0.0018). Error bars represent 
standard error of the mean. N individuals with C/C genotype= 479; N individuals with C/T genotype= 
1,972; N individuals with T/T genotype= 1,989. Value of beta regression coefficient and standard 
error of beta is: ß= -0.5, ßSE= 0.1. 
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receptive and expressive language skills between 15 months and 2 years and developed 
expressive language at 3 years, and were highly positively correlated (Table S5).  
These further association analyses under an additive model showed a suggestive cluster of 
associations between CLRN1 common SNPs and communication skills at 6 months (kb855a), and 
between a larger SNP cluster and vocabulary score at 15 months (kc954) (Table 4.4). The SNPs 
showing highest signals of association were: rs936188 (p=6.01 x 10-4) and rs4680058 (p=3.66 x 10-
3). The risk genotypes G/G for communication skills at 6 months and G/G for vocabulary at 15 
months showed a decrease in the mean scores of communication and vocabulary of 0.43 and 0.72 
less items and words respectively, as compared to the non-risk genotypes of T/T and A/A (Figure 
4.5 b-c). One single SNP (rs4680058) showed suggestive associations to vocabulary scores at 15 
months and 2 years, communication skills at 1.5 years, use of plurals and tenses at 2 years, and 
overall grammar score at 2 years, which were all highly positively correlated measures (Table 4.4 
& S5 for correlations). No associations were observed with vocabulary, language or grammar 
scores at 3 years.  
Taken together, these results show that the association of CLRN1 common variants with early 
language outcomes is only transient (observed up until 2 years) and is most strongly linked to 
expressive communication skills at 1.5 years.  
It needs to be noted that CLRN1 was not fully covered by the genotype assay: the 5’ end was not 
spanned by common SNPs between chr3: 150,678,233- 150,690,786 (12Mb), including 5’UTR, 
exon 1 and the 5’ end of intron 1 (26.7% of the gene length was not covered) (Figure. 4.4) and so 






   Table 4.3. Associations of CLRN1 common variants with hearing and language phenotypes under an additive model 
    Additive Model 























rs4680058 150645351 G 8.21E-01 6.63E-02 1.50E-01 1.27E-03 7.18E-01 9.52E-01 9.96E-01 6.00E-01 
rs1456137 150648811 C 9.40E-01 2.02E-01 1.17E-01 2.12E-02 8.09E-02 5.65E-01 7.30E-01 2.19E-01 
rs936188 150649718 G 6.35E-01 2.35E-01 1.09E-01 9.56E-04 6.28E-01 8.32E-01 7.22E-01 4.15E-01 
rs12635944 150654154 A 9.90E-01 4.40E-01 2.72E-01 4.97E-03 1.02E-01 7.26E-01 5.98E-01 6.76E-01 
rs13092829 150662914 A 6.63E-01 4.57E-01 7.65E-01 5.03E-01 6.08E-01 2.69E-02 4.36E-01 2.81E-01 
rs10935822 150663334 C 8.72E-01 7.65E-01 1.88E-01 2.94E-04 8.44E-01 2.37E-01 2.22E-01 3.90E-01 
rs11924857 150672805 G 9.32E-01 4.60E-01 8.30E-02 1.44E-02 2.18E-01 9.07E-01 4.20E-01 6.50E-01 
rs9825721 150678233 G 1.28E-01 9.54E-01 1.78E-01 2.58E-01 3.52E-01 9.82E-01 5.59E-01 9.65E-01 
Figure 4.4. UCSC custom track of CLRN1 genotyped SNPs. Annotations show four protein coding CLRN1 RefSeq gene transcripts and one non-protein coding transcripts 
(NR_046380.2), located on the reverse DNA strand of chromosome 3. In blue (bottom of figure) are all genotyped SNPs that are of sufficient quality and have been pruned for 
high LD. Top associated SNP is marked in grey box.  
CLRN1 antisense 
A1 is allele 1 (usually minor). 
Grey cells indicate p-values <0.01. Bold values indicate that p-value was significant after a Bonferroni correction for multiple testing. 




Table 4.4. Associations of CLRN1 common variants with early language phenotypes under an additive model 
  
































rs4680058 150645351 G 2.91E-02 3.98E-01 3.66E-03 1.27E-03 4.22E-03 3.44E-03 2.74E-03 8.24E-03 7.18E-01 8.25E-01 8.02E-01 3.83E-01 
rs1456137 150648811 C 7.19E-03 5.45E-01 1.19E-01 2.12E-02 1.67E-01 2.15E-01 4.44E-01 7.72E-01 8.09E-02 8.41E-01 6.54E-01 3.36E-01 
rs936188 150649718 G 6.01E-04 9.93E-01 8.28E-03 9.56E-04 2.06E-01 4.11E-01 4.61E-01 8.21E-01 6.28E-01 7.39E-01 7.96E-01 5.85E-01 
rs12635944 150654154 A 8.62E-03 5.99E-01 5.33E-02 4.97E-03 9.70E-02 5.45E-02 3.05E-01 7.21E-01 1.02E-01 5.66E-01 8.72E-01 2.27E-01 
rs13092829 150662914 A 9.88E-01 8.92E-01 4.10E-01 5.03E-01 6.98E-01 3.14E-01 9.86E-01 6.71E-01 6.08E-01 2.16E-01 3.16E-01 2.66E-01 
rs10935822 150663334 C 3.71E-02 9.38E-01 7.38E-03 2.94E-04 8.11E-02 1.46E-01 3.02E-01 6.77E-01 8.44E-01 4.44E-01 7.89E-01 4.74E-01 
rs11924857 150672805 G 1.44E-01 7.42E-01 7.77E-02 1.44E-02 3.04E-01 3.15E-01 2.78E-01 8.03E-01 2.18E-01 7.68E-01 1.67E-01 5.75E-02 
rs9825721 150678233 G 1.16E-01 6.21E-01 3.72E-01 2.58E-01 4.03E-01 6.06E-01 5.15E-01 8.19E-01 3.52E-01 1.70E-01 3.08E-01 7.62E-01 
A1 is allele 1 (usually minor). 
Grey cells indicate p-values <0.01. Bold values indicate that p-value was significant after a Bonferroni correction for multiple testing. 









































































   


































   
   
   
   
   
   








Figure 4.5. Early expressive language scores per genotype. Risk genotypes: C/C gives lower score on early communication test @1.5Y (a), G/G- to early communication 
test @ 6mths (b) and G/G- to vocabulary test @ 15mths (c). Error bars represent standard error of the mean. Number of available genotyped individuals: a) N individuals 
with C/C genotype=372; N individuals with C/T genotype= 2,280; N individuals with T/T genotype= 3,689; b) N individuals with G/G genotype=622; N individuals with G/T 
genotype= 2,689; N individuals with T/T genotype= 3,045; c) N individuals with G/G genotype=517; N individuals with G/A genotype= 2,521; N individuals with A/A 





4.2.3. A cluster of PCDH15 common variants are marginally associated 
with risk of DLD 
Under the additive model of direct effect, suggestive association was observed for a cluster of 
SNPs, located between intron 12 and 16 (NM_001142771.1 transcript) with DLD status (top SNP 
rs10763086, p= 1.94 x 10-3) (Table 4.5 & Figure 4.6). The top SNP was found to be 1.2 times more 
common in cases (G/G genotype) compared to controls (A/A genotype) (OR= 1.2). Suggestive 
direct associations were also observed with low-frequency thresholds, represented by two SNPs 
and with mid-frequency thresholds, represented by three SNPs (Table 4.5), both located between 
intron 14 and intron 16 (NM_001142771.1 transcript). The top associated SNPs were rs7904409 
(p= 5.24 x 10-3) for low-frequency hearing thresholds and rs11004121 (p= 5.03 x 10-4) for mid-
hearing thresholds (Table 4.5). These analyses suggest that common PCDH15 variants are 
marginally associated with altered hearing abilities (including low and mid-frequency hearing) and 
increased risk for DLD. 




Figure 4.6. UCSC custom track of PCDH15 genotyped SNPs. Annotations show twelve protein coding PCDH15 RefSeq gene transcripts, located on the reverse 
DNA strand of chromosome 10. In blue (bottom of figure) are all genotyped SNPs that are of sufficient quality and have been pruned for high LD. Top associated 






    Table 4.5. Associations of PCDH15 common variants with hearing and language phenotypes under an additive model 
    Additive Model 






















rs7896093 55564355 T 8.88E-01 6.56E-01 9.01E-01 2.81E-01 5.44E-01 8.93E-01 1.04E-02 1.52E-01 
           
rs7904409 55890367 G 8.14E-01 5.24E-03 5.18E-04 9.91E-01 2.70E-01 8.69E-01 2.29E-02 2.89E-03 
rs4447073 55898144 T 8.76E-01 3.73E-02 7.19E-02 7.30E-01 7.56E-01 1.39E-01 3.74E-01 8.00E-03 
rs11004104 55918359 T 8.19E-01 1.45E-01 1.96E-01 7.58E-01 7.67E-01 2.32E-01 9.85E-01 6.67E-03 
rs17646169 55922376 T 8.57E-01 7.39E-01 8.97E-01 1.75E-01 9.62E-01 9.25E-01 6.86E-01 3.11E-01 
rs10509006 55922706 G 3.37E-01 4.86E-01 1.93E-02 4.26E-01 8.28E-01 2.49E-01 7.88E-02 2.26E-01 
rs11004121 55937483 C 3.89E-01 5.62E-03 5.03E-04 6.91E-01 2.54E-01 9.55E-01 2.18E-02 5.88E-02 
rs7093302 55943184 T 8.99E-01 1.87E-01 8.14E-02 8.58E-01 2.78E-01 5.15E-01 1.57E-01 9.47E-03 
rs7914881 55947112 C 4.36E-01 2.41E-02 2.36E-03 3.04E-01 6.42E-01 3.10E-01 2.12E-03 3.05E-03 
rs1561674 55948714 C 4.20E-01 7.04E-01 5.63E-01 4.70E-01 5.86E-01 1.68E-01 5.73E-01 5.63E-01 
rs10825269 55955610 T 5.49E-01 6.13E-02 5.88E-02 7.23E-01 4.93E-01 1.31E-01 6.54E-02 8.62E-02 
rs2384414 55964008 A 9.13E-01 9.00E-01 5.49E-01 5.63E-01 9.11E-01 2.52E-01 5.46E-01 5.20E-01 
rs4082042 55964451 G 7.71E-01 1.45E-01 9.46E-02 8.76E-01 8.41E-01 5.45E-01 6.88E-01 2.49E-02 
rs10825273 55968685 T 7.19E-01 9.03E-02 3.69E-01 8.32E-01 1.79E-01 9.52E-01 3.62E-01 1.39E-01 
rs6481068 55970721 T 8.54E-01 3.88E-01 7.40E-01 4.18E-01 1.08E-01 7.21E-01 5.07E-01 8.66E-02 
rs11004142 55972031 A 9.09E-01 7.89E-02 1.10E-01 5.63E-01 2.50E-01 3.86E-01 5.88E-01 2.50E-03 
rs10763086 55973889 G 7.33E-01 1.35E-02 3.96E-02 7.74E-01 3.26E-01 6.69E-01 3.18E-01 1.94E-03 
           
rs1912982 56569551 G 3.94E-02 7.45E-01 6.59E-01 8.12E-02 6.62E-01 9.98E-01 5.76E-02 8.40E-01 
A1 is allele 1 (usually minor). 
Grey cells indicate p-values <0.01.  




As the DLD status score is a composite measure, based on several aspects of language 
performance (WOLD Comprehension: f8sl040; CCC Intelligibility and Fluency: ku503b and CCC 
Syntax: ku504b scores) (Section 2.2.1.2), additional analyses were performed on each individual 
contributory measure in order to find if one aspect of language was particularly associated with 
PCDH15. Suggestive associations between single variants and all three outcomes were observed 
(Table S6). The strongest signal of suggestive association was between PCDH15 variant 
rs12772008 and CCC Intelligibility and Fluency score represented by p= 4.17 x 10-3 (corrected 
threshold of significance for multiple testing P= 1.23 x 10-4). These results suggest that the three 
language measures (WOLD comprehension, CCC Intelligibility and Fluency, and CCC Syntax) within 
the DLD score all contribute to the suggestive association with PCDH15 common variants and that 
there is no individual measure that is driving the association. This further demonstrates that the 
DLD score as a collective is the most appropriate measure to use in order to capture association 
with PCDH15 variants.  
The suggestive association between common PCDH15 variants and DLD status can also be further 
inspected by testing whether variants within PCDH15 play a role in wider neurodevelopmental 
disorders which require special arrangements at school. To do this, common variants in PCDH15 
were assessed for association with ALSPAC measures of problems requiring special school 
arrangement, dyslexia status and special education needs status. A small cluster of suggestive 
associations were observed with communication and interaction needs at school (SEN), located 
within the same cluster of associations with DLD (Table 4.6).The top associated SNP, rs11004121, 
showed highest signal of association at p=1.17 x 10-3 (corrected threshold of significance for 
multiple testing P= 3.47 x 10-4). 
Taken together, the association analyses suggest that common PCDH15 variants are directly, but 
only marginally associated with DLD status, where WOLD Comprehension, CCC Intelligibility and 
Fluency, and CCC Syntax all contribute to the risk for DLD. Furthermore, common PCDH15 variants 
are likely to also increase the risk for requiring special education provision during Key Stage 3 (11-




Table 4.6. Follow-up associations of PCDH15 common variants (intron 12 to 16) with measures of special school arrangements, dyslexia and SEN statement under 
additive model. 
     Additive Model 
     Problems that require special school arrangement @7.5Y 
Dyslexia 
@9.5Y 

























rs7904409 55890367 G 2.89E-03 0.8232 0.5495 0.1586 0.5803 0.08859 0.3255 0.3375 0.3869 3.16E-03 
rs4447073 55898144 T 8.00E-03 0.9547 0.4851 0.5225 0.2465 0.4176 0.4086 0.07142 0.2366 0.0936 
rs11004104 55918359 T 6.67E-03 0.913 0.6432 0.2867 0.222 0.1366 0.863 0.16 0.3018 0.2318 
rs17646169 55922376 T 0.311 0.681 0.9652 0.3596 0.6171 0.3221 0.6737 0.5539 2.41E-03 6.57E-03 
rs10509006 55922706 G 0.2256 0.9769 0.4882 0.9385 0.9417 0.9098 0.1893 0.6215 0.7706 0.0876 
rs11004121 55937483 C 0.05884 0.9312 0.8397 0.4774 0.694 0.2624 0.5426 0.9044 0.2973 1.17E-03 
rs7093302 55943184 T 9.47E-03 0.6926 0.5785 0.9358 0.5288 0.06188 0.9063 0.6476 0.1711 0.3591 
rs7914881 55947112 C 3.05E-03 0.6922 0.7804 0.4873 0.775 0.4709 0.8595 0.711 0.3247 0.0255 
rs1561674 55948714 C 0.5634 0.7825 0.722 0.04995 0.4446 0.7301 0.358 0.586 0.6514 0.2962 
rs10825269 55955610 T 0.08615 0.3407 0.3761 0.5869 0.9307 0.09019 0.5682 0.09107 0.6501 0.3905 
rs2384414 55964008 A 0.5199 0.1015 0.2312 0.4364 0.7795 0.2573 0.7277 0.1162 0.1782 0.1005 
rs4082042 55964451 G 0.02493 0.4433 0.5369 0.4775 0.9146 0.7541 0.3023 0.3475 0.2242 0.4401 
rs10825273 55968685 T 0.1386 0.1985 0.3469 0.03487 0.265 0.08322 0.3953 0.357 0.8378 0.5767 
rs6481068 55970721 T 0.08662 0.6469 0.7541 0.02744 0.362 0.3908 0.3029 0.4266 0.5861 0.4357 
rs11004142 55972031 A 2.50E-03 0.9417 0.8267 0.1293 0.472 0.3484 0.7963 0.9848 0.1748 0.216 
rs10763086 55973889 G 1.94E-03 0.5454 0.7352 0.2376 0.3365 0.09833 0.9311 0.9704 0.2946 0.316 
A1 is allele 1 (usually minor). 
Grey cells indicate p-values <0.01.  




4.2.4. CDH23 common variants show sporadic association across hearing 
or language measures  
Under the additive model of direct effect, suggestive associations were observed for single SNPs 
and low-frequency hearing thresholds, mid-frequency hearing threshold, communication skills at 
1.5 years and Verbal IQ at 8 years (represented by 2 SNPs) (Table 4.7). No clusters of associated 
SNPs were observed for any one measure, however, the individual SNPs formed a cluster of 
suggestive associations located between intron 11 and 13 on NM_022124.5 transcript (Figure 4.7) 
(Table 4.7). The top SNP (rs11819553 with p=3.24 x 10-3) was marginally associated with Verbal IQ 
at 8 years (Table 4.7 & Figure 4.7). These marginal single variant associations to low- and mid-
hearing thresholds, early communication and Verbal IQ at 8 years are not a strong enough 
evidence of a robust direct link between CHD23 common variants and hearing/language 
outcomes in this cohort sample, and therefore do not warrant any further investigations. Larger 
samples sizes would be needed to replicate these results at a significant level. 
Table 4.7. Associations of CDH23 common variants with hearing and language phenotypes under an 
additive model (only regions of suggestive associations shown). 
 
 
    Additive Model 
    Hearing Language 
Gene SNP 























rs10999801 73150325 A 0.70 0.45 0.77 0.58 0.27 0.42 0.48 0.25 
rs12360332 73152849 T 0.01 0.30 0.0054 0.49 0.75 0.99 0.86 0.65 
           
rs1868003 73386066 A 0.21 0.60 0.49 0.0084 0.28 0.02 0.17 0.06 
rs4746089 73387685 A 0.60 0.82 0.60 0.19 0.78 0.12 0.46 0.10 
rs2394834 73392998 G 0.84 0.08 0.60 0.11 0.68 0.02 0.46 0.02 
rs1900514 73408326 A 0.58 0.74 0.58 0.04 0.01 0.05 0.60 0.06 
rs956734 73408544 A 0.30 0.62 0.52 0.93 0.18 0.75 0.84 0.54 
rs4746093 73409978 A 0.77 0.0096 0.02 0.81 0.78 0.17 0.20 0.25 
rs10999933 73411591 T 0.87 0.82 0.54 0.27 0.82 0.62 0.17 0.76 
rs1900515 73413555 A 0.61 0.87 0.48 0.86 0.18 0.19 0.11 0.54 
rs12573587 73413824 T 1.00 0.05 0.50 0.94 0.79 0.0051 0.36 0.04 
rs7896061 73414010 C 0.95 0.18 0.47 0.67 0.89 0.54 0.87 0.13 
rs10762465 73414206 G 0.49 0.22 0.31 0.90 0.12 0.43 0.32 0.12 
rs7087554 73414577 A 0.56 0.87 0.35 0.72 0.72 0.20 0.17 0.58 
rs1665688 73417236 T 0.92 0.05 0.15 0.91 0.33 0.07 0.57 0.07 
rs1665624 73421248 C 0.69 0.32 0.58 0.66 0.45 0.13 0.21 0.15 
rs11819553 73426465 G 0.59 0.24 0.96 0.79 0.81 0.0032 0.58 0.02 
           
rs1015193 73584426 C 0.37 0.83 0.13 0.40 0.21 0.64 0.49 0.62 
A1 is allele 1 (usually minor). 
Grey cells indicate p-values <0.01.  









Figure 4.7. UCSC custom track of CDH23 genotyped SNPs. Annotations show nine protein coding CDH23 RefSeq gene transcripts, located on the forward DNA 
strand of chromosome 10. In blue (bottom of figure) are all genotyped SNPs that are of sufficient quality and have been pruned for high LD. Top associated 










4.2.5. ADGRV1 and USH1C common variants show sporadic association 
across hearing or language measures  
Under the additive model, only suggestive sporadic SNP associations were observed between 
ADGRV1 and low-and-mid-frequency hearing thresholds and DLD (Table 4.8), and between USH1C 
and low-and-mid-frequency, vocabulary at 3 years and VIQ at 8 years (Table 4.9). These 
suggestive associations were spread across both genes and therefore did not form a particular 
cluster of association (Table 4.8 and Table 4.9). The top SNP for ADGRV1 (rs2007538, p= 0.0018) 
was marginally associated with mid-frequency hearing thresholds (Table 4.8), while the top SNP 
for USH1C (rs2237960, p= 0.0006) was marginally associated with VIQ at 8 years. Similar to the 
CDH23 results above, these marginal sporadic ADGRV1 and USH1C variant associations within the 
investigated cohort are not robust and do not warrant any further analysis. Larger samples sizes 
would be needed to replicate these results at a significant level. 
Table 4.8. Associations of 5’ ADGRV1 common variants with hearing and language phenotypes under an 
additive model (only regions of suggestive associations shown). 
 
 
    Additive Model 

























rs10514328 89847694 T 0.25 0.46 0.76 0.91 0.18 0.05 0.72 0.77 
                   
rs16869016 90000210 T 0.49 0.0039 0.0064 0.34 0.96 0.29 0.19 0.54 
                   
rs949787 90251205 T 0.04 0.96 0.96 0.79 0.06 0.27 0.17 0.0042 
                   
rs2007538 90374713 C 0.03 0.04 0.0018 0.20 0.43 0.55 0.68 0.69 
                   
rs4537089 90466296 C 1.00 0.97 0.66 0.55 0.27 0.08 0.16 0.82 
A1 is allele 1 (usually minor). 
Grey cells indicate p-values <0.01.  




Table 4.9. Associations of USH1C common variants with hearing and language phenotypes under an 
additive model 
    Additive Model 
























rs1076204 17506874 C 0.40 0.58 0.79 0.29 0.02 0.16 0.53 0.64 
rs12278908 17508140 A 0.17 0.08 0.08 0.65 0.55 0.53 0.95 0.14 
rs4757527 17510565 G 0.74 0.81 0.78 0.09 0.0089 0.56 0.73 0.42 
rs17703233 17513147 C 0.62 0.84 0.78 0.02 0.04 0.56 0.70 0.27 
           
rs2190454 17533635 G 0.39 0.05 0.85 0.28 0.72 0.66 0.20 0.12 
rs2237960 17538048 A 0.80 0.26 0.67 0.43 0.30 0.0006 0.10 0.66 
rs10766408 17539212 T 0.56 0.11 0.37 0.07 0.60 0.17 0.07 0.06 
rs11603262 17540079 T 0.20 0.11 0.28 0.32 0.05 0.14 0.73 0.43 
rs7129173 17541798 A 0.96 0.54 0.36 0.02 0.19 0.65 0.58 0.32 
rs2041032 17542649 T 0.83 0.28 0.26 0.02 0.23 0.46 0.59 0.03 
rs16934382 17551893 A 0.10 0.29 0.0020 0.78 0.98 0.95 0.93 0.11 
rs2041027 17553105 A 0.90 0.07 0.07 0.02 0.81 0.82 0.92 0.01 
           
rs7119071 17572402 A 0.75 0.01 0.38 0.39 1.00 0.97 0.31 0.05 
rs10766410 17573329 A 0.76 0.0058 0.21 0.25 0.70 0.91 0.81 0.02 
rs7951242 17573927 T 0.60 0.14 0.76 0.90 0.29 0.35 0.69 0.59 
rs4757543 17574588 T 0.26 0.52 0.93 0.78 0.35 0.18 0.66 0.31 
 
 
4.2.6. CIB2, WHRN and MYO7A show no association of their common 
variants with hearing or language milestones 
Association analyses under the additive model showed no significant or suggestive associations 
between common variants in CIB2, WHRN and MYO7A and any of the hearing or language 
phenotypes tested (Table 4.10-4.12). 
A1 is allele 1 (usually minor). 
Grey cells indicate p-values <0.01.  




Table 4.10. Associations of CIB2 common variants with hearing and language phenotypes under an additive 
model 
Table 4.11. Associations of WHRN common variants with hearing and language phenotypes under an 
additive model 
    Additive Model 
    Hearing Language 
Gene SNP 
BP (hg19) 






















rs2274159 117166246 A 0.02 0.67 0.95 0.91 0.55 0.11 0.77 0.35 
rs942519 117169033 A 0.01 0.87 0.80 0.99 0.47 0.08 0.41 0.20 
rs2236388 117169300 A 0.49 0.12 0.38 0.87 0.22 0.66 0.48 0.96 
rs1075559 117174124 G 0.24 0.33 0.91 0.23 0.98 0.17 0.88 0.55 
rs10081699 117182478 G 0.10 0.15 0.51 0.36 0.62 0.06 0.59 0.03 
rs10739411 117183149 G 0.36 0.57 0.84 0.96 0.75 0.68 1.00 0.20 
rs2181928 117185395 A 0.03 0.21 0.48 0.88 0.85 0.18 0.63 0.20 
rs2274162 117187569 T 0.08 0.57 0.94 0.25 0.66 0.74 0.89 0.55 
rs7046973 117193206 G 0.19 0.26 0.45 0.93 0.87 0.31 0.41 0.16 
rs10982218 117200140 C 0.99 0.63 0.35 0.76 0.81 0.51 0.07 0.32 
rs942520 117214909 C 0.96 0.13 0.35 0.96 0.77 0.95 0.66 0.93 
rs10759707 117222287 A 0.51 0.24 0.27 0.62 0.72 0.77 0.77 0.15 
rs10217748 117225658 T 0.80 0.35 0.72 0.34 0.26 0.47 0.69 0.62 
rs4979407 117228115 C 0.78 0.24 0.05 0.17 0.85 0.84 0.73 0.21 
rs1535971 117229400 T 0.49 0.49 0.98 0.46 0.75 0.76 0.60 0.30 
rs10982234 117230017 C 0.57 0.64 0.45 0.32 0.48 0.53 0.31 0.92 
rs1123056 117236557 T 0.77 0.62 0.67 0.66 0.39 0.50 0.29 0.97 
rs17807115 117256467 G 0.25 0.55 0.15 0.78 0.17 0.83 0.65 0.75 
rs4979415 117261599 A 0.33 0.49 0.76 0.84 0.99 0.30 0.14 0.70 
rs4979418 117264083 G 0.41 0.23 0.20 0.47 0.40 0.69 0.11 0.97 
rs2296262 117265406 T 0.61 0.50 0.23 0.95 0.62 0.88 0.66 0.27 
 
    Additive Model 
























rs2289524 78390414 C 0.40 0.23 0.49 0.30 0.88 0.97 0.88 0.24 
rs12593575 78390909 T 0.06 0.15 0.50 0.82 0.40 0.93 0.57 0.19 
rs2867922 78391969 A 0.36 0.94 0.90 0.36 0.53 0.91 0.39 0.96 
rs7182113 78392357 A 0.22 0.05 0.19 0.99 0.77 0.83 0.89 0.16 
rs9806257 78395362 C 0.68 0.24 0.48 1.00 0.65 0.62 0.55 0.68 
rs16953973 78400640 T 0.11 0.64 0.06 0.92 0.40 0.96 0.32 0.74 
rs3784327 78402258 A 0.74 0.65 0.14 0.46 0.33 0.91 0.95 0.38 
rs11856417 78404315 A 0.14 0.97 0.03 0.45 0.54 0.43 0.62 0.32 
rs17478430 78406959 C 0.79 0.48 0.74 0.51 0.73 0.84 0.28 0.84 
rs16969514 78410289 C 0.75 0.76 0.82 0.42 0.89 0.21 0.65 0.92 
rs1542101 78413016 G 0.15 0.79 0.23 0.49 0.35 0.37 0.34 0.88 
A1 is allele 1 (usually minor). 
A1 is allele 1 (usually minor). 
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Table 4.12. Associations of MYO7A common variants with hearing and language phenotypes under an 
additive model 
4.2.7. USH1G and HARS common variants are not covered by the genotype 
assay 
Due to the small size of USH1G (7Kb) and HARS (17Kb), plus filtering of low-quality variants and 
pruning for variants in high LD, no common variants within the genotype assay were left covering 
these genes. 
    Additive Model 

























rs2276031 76832011 T 0.82 0.61 0.35 0.96 0.78 0.17 0.28 0.88 
rs1043418 76836350 C 0.58 0.66 0.17 0.57 0.65 0.03 0.03 0.58 
rs7943716 76837499 A 0.54 0.72 0.69 0.15 0.88 0.69 0.94 0.62 
rs10899353 76837552 T 0.44 0.60 0.93 0.86 0.34 0.99 0.04 0.10 
rs7121485 76840709 G 0.60 0.62 0.30 0.89 0.70 0.01 0.19 0.63 
rs7121629 76840798 G 0.06 0.32 0.06 0.67 0.09 0.56 0.95 0.99 
rs948969 76848035 G 0.78 0.86 0.48 0.94 0.98 0.17 0.10 0.80 
rs1052030 76853783 C 0.34 0.85 0.60 0.10 0.49 0.85 0.96 0.10 
rs12279716 76858756 T 0.14 0.90 0.32 0.97 0.90 0.70 0.46 0.81 
rs3737454 76868278 A 0.87 0.14 0.84 0.97 0.49 0.75 0.08 0.83 
rs762667 76868372 C 0.76 0.45 0.34 0.84 0.10 0.43 0.54 0.32 
rs3740763 76873620 T 0.56 0.44 0.99 0.37 0.31 0.86 0.92 0.72 
rs4944147 76880518 A 0.72 0.49 0.73 0.83 0.29 0.22 0.71 0.21 
rs4945156 76892179 A 0.30 0.85 0.51 0.66 0.94 0.30 0.19 0.15 
rs3758708 76894463 T 0.20 0.51 0.12 0.23 0.26 0.89 0.36 0.80 
rs12805353 76898797 T 0.21 0.09 0.73 0.73 0.41 0.63 0.31 0.25 
rs3781694 76899265 A 0.07 0.04 0.42 0.41 0.50 0.59 0.41 0.31 
rs948962 76919478 A 0.17 0.02 0.40 0.51 0.66 0.53 0.08 1.00 
rs885442 76920038 T 0.05 0.01 0.54 0.24 0.50 1.00 0.07 0.73 
rs12793189 76921090 A 0.19 0.07 0.73 0.46 0.38 0.39 0.01 0.78 
rs12793619 76921358 A 0.88 0.31 0.32 0.71 0.32 0.19 0.05 0.26 
rs11237123 76922946 A 0.90 0.34 0.49 0.84 0.53 0.24 0.04 0.46 




Across the eleven Usher genes analysed, three genes (USH2A, CLRN1, PCDH15) showed evidence 
of association to hearing and/or language measures across multiple time points (Table 4.13). 
Three further genes (CDH23, ADGRV1 and USH1C) showed sporadic associations to hearing and 
language outcomes (Table 4.13), which were represented by single SNPs and therefore no trend 
was observed. The Usher genes WHRN, MYO7A and CIB2 did not show association of their 
common variants to hearing or language outcomes and USH1G and HARS common variants were 















Effect of biallelic 
mutations on hearing 
in USH syndrome 




USH2A low-frequency indirect none 
congenital & moderate 
hearing loss 
cell adhesion & 
signalling 
stereocilia ankle links 
transient (embryonic 
development in ankle links) 
negligible 
CLRN1 none direct none 
post-lingual hearing 
loss 
cell adhesion hair bundle 







congenital & profound 
hearing loss 
cell adhesion, 
upper tip link 
stereocilia lateral, kinociliary 
and tip links 
transient (embryonic in lateral 
links) and postnatal in mature 
hair cells 
prenatal (CBC); 
postnatal (HIP, AMY, 







congenital & profound 
hearing loss 
cell adhesion, 
lower tip link   
stereocilia lateral, kinociliary 
and tip links 
transient (embryonic in lateral 
links) and postnatal in mature 
hair cells 







congenital & moderate 
hearing loss 
cell adhesion  stereocilia ankle links 
transient (embryonic 
development in ankle links) 
early prenatal (STR, 
AMY, HIP); postnatal 







congenital & profound 
hearing loss 
scaffold protein 
stereocilia upper tip link and 
synapse 
embryonic & postnatal hair 
cells 
prenatal (small peak in 
HIP); postnatal (HIP, 
STR AND MD) 
WHRN none none none 
congenital & moderate 
hearing loss 
scaffold protein 
stereocilia ankle link, 
stereocilia tip & synapse 
transient (embryonic 
development in ankle links) 
N/A 
MYO7A none none none 




hair cell cytoplasm, hair 
bundle, upper tip link 
density 
embryonic & postnatal hair 
cells 
N/A 
CIB2 none none none 




stereocilia near tip 
no data on embryonic 





N/A N/A N/A N/A N/A N/A N/A N/A 
Brain expression data is from the Human Brain Transcriptome Project (https://hbatlas.org/pages/hbtd).  




4.3.1. USH2A common variants and hearing/language abilities 
The associations of common USH2A variants with hearing abilities suggests that individuals with 
common risk variants located at the start of the gene (5’ end) are susceptible to having difficulties 
detecting low-frequency sounds. Moreover, individuals carrying USH2A risk variants in the 
presence of altered low-frequency hearing thresholds were more likely to have a limited 
vocabulary than those who carried only one of these risk variants in isolation. This indicates a 
directionality of effects which stems from low-frequency hearing thresholds and further shows 
that hearing can modulate the effects of USH2A upon language development (Figure 4.8a). These 
population-based findings are in line with the results from the discovery family, implicating 
USH2A in impaired auditory processing and language, suggesting that the pathology of APD may 
stem from subtleties in early hearing abilities (Perrino et al., 2020). As peripheral auditory 
mechanisms are not typically included in the diagnosis of APD, rather, individuals are only 
screened for overt hearing loss, therefore subtle differences at low-frequency hearing abilities 
would be missed. As auditory perception involves the integration of bottom-up, auditory ‘sensory’ 
information (from the inner ear up) with top-down, multimodal ‘cognitive’ information (from the 
auditory cortex down) (Moore et al., 2010), a subtle change in low-frequency hearing can exert a 
small, but potentially deleterious effect that disrupts higher order processes and therefore, 
language. Further studies would need to be performed to investigate the underlying mechanisms. 
4.3.2. CLRN1 common variants and language abilities 
The direct association of common CLRN1 variants with very early expressive communication skills 
was only transient and not observed with later language markers. This suggests that children who 
carried CLRN1 risk variants were more likely to show a slight delay in their communication abilities 
during pre-lingual and early lingual period compared to children who did not carry the risk 
variants (Figure 4.8c). Clarin-1 localises to the mouse inner ear hair bundle (Adato et al., 2002) 
(Table 4.13) with complete loss of clrn1 in knock-out models resulting in attenuated, but not 
completely lost hair bundle function (Gopal et al., 2015). Clarin-1 has been therefore proposed as 
essential for the early stages of hair cell development but not required to maintain the integrity of 
hair bundles. This is consistent with the effects of recessive pathogenic CLRN1 variants in USH3 
individuals (Gopal et al., 2015; Geng et al., 2012). USH3 individuals are born hearing, but fail to 
maintain proper hearing function (Plantinga et al., 2005) (Table 4.13). This suggests that they 
develop functional hair cells but cannot maintain them, leading to progressive loss of hair bundle 
structure and function over time, resulting in post-lingual hearing loss. This might also explain why 
no association was found to any of the hearing abilities tested (low and mid-frequency and risk of 
OME) at 7 years of age when normal/close to normal hearing function is still maintained. This 
explanation is further supported by the highly variable type and degree of progressive hearing 
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loss amongst USH3 patients showing asymptomatic to moderate hearing presentation at young 
age (Plantinga et al., 2005; Abu-Ameerh et al., 2020). The post-lingual effects of CLRN1 on hearing 
abilities therefore cannot explain the observed susceptibility to pre-lingual and early lingual 
communication delays in children with risk CLRN1 common variants (Figure 4.8c). CLRN1 has not 
been shown to be associated with language abilities in the literature and its expression across 
different regions of the brain is negligible (Table 4.13). Further research is needed to investigate 
the true effect of common CLRN1 variants on early language and the molecular mechanism 
behind it.  
4.3.3. PCDH15 common variants and language abilities 
Common PCDH15 variants were found to be directly, but only marginally associated with hearing 
abilities (to low and mid-frequencies) and DLD risk (Figure 4.8b). Children who carried these risk 
variants were also more likely to require special help with their communication and interaction 
skills at school (11- 13 years of age), compared to children who did not carry the risk variants. 
Protocadherin-15 is a structural protein at the tip link of stereocilia (Alagramam et al., 2011), also 
expressed in hair cell synapses and spiral ganglion neurons (SGN), suggesting a role in synaptic 
maturation (Zallocchi et al., 2012). Defective pcdh15 in knock-out mice show disordered 
arrangements of stereocilia in hair cells and a reduction in the number of SGN (Washington et al., 
2005). Phenotypically USH1F affected patients present with congenital and profound hearing loss 
(Ahmed et al., 2001). Pathogenic variants within PCDH15 have also been associated with poor 
cochlear implantation outcomes, with individuals with bi-allelic PCDH15 mutations showing 
poorer auditory receptive ability, speech perception and speech intelligibility compared to 
controls (Wu et al., 2015). The poorer outcomes were attributed to the preferential expression of 
PCDH15 in SGN compared to other parts of the cochlea, with biallelic mutations leading to more 
severe pathology affecting the auditory neural pathway (Nishio, Takumi and Usami, 2017). Libé-
Philippot et al. showed that Pcdh15 is expressed in GABAergic interneurons of the developing 
auditory cortex (Libé-Philippot et al., 2017). Moreover, Pcdh15 knock-out mice displayed impaired 
interneuron development, directly as a result from an intrinsic role of Pcdh15 in the developing 
auditory cortex (before the onset of hearing), rather than as a consequence of the peripheral 
auditory impairment in the knock-out mice (Libé-Philippot et al., 2017). According to the Human 
Brain Transcriptome Project, PCDH15 shows low expression in embryonic development across 
different regions of the brain, which increases and peaks in the cerebral cortex between 19 and 
24 prenatal weeks, followed by relatively low expression postnatally (Table 4.13). Based on this, a 
plausible hypothesis could be that the observed association to DLD risk (which may also lead to an 
increased need of special help with communication and interaction) in children carrying PCDH15 
risk common variants occurs directly through the auditory neural pathway and possibly as a result 
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of interneuron deficit in the auditory cortex. Larger samples sizes would, however, be needed to 
replicate this finding at a significant level and to further study the biology of this relationship.  
 
 
Figure 4.8. USH common variants association models. 
a) USH2A: altered hearing thresholds combine with existing genetic factors to moderate the risk of early 
vocabulary outcomes 




In summary, in Results Chapter 2, we hypothesised that common variants in Usher genes form 
part of a complex model where common risk variants contribute to the susceptibility to altered 
hearing and/or language ability or skills (H2). This hypothesis is confirmed by the presence of 
direct and indirect associations between USH2A, CLRN1 and PCDH15 common SNPs and low-
frequency hearing thresholds, early language markers and language outcomes such as DLD. This 
further supports a risk model for hearing difficulties such as auditory processing, which may 
indirectly contribute to language difficulties, involving common genetic variants. This is in line 
with complex models of genetic contribution to other neurodevelopmental and learning/hearing 
disorders such as language disorders (Gialluisi et al., 2014; Luciano et al., 2013), dyslexia (Gialluisi 
et al., 2020), ASD (Arking et al., 2008; Grove et al., 2019) and ARHL (Wells et al., 2019). 
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5. Results Chapter 3: Gene-based analyses of rare 
variants 
5.1. Rationale 
Findings from Results Chapter 2 indicated that common variation across some USH genes (USH2A, 
CLRN1 and PCDH15) play a complex role in low-frequency hearing abilities and/or language 
development. Research has shown that rare and common variants can both play a role in complex 
disorders (Fritsche et al., 2016; Chen et al., 2017). This led to Hypothesis 3 (H3) where in order to 
gain a complete picture of the role of Usher gene variation in a complex model, we hypothesised 
that multiple rare variants across coding USH gene regions have an effect on hearing, auditory 
processing and/or language abilities. Therefore, H3 considers the combinatory effect of rare risk 
variants to susceptibility to disease or altered ability in a single multivariate analysis. 
To test H3, gene-based analyses (Section 2.4.3) were performed within RVTESTS on the eleven 
USH candidate genes (USH2A, CLRN1, CDH23, PCDH15, ADGRV1, USH1C, USH1G, MYO7A, WHRN, 
CIB2, HARS) using whole genome sequence data from ALSPAC UK10K core cohort (Section 2.3.4). 
The phenotypes tested for association were the same three measures of hearing (low-frequency 
hearing, mid-frequency hearing and OME status) and the same five measures of language (early 
communication skills, early vocabulary size, NWR, VIQ, DLD status) as tested in Results Chapter 2 





Collectively gene-based association results showed that rare variants within USH2A were 
suggestively associated with mid-frequency hearing abilities, whereas rare variants within CLRN1 
and ADGRV1 were suggestively associated with markers of language (Table 5.1). The sections 
below review each of the significant genes one by one. 
Table 5.1. USH genes gene-based association testing results using Burden-Zeggini tests  
5.2.1. Rare USH2A variants are suggestively associated with altered mid-
frequency hearing thresholds  
USH2A showed an increased rare variant burden in relation to altered mid-frequency hearing 
thresholds (gene-based p= 0.0073) (Table 5.2). Sub-grouping rare USH2A variants by function and 
repeating the Burden-Zeggini (BZ) association test showed that the likely rare variant drivers of 
association reside within USH2A exons (p= 0.0005) (Table 5.2). Further dividing USH2A rare exonic 
variants into types (missense, stop-gain, splice-site and synonymous) showed that the suggestive 
association to mid-frequency hearing threshold was driven by rare missense USH2A variants (p= 
0.0017) (Table 5.2). No associations were observed with language outcomes (Table 5.2). 




















USH2A 0.09 0.61 0.0073 0.61 0.90 0.14 0.70 0.25 
CLRN1 0.96 0.86 0.33 0.87 0.85 0.0069 0.46 0.12 
ADGRV1 0.34 0.10 0.58 0.07 0.13 0.24 0.00095 0.30 
HARS 0.20 0.99 0.91 0.81 0.30 0.65 0.72 0.88 
WHRN 0.07 0.03 0.02 0.21 0.88 0.91 0.40 0.44 
PCDH15 0.05 0.28 0.25 0.67 0.48 0.73 0.75 0.87 
CDH23 0.26 0.68 0.36 0.65 0.36 0.10 0.03 0.94 
USH1C 0.99 0.44 0.82 0.08 0.85 0.12 0.78 0.01 
MYO7A 0.59 0.92 0.78 0.68 0.35 0.83 0.64 0.68 
CIB2 0.67 0.62 0.83 0.79 0.87 0.33 0.69 0.37 
USH1G 0.05 0.09 0.06 0.74 0.74 0.17 0.30 0.64 
P-values for each hearing and language outcome are reported. Grey cells indicate p-values < 0.01. 
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The number of variants tested within each subgroup and p-values are reported.  
Grey cells indicate p-values < 0.01.  
Table 5.2. USH2A gene-based association testing results using Burden-Zeggini, grouping variants by function 
in relation to mid-frequency hearing thresholds. 




Freq _min  
(association p-value) 
Baseline rare variants 5361 0.0073 
By function  
rare intronic 5178 0.02 
rare regulatory 45 0.01 
rare exonic 138 0.0005 
rare missense 87 0.0017 
rare stop-gained 3 0.95 
rare splice-site 5 0.05 
rare synonymous 43 0.10 
 
5.2.2. Rare CLRN1 variants are suggestively associated with altered 
Verbal IQ 
Suggestive association was found between rare CLRN1 variants and Verbal IQ score at 8 years of 
age (p= 0.0069) (Table 5.3). Sub-grouping rare CLRN1 variants by function and repeating the BZ 
analysis showed nominal association with MinP= 0.012 for rare intronic variants (Table 5.3). Next, 
using Haploview, the CLRN1 variants were grouped by position, showing two broad blocks of LD; a 
3’ block (incorporating five smaller blocks in tight LD) and a 5’ block (Figure 5.1). The BZ test was 
repeated with the rare variants residing in the 5’ and 3’ LD blocks. Again, no association with p< 
0.01 was observed with VIQ at 8 years.  
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Table 5.3. CLRN1 gene-based association testing results using Burden-Zeggini, grouping variants by function 
and position in relation to Verbal IQ at 8 years. 
 
 





Baseline rare variants  344 0.0069 
By function 
rare intronic  324 0.012 
rare exonic  6 0.046 
rare regulatory 14 0.372 
By position 
5’ LD block rare 118 0.133 
3’ LD block rare 178 0.016 
The number of variants tested within each subgroup and p-values are reported.  
Grey cells indicate p-values < 0.01.  
 
Figure. 5.1. Linkage disequilibrium analysis of CLRN1 SNPs (plot generated using Haploview). Linkage 
disequilibrium is displayed by standard colour scheme, with bright red for very strong LD (LOD ≥2, D’ =1), pink 
red (LOD ≥2, D’ <1) and white for no LD (LOD < 2, D’ <1). Six LD blocks were generated and further grouped into 
3-and-5-prime end LD blocks. Canonical CLRN1 transcript is marked in black box according to UCSC browser. 
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5.2.3. Rare intronic variants in ADGRV1 are suggestively associated with 
altered Nonword repetition score  
Suggestive association was observed between rare variants across AGDRV1 and NWR at 8 years 
(p= 0.00095) (Table 5.4). Further gene-based analysis showed that this association was driven by 
rare intronic variants (p=0.00122). As the ADGRV1 gene is relatively large (90 exons), Haploview 
software could not generate an LD plot. Instead, the annotated rare variants within the ADGRV1 
introns were split by position manually. Rare variants within the 5’ end of the gene formed rare 
intronic 5’ end (including 1759 variants within introns 1 to 82) and the rare variants within the 3’ 
end of the gene formed rare intronic 3’ end (including 1814 variants within intron 83 to intron 89) 
(Figure 5.2). Repeating the BZ model on both subgroups of variants resulted in rare intronic 
variants located within intron 83 to intron 89 showing a suggestive signal of association 
(p=0.00387). This group of variants were further divided into rare variants within intron 83 to 85 
(N=1205 variants) and rare variants within intron 86 to 89 (N=609 variants). Repeating the BZ 
model for the 2 groups showed that the signal of increased burden to altered nonword repetition 
was likely resulting from intron variants between introns 83-85 (towards the middle of the gene). 
The rare variants within the two largest introns of the gene (intron 83 and intron 85) were 
separately run through the BZ model and showed that the association signal in ADGRV1 was most 
heavily concentrated in rare variants within intron 85 (p= 0.00041).  
5.2.4. Rare Variants in HARS, WHRN, PCDH15, CDH23, USH1C, MYO7A 
CIB2 and USH1G show no associations to the hearing and language 
outcomes tested 
Gene-based analyses showed no significant or suggestive associations of rare HARS, WHRN, 
PCDH15, CDH23, USH1C, MYO7A, CIB2 and USH1G variants with the tested hearing or language 




Table 5.4. ADGRV1 gene-based association testing results using Burden-Zeggini, grouping variants by frequency, function and position 
 in relation to nonword repetition score at 8 years. 
 





 (association p-value) 
Baseline rare variants 3718 0.00095 
By function 
rare intronic 3573 0.00122 
rare exonic 137 0.429 
rare regulatory 8 0.037 
By position 
rare intronic 5' end (intron 1-82) 1759 0.016 
rare intronic 3’ end (intron 83-89) 1814 0.00378 
rare intronic 3' end (intron 83-85) 1205 0.00399 
rare intronic 3' end (intron 86-89) 609 0.077 
rare intron 83 557 0.460 
rare intron 85 553 0.00041 
The number of variants tested within each subgroup and p-values are reported. Grey cells indicate p-values < 0.01.  
Figure. 5.2. ADGRV1 gene-based analysis by position (ENST00000405460 Ensembl transcript is made of 90 exons and 89 introns). For gene-based analysis by position, the 




Complex disorders such as auditory processing disorder and speech/language disorders represent 
a continuum with high heterogeneity, supported by findings in Results Chapters 1 and 2. Gene-
based analyses, applied here, offer further modelling of complex effect as they allow the 
consideration of the combined effect of rare risk factors across the entire gene. The results 
revealed that rare missense USH2A variants were suggestively associated with mid-frequency 
hearing abilities, whereas rare CLRN1 and rare ADGRV1 variants (concentrated within intron 
85/89) showed suggestive associations to VIQ and NWR performance, respectively (Table 5.6). No 
association was detected between rare variants in PCDH15, CDH23, USH1C, WHRN, MYO7A, CIB2, 




Table 5.6 Summary results for the combined effect of rare variants in 11 Usher genes on hearing and language phenotypes plus wider effects and protein function 
Gene 
 Rare variants 
 & hearing 
Rare variants 
& language 




Effect of biallelic 
mutations on hearing in 
USH syndrome 










 (early vocab) 
congenital & moderate 
hearing loss 













post-lingual hearing loss cell adhesion hair bundle 
embryonic & postnatal hair 
cells 
negligible 





congenital & profound 
hearing loss 
cell adhesion, 
upper tip link 
stereocilia lateral, 
kinociliary and tip 
links 
transient (embryonic in 
lateral links) and postnatal 
in mature hair cells 
prenatal (CBC); 
postnatal (HIP, AMY, 
MD, NCX, STR) 





congenital & profound 
hearing loss 
cell adhesion, 
lower tip link   
stereocilia lateral, 
kinociliary and tip 
links 
transient (embryonic in 
lateral links) and postnatal 
in mature hair cells 








congenital & moderate 
hearing loss 




development in ankle links) 
early prenatal (STR, 
AMY, HIP); postnatal 
(HIP, AMY, NCX, STR) 




congenital & profound 
hearing loss 
scaffold protein 
stereocilia upper tip 
link and synapse 
embryonic & postnatal hair 
cells 
prenatal (small peak 
in HIP); postnatal 
(HIP, STR AND MD) 
WHRN none none none none 
congenital & moderate 
hearing loss 
scaffold protein 
stereocilia ankle link, 
stereocilia tip & 
synapse 
transient (embryonic 
development in ankle links) 
N/A 
MYO7A none none none none 




hair cell cytoplasm, 
hair bundle, upper 
tip link density 
embryonic & postnatal hair 
cells 
N/A 
CIB2 none none none none 




stereocilia near tip 
no data on embryonic 





none none N/A N/A N/A N/A N/A N/A N/A 
Brain expression data is from the Human Brain Transcriptome Project (https://hbatlas.org/pages/hbtd).  





5.3.1. USH2A rare variants and hearing abilities 
USH2A is directly associated with hearing. While common variants show strong associations with 
low-frequency hearing abilities and indirect associations with vocabulary size, rare variants are 
associated with mid-frequency abilities (perhaps just due to insensitivity of these metrics to 
detect associations with low-frequency) (Table 5.6). The USH2A findings are consistent with 
emerging evidence that different variant types within the same gene can associate with variable 
and different outcomes (Lenassi et al., 2015; Molina-Ramírez et al., 2020; Toma et al., 2018). This 
forms an allelic hierarchy of disease-causing high impact variants and complex risk variants as 
examined in this study, and represents a shift from Mendelian genetic models. If two rare 
pathogenic USH2A disease-causing variants are inherited in a recessive form, that will lead to the 
presentation of Usher Syndrome or a nonsyndromic retinopathy (Lenassi et al., 2015). However, if 
only one pathogenic variant is inherited in a heterozygous form alongside common risk and rare 
coding USH2A variants with marginal effects upon protein function, this is likely to contribute to 
subtle changes in the processing of low-frequency sounds (opposite frequency end to the high-
frequency hearing loss observed in USH2). Such subtle changes would not necessarily be detected 
in a clinical setting, where the focus would be on USH2-related high-frequency hearing loss. While 
it is unlikely that such subtle changes in hearing thresholds at low frequencies will directly lead to 
language disorder, we hypothesise that mild changes in low-level hearing can exert a snow-ball 
effect that disrupts higher order communicative processes. This model is analogous to the model 
of persistent OME, which in itself does not lead to a language disorder, but may represent a risk 
factor if recurrent (Rosenfeld et al., 2016).  
5.3.2. CLRN1 rare variants and language abilities 
Both gene-based analyses and single common SNPs analyses of CLRN1 variation showed 
association with language markers: significant association between common CLRN1 variants and 
early language communication deficits and marginal association of rare variants with Verbal IQ at 
8 years (Table 5.6). The finding that different variants (common vs rare) correlated with different 
language outcomes might reflect the complex nature of association studies and defining 
phenotypes, which on an individual level do not always reflect aetiology. The absence of any 
association to hearing measures could be explained by the preserved normal hearing function in 
childhood even for biallelic CLRN1 mutations known to cause post-lingual hearing loss in USH3 
(see Results Chapter 2). To better understand the involvement of CLRN1 in language abilities, 
further genetic analyses using larger databases would need to be performed. 
5.3.3. ADGRV1 rare variants and language abilities 
Association results of both common and rare variants within ADGRV1 suggest that intronic risk 
variants, located between introns 83 and 86 may be important factors for language abilities. 
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Gene-based analyses of rare variants showed an increased burden to NWR likely represented by 
ADGRV1 rare variants within intron 85. Sporadic marginal association was observed between a 
common ADGRV1 SNP (rs2007538) located in intron 83 and mid-frequency hearing abilities and 
another common SNP (rs949787) in intron 86 and DLD, suggesting the variants are proxies (Table 
5.6). Biallelic pathogenic variants in ADGRV1 cause USH2C with congenital moderate to severe 
hearing impairment in the first or second decade of life (Weston et al., 2004). Loss of Adgrv1 in 
Vlgr1/del7TM mice result in lack of ankle links which disturbs the organisation of the hair bundles 
leading to profound deafness by 3 weeks of age (McGee et al., 2006), thus recapitulating the 
symptoms found in USH2C patients. Moreover, a homozygous truncating mutation in the mouse 
ortholog Adgrv1 (Adgrv1frings/frings mouse), was found to cause audiogenic seizures (Skradski et al., 
2001). In humans 5q14.3 microdeletions, incorporating ADGRV1, and heterozygous missense 
ADGRV1 mutations are identified in patients with febrile seizures and myoclonic epilepsy (Myers 
et al., 2018; Han et al., 2020). While most reported homozygous mutations associated with 
USH2C result in frameshift/truncation (Weston et al., 2004; Hilgert et al., 2009; Ebermann et al., 
2010; Besnard et al., 2012), vast majority of mutations leading to seizures are heterozygous 
missense (Myers et al., 2018; Han et al., 2020) suggesting that the complete absence or lack of 
function of ADGRV1 leads to USH2C while protein dysfunction caused is likely to result in seizures 
via a different molecular pathway.  
ADGRV1 belongs to the family of G-protein coupled receptor, known to be expressed in the 
central nervous system (CNS) and to play a role in neurodevelopment, with members of the 
family associated with ADHD (ADGRL3) and schizophrenia (ADGRB3) (McMillan et al., 2002; 
DeRosse et al., 2008; Arcos-Burgos et al., 2010). The exact mechanisms by which ADGRV1 is 
involved in epilepsy is not known, but it is suggested it might be through its epilepsy-related 
repeat (EAR) domain, which is the same as the functional domain found in the LGI1 gene, known 
to cause autosomal dominant lateral temporal epilepsy with auditory features (Scheel, Tomiuk 
and Hofmann, 2002). The EAR domain is thought to be important in attaching to an antiepileptic 
ligand or in interfering with synaptogenesis or axon guidance for its critical role in developing 
epilepsy (Scheel, Tomiuk and Hofmann, 2002). All reported individuals harbouring ADGRV1 
pathogenic variants resulting with myoclonic epilepsy also had intellectual disability or 




Results Chapter 3 was based on the hypothesis that rare variants in USH genes play a role in a 
complex model where multiple rare risk variants in combination contribute to the susceptibility to 
altered hearing and/or language ability or skills (H3). This hypothesis is confirmed by the presence 
of association (increased burden) between USH2A, CLRN1 and ADGRV1 rare variants and mid-
frequency hearing thresholds or language markers such as Verbal IQ and nonword repetition. This 
combines with evidence from Results Chapter 2 and demonstrates the important role of common 
and rare variants within some Usher genes in complex models of hearing, auditory processing and 
language, suggesting that there is no one single risk variant, but a complex mix of variation across 
the USH genes might explain some of the APD risk. This combined risk is also in line with wider 
evidence from neurodevelopmental disorder risk involving the influence of common genetic 
variants in combination with rare variants (Villanueva et al., 2015; Chen et al., 2017; Satterstrom 
et al., 2020). 
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6. Results Chapter 4: Phenotype-driven rare 
Mendelian analysis 
6.1. Rationale 
Based on H1 in Results Chapter 1, pathogenic coding variants in the candidate USH genes in a 
heterozygous form showed an increased risk of delayed language milestones and subtle hearing 
difficulties, but no clinical distinct carrier phenotype. Additionally, Results Chapter 3 showed that 
rare variants may be important in some USH genes with regards to language and hearing 
development. These genotype-driven approaches were, however, restricted to the candidate USH 
genes and would have missed detecting many other genes that may also play a role. Therefore, in 
Results Chapter 4, we hypothesise that difficulty discriminating words in noisy environment (as a 
potential sign of suspected APD- sAPD) in a small number of ALSPAC children can be explained by 
rare coding pathogenic variants on a genome-wide level using a phenotype to genotype approach. 
This is the first study that considers the direct effect of rare pathogenic variants on a suspected 
APD phenotype, which has not been addressed in the literature before. Therefore, this is an 
exploratory study, presenting preliminary results. 
For the purpose of Results Chapter 4, the ALSPAC UK10K core cohort was screened to produce a 
sAPD cohort of individuals whose word discrimination threshold in quiet was within expected 
ranges, but whose word discrimination threshold in noise was elevated 1SD above the mean 
(Section 2.3.5). The performance of identified sAPD individuals on neurodevelopmental ALSPAC 
measures (available through the ALSPAC phenotype dataset- Section 2.2) was compared to 
control individuals, allowing the investigation of the wider phenotype that may present together 
with difficulties recognising speech in noisy environment (Figure 2.15). Potentially deleterious 
coding variants within each sAPD individual were identified through VCFtools and annotated 
through SnpEff and wAnnovar (Section 2.5.1) and ranked for pathogenicity following ACMG 




6.2.1. sAPD cohort characteristics 
Characterising the sAPD individuals at a broad neurodevelopmental level showed that, as a group, 
sAPD individuals performed below expected on a measure of early vocabulary at 2 and at 3 years 
(ALSPAC codes ke643 and kg865) (Cohen’s d= 0.48; 95% CI= 0.08- 1.05 for vocabulary at 2 years 
and Cohen’s d= 0.65, 95% CI= 0.06- 1.23 for vocabulary at 3 years) (Table 6.1a) (Figure 6.1a). 
Although the effect size of the difference between the means of the sAPD group and the control 
group is considered as medium, the 95% CI for both measures spans the value of 0 (95% CI= 0.08- 
1.05 and 95% CI= 0.06- 1.23), which indicates lower confidence (<95%) in the effect sizes, likely 
due to the small sample size. 
Analysis of available discrete measures showed that children with sAPD are more likely to suffer 
from otitis media with effusion/abnormal middle ear pressure very early in life compared to 
controls (RR= 1.6, 95% CI= 1.08- 2.399 for OME at 1.5Y and RR= 1.49, 95% CI= 0.604- 3.66 for OME 
at 2.5 Y) (Table 6.2). However, at 7Y the sAPD group showed the opposite results: sAPD individuals 
were less likely to suffer from otitis media with effusion/abnormal middle ear pressure compared 
to controls (RR= 0.493, 95% CI= 0.135- 1.807) (Table 6.2 & Figure 6.1b), suggesting that risk of 
OME was transient and only elevated during early life. Teachers rated the general ability of sAPD 
children as average or below average more often than expected (RR= 2.1943, 95% CI= 1.06- 4.53) 
and expressed complaints towards the sAPD children more often than expected (RR= 1.57, 95% 
CI= 0.55- 4.46) (Table 6.2 and Figure 6.1c-d). sAPD children were much more likely to also have 






Table 6.1a. Quantitative measures of language, reading and cognition in individuals with sAPD compared to controls from ALSPAC dataset (lower scores represent poor performance) 
 
 
Table 6.1b. Quantitative measures of hearing and friendship in individuals with sAPD compared to controls from ALSPAC dataset (higher scores represent poor performance) 
 
 


















Vocabulary Score 2 years 35 - 228 136.2308 163 22 - 246 161.23 50.27 79.2 4 of 13 
Vocabulary score 3 years 0 - 246 215.75 164 132 - 246 233.28 20.69 195 2 of 12 
Plurals score 3 years 5 - 12 9.82 163 5 - 12 10.53 1.74 7 1 of 11 
Past tense score 3 years 11 - 42 34 164 3 - 42 34.62 9.43 12 1 of 10 
Word combination score 3 years 0 - 26 21.5 162 0 - 26 22.75 4.08 16 1 of 12 
Language score 3 years 216 - 324 303.4 161 183 - 326 301.92 28.86 244.4 1 of 13 
Reading score 7 years 11 - 43 28.0769 164 6 - 46 30.77 8.05 15.25 1 of 13 
Spelling score 7 years 2 - 15 7.2308 164 0 - 15 9.02 3.99 2 0 of 13 
Nonword Repetition 8 years 3 - 12 6.77 163 1 - 12 7.91 2.41 4 1 of 13 
WOLD comprehension 8 years 4- 10 7.307692 163 2- 14 8.06 1.85 5 1 of 13 
WISC - Verbal IQ 8 years 83 - 144 105.6923 161 74 - 151 112.16 16.21 86.2 1 of 13 
WISC - Performance IQ 8 years 69 - 123 102.9231 160 55 - 137 102.9 16.74 75.1 1 of 13 
WISC - Total IQ 8 years 77 - 137 104.7692 160 68 - 144 108.88 15.51 88 1 of 13 


















Air conduction Right average 0.5, 1, 2, 4 kHz 7 years 1.25 - 12.5 6.6346 151 0 - 35 8.48 4.73 16.75 0 of 13 
Air conduction Left average 0.5, 1, 2, 4 kHz 7 years 0 - 15 6.9792 148 0 - 42.5 7.99 6.11 17.62 0 of 12 
Low_frequency_min 7 years 0 - 20 10 138 0 - 40 10.65 5.66 20 0 of 12 
Mid_frequency_min 7 years 0 - 10 3.8892 140 0 - 33.33 4.96 4.26 13.25 0 of 12 




Table 6.2. Discrete measures of educational support, neurodevelopmental disorders and hearing in individuals with sAPD compared to controls from ALSPAC database 
 




OME/abnormal middle ear pressure (< -100 daPa)  1.5 years 7 of 13 0.538 55 of 142 0.387 
OME/abnormal middle ear pressure (< -100 daPa)  2.5 years 3 of 12 0.25 34 of 150 0.227 
Carer worried about child’s speech 2.5 years 0 of 13 0 12 of 161 0.075 
OME/abnormal middle ear pressure (< -100 daPa)  7 years 2 of 13 0.154 47 of 154 0.305 
Hearing Impairment 7 years 0 of 13 0 6 of 154 0.039 
Teacher's rating of child is average/below average 7 years 4 of 7 0.57 25 of 96 0.26 
Child received complaints from the teacher  7.5 years 3 of 12 0.25 25 of 157 0.15 
Child currently has uncontrollable tics or twitches 7.5 years 1 of 12 0.083 0 of 156 0 
Child has learning difficulties requiring special arrangements at school 7.5 years 0 of 12 0 3 of 152 0.02 
Child has speech problems requiring special arrangements at school 7.5 years 0 of 12 0 0 of 152 0 
Child has hearing problems requiring special arrangements at school 7.5 years 0 of 12 0 4 of 152 0.026 
Child has eyesight problems requiring special arrangements at school 7.5 years 0 of 12 0 0 of 152 0 
 Child has physical problems requiring special arrangements at school 7.5 years 0 of 12 0 0 of 152 0 
Child has reading difficulties requiring special arrangements at school 7.5 years 0 of 12 0 7 of 152 0.046 
Child has emotional/behavioural problems requiring special arrangements at school 7.5 years 1 of 12 0.083 2 of 152 0.013 
DAWBA DSM-IV clinical diagnosis - Any ADHD disorder 7.5 years 2 of 12 0.167 2 of 156 0.013 
DAWBA DSM-IV clinical diagnosis - Any oppositional-conduct disorder 7.5 years 1 of 12 0.083 4 of 156 0.026 
Child has ever had speech/language therapy 7.5 years 1 of 12 0.083 17 of 156 0.109 
Child stutters/stumbles when speaks 8 years 1 of 13 0.077 8 of 163 0.049 
 Mother told child has Dyslexia 9 years 0 of 11 0 7 of 153 0.046 
B6b: Mother told child has Dyspraxia 9 years 0 of 11 0 6 of 154 0.039 
B6e: Mother told child has Dyscalculia 9 years 0 of 11 0 1 of 152 0.07 
DLD status  2 of 8 0.25 12 of 99  0.12 
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Figure 6.1. Differences in the performance of sAPD group compared to controls on a range of neurodevelopmental measures. 
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6.2.2. Gene variant analysis 
In total 7,392,168 variants were considered in all 13 sAPD individuals (Figure 2.14 in Section 
2.4.4). All variants had a quality score over 6.2 (QUAL score) and a minimum mean depth of 4.97 
per individual (consistent with the UK10K low sequencing coverage). Ninety one percent of 
variants were SNPs, 76% of which had MAF > 0.05 and were therefore considered to be common. 
On average, 2,036,823 genetic variants (which were alternative to the Ref variant) were identified 
in each of the thirteen sAPD individuals.  
Following the filtering exclusion steps (shown in Figure 2.14 in Section 2.4.4), 655 novel 
potentially deleterious variants were highlighted in the thirteen individuals with sAPD (Table S7). 
These variants were classed by function into 59 null variants (including stop-gain, frameshift and 
splice variants), 2 stop-loss and 4 start loss, 585 missense variants and 2 transcription factor 
ablation sites. Each group of variants was considered separately when applying ACMG 
classification for pathogenic or likely pathogenic variants. Under the secondary variant search 
criteria, a further 72 missense variants with MAF ranging from 6.6x10-5 to 0.047 (according to 
gnomAD_NFE population) were detected in the four sAPD individuals with primary 
pathogenic/likely pathogenic variant (individuals 17275, 465, 518, 16005). 
6.2.2.1. Primary variants classed as pathogenic/likely pathogenic 
Of the null LoF variants, a frameshift variant in GRHL3 (heterozygous in individual 17275), a splice 
variant in FAT4 (heterozygous in individual 465) and a frameshift variant in IFT88 (heterozygous in 
individual 518) were classified as pathogenic (GRHL3 and FAT4) and likely pathogenic (IFT88), 
according to the ACMG guidelines (Table 6.3). Of the missense variants, a variant in DIAPH1 
(heterozygous in individual 17275) and a variant in NAV2 (heterozygous in individual 16005) were 
classified as likely pathogenic, according to the ACMG guidelines (Table 6.4).  
The GRHL3 frameshift variant (chr1: 24669442, AGACT>A, (hg19), c.1350_1353delTGAC, 
p.Asp451fs, ENST00000350501) is a null variant (PVS1), it is absent from the gnomAD non-Finnish 
European (NFE) population database (PS4), and occurs in a gene known to be involved in cleft 
palate/lip disorder (Van der Woude syndrome 2 MIM: 606713), which has been linked to auditory 
processing difficulties (Ma, McPherson and Ma, 2016) (PP4) (Table 6.3). A second likely 
pathogenic heterozygous missense variant was found in the same individual in the deafness gene 
DIAPH1 (rs745742167) (Table 6.4). 
The FAT4 splice variant rs762672127 (chr4: 126384823, G>T (hg19), c.11899+1G>T, 
ENST00000394329) is a null variant (PVS1) absent from the gnomAD NFE population database 
(PS4), its deleterious effect is supported by multiple lines of computations evidence (PP3) and the 
gene is involved in a relevant disorder with affected hearing (PP4) (Table 6.3). No secondary 
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putative pathogenic changes were found in the same gene, however the secondary variant search 
detected a missense variant in SLC9A3R1 within the same individual (Section 6.2.2.2). 
The IFT88 frameshift variant (chr13: 21265255, AG>A, (hg19), c.2445delG, p.Ile816fs, 
ENST00000319980) is in a hot spot for frameshift variants (PM1), it is absent from the gnomAD 
NFE population database (PS4), and occurs in a gene known to be involved in deafness (PP4) 
(Table 6.3). No secondary putative pathogenic changes were found in the same gene (or other 
deafness genes according to the criteria used in secondary variant search). 
The DIAPH1 variant rs745742167 (chr5: 140958708, G>A (hg19), c.880C>T, p.Arg294Cys 
ENST00000253811) and the NAV2 variant rs771443047 (chr11: 20065723, G>T (hg19), c.3173G>T, 
p.Gly1058Val, ENST00000396087) are missense variants absent from the gnomAD NFE population 
database (PS4) (Table 6.4). Their deleterious effect is supported by multiple lines of computations 
evidence (SIFT, PolyPhen2, CADD, GERP, PhyloP and PhastCons all showing deleterious scores: 
PP3) and they occur at well-established functional protein domains (PM1) (Table 6.4). DIAPH1 is a 
known deafness gene, with pathogenic variants known to cause Deafness, autosomal dominant 1 
(MIM: 124900), while NAV2 is a deafness candidate gene, with hypomorphic mutant mice 




Table 6.3. Null LoF variants classed as pathogenic/likely pathogenic according to ACMG classification 
 
Table 6.4. Missense variants classed as pathogenic/likely pathogenic according to ACMG classification 
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6.2.2.2. Secondary variants classed as pathogenic in Clinvar 
The USH2A rs148660051 (chr1: 215963510, C>T (hg19), c.10073G>A, p.Cys3358Tyr 
ENST00000366943) and the SLC9A3R1 rs35910969 (chr17: 72745313, C>G (hg19), c.328C>G, 
p.Leu110Val, ENST00000262613) are missense variants reported as pathogenic in Clinvar (Table 
6.5). The USH2A variant, here identified in a single individual (17275) in a heterozygous state  
(Table 6.6), has been reported as pathogenic in compound heterozygous state in patients with 
USH2, atypical Usher and non-syndromic retinitis pigmentosa (McGee et al., 2010; Le Quesne 
Stabej et al., 2012; Garcia-Garcia et al., 2011) and was also detected in Result Chapter 1 (Table 
3.1). This pathogenic variant had a MAF of 0.0057 (gnomAD_NFE), which did not meet the 
threshold to be included in the primary variant filtering (Figure 2.14). The SLC9A3R1 variant 
detected here in a single individual in heterozygous state (Table 6.5) has been previously reported 
as pathogenic in 2 unrelated patients (1 female and 1 male) with impaired renal phosphate 
absorption resulting in calcium nephrolithiasis and decreased bone mineral density with 
autosomal dominant inheritance (Karim et al., 2008). While recessive pathogenic variants in 
USH2A are a well-known cause of USH2 and have been a focus in this thesis, dominant pathogenic 
missense variants in SLC9A3R1 have been linked to human ARHL (Girotto et al., 2019), which 





Table 6.5. Secondary variants reported as pathogenic according to Clinvar 
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Five pathogenic/ likely pathogenic heterozygous variants within GRHL3, FAT4, IFT88, DIAPH1 and 
NAV2 were identified in four individuals out of 13 with sAPD, yielding a detection rate of 30%. 
Under the selection criteria to identify very rare pathogenic variants (not reported in 
gnomAD_NFE population) within candidate genes associated with closely related phenotypes to 
hearing/sAPD, no such variants were detected in the remaining nine individuals with sAPD. Each 
individual’s neurodevelopmental profile together with identified candidate genes and their 
potential role in APD are discussed below.  
6.3.1. GRHL3, DIAPH1 and USH2A in individual 17275 
Individual 17275 was found to carry a pathogenic heterozygous frameshift variant 
(c.1350_1353delTGAC, p.Asp451fs) in the cleft lip/palate gene GRHL3, which is classified as 
extremely intolerant for loss of function variants (pLI and o/e scores) (Table 6.3). The same 
individuals was also found to harbour a heterozygous likely pathogenic missense variant in the AD 
deafness gene DIAPH1 (c.880C>T, p.Arg294Cys) which was predicted to be damaging by six 
bioinformatics tools (Table 6.4) and another secondary heterozygous missense variant in the AR 
Usher syndrome gene USH2A (c.10073G>A, p.Cys3358Tyr), which has been previously reported as 
pathogenic in homozygous/compound heterozygous individuals with USH2 and/or RP (Table 6.5). 
6.3.1.1. Neurodevelopmental profile of 17275 
Individual 17275 showed word discrimination thresholds in quiet to be well within the expected 
normal range (taken from the 180 ALSPAC individuals with available scores), while his word 
discrimination thresholds in noise were elevated above the 95th percentile, assigning the sAPD 
status. Very early on (at six months), individual 17275 showed fine-and-gross motor coordination 
difficulties (Table 6.6). Between 2 and 4 years, both his expressive and receptive language 
(measured by vocabulary and grammar scores, number of unintelligible responses, verbal 
comprehension and VIQ scores) were below expected, indicating early language difficulties or 
delays (Table 6.6). The individual also suffered from recurrent middle ear infections (otitis media 
with effusion) between 8 months and 3.5 years of age (Table 6.6), which is a crucial time during 
which both receptive and expressive language develops (Paul and Roth, 2011). Recurrent OME 
can result in mild and temporary hearing loss, which might directly impact on developing 
language skills within those early years and in such a way contribute to the deficits of individual 
17275 in early receptive and expressive language. Nevertheless, individual 17275 had normal pure 
tone audiometry for both ears (mean hearing level at 0.5, 1, 2 and 4 kHz ≤ 20 dB HL) and normal 
middle ear functioning recorded at 7 years and average VIQ at 8 years (Table 6.6), suggesting the 
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earlier ear and language problems had cleared. The individual was clear of any overt hearing loss 




Table 6.6. Individual 17275 neurodevelopmental profile and proposed genotype 















-poor fine and gross motor coordination skills (6mths) 
-poor expressive and receptive language skills (2-4Y) 
-low average VIQ and Fullscale IQ; average PIQ (4Y) 
-average VIQ, PIQ and total IQ (8Y) 
-poor verbal comprehension on 1 WISC subtest (8Y) 
-impaired middle ear functioning (1.5-3.5Y) 
-recurrent middle ear infections (OME) (8m-3.5Y) 
-normal middle ear functioning and no middle ear infections (7Y) 
- hearing thresholds in normal range (7Y) 
-no hearing loss diagnosed (7Y) 
-no psychiatric clinical diagnosis (ADHD, oppositional/conduct 
disorder, pervasive developmental disorder, anxiety, phobia, 





































6.3.1.2. Candidate genes in individual 17275 
GRHL3 
GRHL3 belongs to the family of three highly conserved grainyhead-like transcription factors 
(GRHL1-3) which play a crucial regulatory role in epithelial development, maintenance and 
homeostasis (Bray and Kafatos, 1991). While GRHL2 has been implicated in AD human age-related 
hearing impairment and deafness (Peters et al., 2002; Van Laer et al., 2008), mutations in GRHL3 
cause AD syndromic (Van der Woude Syndrome 2) and non-syndromic isolated cleft lip and palate 
(CL/P) (Peyrard-Janvid et al., 2014; Basha et al., 2018), and neural tube defects such as spina 
bifida (Lemay et al., 2017). Mouse Grhl3 is expressed early in development (at E8.5) in non-neural 
ectoderm adjacent to the neural plate, which undergoes folding to form the neural tube with 
widespread expression in the surface ectoderm, progressively increasing until E15.5 (Ting et al., 
2003). Furthermore, mouse Grhl3 is expressed in developing brain, localised specifically in the 
habenula (strongest levels), striatum and posterior lateral ventricles. The habenula is known to 
regulate locomotor and cognitive functions, including action planning and decision making, and 
operates to prevent over-stimulation of both serotonergic and dopaminergic systems (Hikosaka, 
2010). Behavioural tests on mice with conditionally deleted Grhl3 in the adult brain (as 
constitutive loss of Grhl3 causes early post-natal death) showed significant defects in locomotor 
activity with affected mice taking shorter, quicker and more frequent steps, as an indicator of 
hyperactivity related behaviours (Dworkin et al., 2017).  
A highlight in individual 17275’s development is his recurrent OME episodes between 8 months 
and 3.5 years of age which is likely to have impacted their early language development and 
hearing. Moreover, OME has been linked to cleft lip/palate with higher incidence amongst 
individuals with cleft lip/palate (Sheahan et al., 2003; Mangia et al., 2019) and so it is likely that 
auditory processing difficulties may be secondary. A recent scoping review looking at association 
of comorbidities with non-syndromic CL/P diagnosis summarised eight papers in the literature 
that reported auditory processing difficulties in the non-syndromic CL/P population (van Eeden 
and Stringer, 2020). The emerging theme was that children with non-syndromic CL/P were more 
likely to score poorly on behavioural tests, language processing with noise distractions and 
discrimination of non-verbal sounds tests (presentation overlapping with auditory processing 
difficulties) than age matched non-CL/P controls (van Eeden and Stringer, 2020). The fact that the 
ALSPAC individual 17275 carried a heterozygous pathogenic variant in GRHL3, a gene implicated 
in CL/P, and is suspected of having auditory processing difficulties (because of elevated word 
discrimination thresholds in noise) could be suggestive of common aetiological risk factors. It also 
needs to be noted that there was no available data on CL/P symptoms or diagnosis for individual 
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17275, so this data is very preliminary and only suggestive until further in-depth investigations of 
the role of GRHL3 in auditory processing are completed. 
DIAPH1 
DIAPH1 encodes the mammalian diaphanous-related formin-1 (mDia1), a protein that plays a role 
in the regulation of cell morphology and cytoskeletal organization (Al-Maawali et al., 2016). It is 
widely expressed in embryonic mouse forebrain and brainstem (including the ventricular and 
subventricular zone progenitor cells) and in the cerebral cortex, basal ganglia, hippocampus, 
thalamus and external granular layer of cerebellum during postnatal development (Ercan-
Sencicek et al., 2015). Neuhaus et al. found Diaph1 expression in the organ of Corti of mouse 
cochlea, specifically in the pillar cells (contributing to the rigidity of the organ of Corti) and at the 
base of OHCs and also in neuronal ear structures, including spiral ganglion neurons and the 
cochlear nerve (Neuhaus et al., 2017). Mutations in DIAPH1 have been associated with AD SNHL 
and AR microcephaly and seizures (Lynch et al., 1997; Ercan-Sencicek et al., 2015). There is a 
phenotype-genotype correlation with heterozygous, presumably truncating DIAPH1 mutations 
predominantly located within the Diaphanous-autoregulatory domain (DAD) (5 out of 7 reported 
mutations) causing AD deafness (in some cases associated with thrombocytopenia) (Lynch et al., 
1997; Stritt et al., 2016; Neuhaus et al., 2017; Kang et al., 2017; Baek et al., 2012; Ueyama et al., 
2016), while homozygous truncating DIAPH1 mutations located towards the middle of the gene 
and affecting the Formin Homology 2 (FH2) domain cause microcephaly (Ercan-Sencicek et al., 
2015; Al-Maawali et al., 2016). The FH2 domain is the central catalytic element of formins which 
nucleates actin filament formation and regulates filament elongation (Higgs and Peterson, 2005). 
The missense heterozygous c.880C>T (p.Arg294Cys) variant in 17275 individual is predicted to 
affect the FH3 domain, which has not been linked to causative mutations in either AD deafness or 
microcephaly before (Figure 6.2). The FH3 domain, which is structurally and functionally least 
conserved FH domain (Wallar and Alberts, 2003) is believed to mediate the subcellular localisation 
of mDia proteins (Kato et al., 2001). The DAD domain is highly conserved and shares a mutually 
exclusive binding site with Rho in the GBD/FH3 region which keeps the protein in inactive 
confirmation (Rose et al., 2005). A small region of conserved amino acids in the GDB/FH3 domain 
are considered to be putative DAD binding site. A p.Ala256Asp mutation (which is close proximity 
to the p.Arg294Cys identified here) was found to significantly reduced the affinity of DAD binding 
to mDia, but it did not affect Rho binding (Rose et al., 2005). This means the protein will not be 
able to stay in inactive conformation, which will affect the regulation of its function. However, no 
mutations with clinical relevance have been observed within the FH3 domain, and therefore their 
potential effect has not been studied in those circumstances. The p.Arg294Cys mutation changes 
the highly conserved arginine to cysteine residue, evidenced by the high conservation GERP, 
PhyloP and PhastCons scores (Table 6.5). The very low population MAF of 0.000008014 (gnomAD) 
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and the multiple pathogenic in silico predictions deem the detected DIAPH1 variant of particular 
interest, especially because individual 17275A carries other two pathogenic variant in GRHL3 and 
USH2A. On the individual’s genetic background, it is possible that the DIAPH1 variant is a 
hypomorph (causing loss of some of the protein’s activity compared to wild type) and as such 
acting as a risk variant that in combination with the other two pathogenic variants, further 




USH2A is the gene responsible for AR USH2A and Retinitis Pigmentosa (Section 1.3.3.1). The 
variant c.10073G>A (p.Cys3358Tyr) detected here has been reported as pathogenic in both USH2 
and RP, but also indicated as a RP-specific by multiple studies when in compound het state 
(McGee et al., 2010; Le Quesne Stabej et al., 2012; Garcia-Garcia et al., 2011), which would 
challenge its role in hearing. Nevertheless, based on the identification of the same pathogenic 
variant in USH carriers (Results Chapter 1) and evidence from Results Chapters 2 and 3 showing 
that USH2A variation is likely to play a role in APD risk, the c.10073G>A USH2A pathogenic variant 
is likely to contribute to APD susceptibility which may also be influenced by the identified variants 
in GRHL3, DIAPH1 in individual 17275.  
There has been no reported functional links or detected interactions between the GRHL3, DIAPH1 
and USH2A genes, therefore although the finding of pathogenic variants within those three genes 
in individual 17275 is of particular interest, their effect (whether combinatory or individually) on 
sAPD phenotype is unknown. It might be that in combination, the three variants contribute to a 
susceptibility to auditory processing difficulties, or it might be that they are unrelated and one or 
Figure. 6.2. Structure of DIAPH1 gene (ENST00000253811) with 28 exons and corresponding protein 
(adapted from (Wu et al., 2020)). The likely pathogenic variant detected here is located in exon 9 of the 
gene (highlighted in blue). Domains of DIAPH1 protein and locations of variants previously detected and 
are associated with heterozygous hearing loss are indicated above the protein diagram and the ones 




more are incidental findings, not directly involved in auditory processing aetiology (for example 
GRHL3 which role in the auditory system is unknown). Further genetic and functional studies of a 
diagnosed APD cohort and mouse models are required to investigate any overlapping pathways 
and understand the molecular links, if any, between these three genes. 
6.3.2. FAT4 and SLC9A3R1 in individual 465 
Individual 465 was found to have a pathogenic heterozygous splicing variant in the planar polarity 
gene FAT4 (c.11899+1G>T), which has a high intolerance score for LoF variants (pLI and o/e ratio) 
(Table 6.3). A secondary heterozygous missense variant, previously reported as pathogenic in 
heterozygous state, was also found in SLC9A3R1, known to have mutations that might lead to 
dominant inheritance of ARHL (c.328C>G, p.Leu110Val) (Table 6.5).  
6.3.2.1. Neurodevelopmental profile 
Individual 465 showed word discrimination thresholds in quiet to be at the higher end of the 
expected normal range (taken from the 180 ALSPAC individuals with available scores), while his 
word discrimination thresholds in noise were elevated above the 95th percentile, assigning the 
sAPD status. Very early on (at six months), individual 465 showed communication and gross motor 
coordination difficulties (Table 6.7). At 15 months he had early receptive language difficulties and 
between 2 and 3 years of age he also showed expressive language difficulties (Table 6.7). Later on, 
at 8 years, individual 465 was reported to stutter/stumble when speaking; he had a low NWR 
score and an average Verbal IQ, while his Performance IQ was very low (below the expected 5% of 
the tested population) (Table 6.7). Further assessment of cognitive function, done through the 
Weschler Intelligence Scale for Children (WISC) confirmed the poor performance of individual 465 
on verbal and non-verbal tests: slightly worse performance than controls on vocabulary and 
comprehension subtests (testing the child’s understanding of the meaning of different words and 
situations) and very poor performance compared to controls on block design and object assembly 
(testing the ability to copy a specific pattern and to put puzzles together) (Table 6.7). Individual 
465 also showed recurrent ear problems between the age of 1.5 and 4 years which consisted of 
earache, ear discharge (including pus/mucus), sore and red ears and pulling/scratching of ears 
(Table 6.7). Hearing abilities of individual 465 were reported to get worse during a cold between 
3.5 and 4.5 years and a hearing problem was noted by a health visitor at 3 years (Table 6.7). 
However, no clinical referral was made and the child’s pure tone audiometry at 7 years was 
normal for both ears (mean hearing level at 0.5, 1, 2 and 4 kHz ≤ 20 dB HL) with no hearing 
impairment and no psychiatric disorder diagnosed (Table 6.7).
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 Table 6.7. Individual 465 neurodevelopmental profile and proposed genotype 









-poor communication and gross motor coordination skills (6mths) 
-poor expressive and receptive language skills (2-3Y) 
-low Nonword repetition score (8Y) 
-average VIQ and very low PIQ, below average total IQ (8Y) 
-poor perceptual reasoning on 2 WISC subtests (8Y) 
-poor verbal comprehension on 1 WISC subtest (8Y) 
-stuttering/stumbling when speaking (8Y) 
-recurrent ear problems (earache, ear discharge, red ears) (1.5-3.5Y) 
-impaired middle ear functioning and middle ear infection (1.5Y) 
-hearing worsens during a cold (3.5Y) 
-health visitor noticed a problem with hearing (3Y) 
-normal middle ear functioning and no middle ear infections (7Y) 
- hearing thresholds in normal range (7Y) 
-no hearing loss diagnosed (7Y) 
-no psychiatric clinical diagnosis ( ADHD, oppositional/conduct 
disorder, pervasive developmental disorder, anxiety, phobia, 
depressive disorder ) (7.5Y) 
-no known disorder reported by family (dyslexia, dyspraxia, dysgraphia, 
dysorthographia, dyscalculia, ASD) (7.5Y) 
-no recognised difficulties/delays requiring special education (7.5Y) 
FAT4  
(c.11899+1G>T) 
616006; AR;  Hennekam 
lymphangiectasia-
lymphedema syndrome 2 
 
615546; AR;  Van 
Maldergem syndrome 2 
SLC9A3R1  
(c.328C>G; p.Leu110Val) 






hearing loss (Girotto 
et al. 2019) 
163 
 
6.3.2.2. Candidate genes in individual 465 
FAT4, the fat atypical cadherin 4, is the mammalian homolog of Drosophila Fat4, which plays a key 
role in vertebrate planar polarity (Saburi et al., 2012). Planar polarity (as explained in Section 
1.3.4.1) is the organisation of cells within the plane of a tissue, as shown by the orderly 
arrangements of hair cells in the cochlea. Fat4-/- mice exhibit distinctive planar polarity 
phenotypes, including misorientation of hair cells (predominantly in the third row OHCs) and 
short and deformed cochleae in inner ear (Mao et al., 2011; Saburi et al., 2012), illustrating the 
role of the Fat4 in inner ear development. Fat4 is expressed in all layers of the developing mouse 
brain, and in both the neural tube and the intervertebral discs during development (Rock, 
Schrauth and Gessler, 2005). Vangl2, a core “planar cell polarity” gene important in axon turning 
for innervation of OHCs (Ghimire, Ratzan and Deans, 2018), has been shown to cooperatively 
interact with Fat4, where mutating one copy of Vangl2 significantly increased the severity of 
cochlear ducts shortening in Fat4–/– cochlea (Saburi et al., 2012). Furthermore, the Dchs1, 
encoding another protocadherin that is a ligand to Fat4, functions with Fat4 to control tissue 
patterning and is essential in the development of several organs, including ear and cochlea (Mao 
et al., 2011). Homozygous mutations in the human FAT4 cause Van Maldergem syndrome (VMS), 
an AR disorder characterised by intellectual disability, craniofacial, auditory malformations 
resulting in hearing loss, renal, skeletal and limb malformations (Cappello et al., 2013). Biallelic 
mutations in the same gene also cause Hennekam lymphangiectasia-lymphedema syndrome-2, 
which is a distinct disorder with lymphedema with overlapping features (such as intellectual 
disability, dysmorphic features and hearing loss in some patients) (Alders et al., 2014). Cases with 
mild manifestations of VMS have also been reported (van der Ven et al., 2017), which might 
explain the low PIQ in individual 465 and his early ear recurrent discomfort (earache, discharge, 
red/sore ears), OME at 1.5Y and concerns over a hearing problem with no overt hearing loss as a 
result of a monoallelic splicing LOF FAT4 variant. As the expression of Fat4 in mouse ear has not 
been studied, its expression in the mouse organ of Corti was examined using the gEAR portal 
(Hertzano and Orvis, https://umgear.org/), which displays data from the mouse organ of Corti at 
postnatal day P0 to P7. Fat4 shows very little expression in the hair cells, but is strongly expressed 
in non-sensory cells at P0 (Cai et al., 2015). The direct role of Fat4 in inner ear OHCs’ orientation 
and the FAT4’s causative role in human disease associated with hearing loss, makes the gene a 
relevant candidate for sAPD.  
SLC9A3R1 encodes the Na+/H+ Exchange Regulatory factor 1 (NHERF1) protein, which belongs to 
NHERF family of scaffolding proteins. It has been shown that protein-protein interactions 
involving NHERFs take place in the cochlea and a Nherf1 KO mouse displays hearing deficits with 
hair cell anomalies (Kamiya et al., 2014). A recent study by Girotto et al confirmed the role of 
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SLC9A3R1 in the hearing system’ function and development and demonstrated its role in human 
adult-related hearing loss (Girotto et al., 2019). A missense variant in SLC9A3R1 (c.539G>A) was 
detected in two unrelated patients with ARHL, characterised by severe to profound high-
frequency hearing loss (Girotto et al., 2019). However, the same heterozygous SLC9A3R1 variant 
detected here (c.328C>G) was previously reported as pathogenic in 2 unrelated patients with 
impaired renal phosphate absorption resulting in calcium nephrolithiasis and decreased BMD 
(Karim et al., 2008) (suggesting this might be an unrelated finding), but hearing abilities of those 
patients were not tested and therefore are unknown. The deleterious effect of c.328C>G, 
suggested by SIFT, PolyPhen and CADD is not very strong (Table 6.5) and the amino acid Leu at 
position 110 of the protein is not very conserved (Table 6.5), suggesting that the effect of the 
variant on the protein might not be as deleterious as suggested by Karim et al. to cause disease. 
Nevertheless, the involvement of SLC9A3R1 in auditory processing skills is of interest as the 
contribution of c.328C>G to hearing abilities might be subtle enough to contribute to such 
difficulties and would require further investigations.   
6.3.3. NAV2 in individual 16005 
Individual 16005 was found to carry a likely pathogenic heterozygous missense variant in the 
candidate deafness gene NAV2 (c.3173G>T), which was predicted to be damaging by six 
bioinformatics tools (Table 6.4).  
6.3.3.1. Neurodevelopmental profile 
Individual 16005 showed word discrimination thresholds in quiet to be at the higher end of the 
expected normal range (taken from the 180 ALSPAC individuals with available scores), while his 
word discrimination thresholds in noise were elevated above the 95th percentile assigning the 
sAPD status. Between 2 and 3 years of age, individual 16005 showed expressive language 
difficulties with grammar, plurals and vocabulary scores placed in the expected bottom 5% of the 
tested population (Table 6.8). He also never babbled and never used gestures to get what he 
wanted below the age of 3, suggesting a delay in expressive language development. His Verbal IQ 
measured at 4 years (WPPSI) and later at 8 years (WISC) was of average performance (on a 
general population level), however WISC information and comprehension scores were below the 
expected 10% of the tested population, illustrating that some difficulties with verbal 
comprehension remained (Table 6.8). Individual 16005 also experienced earache before 1.5 and 
2.5 years of age and hearing that deteriorated during a cold at 3.5 years but had normal pure tone 




Table 6.8. Individual 16005 neurodevelopmental profile and proposed genotype 







-poor expressive language skills (2-3Y) 
-child never babbled or used gestures to communicate (3Y) 
-poor receptive language (comprehension) (4Y) 
-average VIQ, PIQ and Fullscale IQ (4Y) 
-average VIQ, high average PIQ and average IQ (8Y) 
-poor verbal comprehension on 1 WISC subtest (8Y) 
-poor general knowledge on 1 WISC subtest (8Y) 
-some ear problems (1.5-2.5Y) 
-hearing worsens during a cold (3.5Y) 
-normal middle ear functioning and no middle ear infections 
(1.5-7Y) 
-normal pure tone air conduction (7Y) 
-no hearing loss diagnosed (7Y) 
-no psychiatric clinical diagnosis (ADHD, oppositional/conduct 
disorder, pervasive developmental disorder, anxiety, phobia, 
depressive disorder) (7.5Y) 
-no known disorder reported by family (dyslexia, dyspraxia, 
dysgraphia, dysorthographia, dyscalculia, ASD) (7.5Y) 
 







in mice (Peeters 
et al., 2004) 
Associated with 
risk of AD (Wang 
et al., 2018) 
 
 
6.3.3.2. Candidate gene in individual 16005 
Neuron navigator 2 (Nav2) is the closest human homolog and ortholog of Caenorhabditis elegans 
UNC-53, showing a conserved function in axon elongation and cell migration (Muley et al., 2008; 
Stringham and Schmidt, 2009). Hypomorphic mutant mice, containing a gene trap which 
eliminates the expression of the full-length Nav2 transcript, are ataxic and show impaired sense of 
hearing (with increased startle thresholds compared to wild-type), together with defects in cranial 
nerve development and cerebellar development (McNeill et al., 2010; Peeters et al., 2004). A 
recent study looking into the expression of mouse Nav2 in CNS throughout development showed 
most abundant expression in the cerebellum, hippocampus, cortex, and thalamus during late 
embryogenesis and early postnatal life, suggesting a role of NAV2 in CNS development (Pook, 
Ahrens and Clagett-Dame, 2020). In human disease, NAV2 has been suggested as a candidate 
Alzheimer’s disease risk gene (Wang et al., 2017a). As the expression of Nav2 in mouse ear has 
not been studied, its expression in the mouse organ of Corti was examined using the gEAR portal 
(Hertzano and Orvis, https://umgear.org/), which displays data from the mouse organ of Corti at 
postnatal day P0 to P7. Nav2 shows to be expressed at high levels in both sensory hair cells and in 
supporting cells at P0 (Cai et al., 2015), supporting its role in hearing and its candidate role in 
deafness and possibly sAPD. 
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6.3.4. IFT88 in individual 518  
Individual 518 was found to carry a heterozygous pathogenic frameshift deletion variant in the 
planar cell polarity gene IFT88 (c.2445delG), which is not expected to result in loss of function 
(pLI=0) but might be sufficient to increase risk (Table 6.3).  
6.3.4.1. Neurodevelopmental profile 
Individual 518 showed word discrimination thresholds in quiet to be well within the expected 
normal range (taken from the 180 ALSPAC individuals with available scores), while his word 
discrimination thresholds in noise were elevated above the 95th percentile, assigning the sAPD 
status. Individual 518 showed a difficulty with very early communication (at 6 months) and 
“sometimes talked with words in the wrong order” at 3 years, followed by a poor score on WPSSI 
visual special reasoning subtest block design at 4 years (Table 6.9). However, his later language 
scores were within the expected rage with Verbal IQ at 8 years being above average, suggesting 
that the earlier language problems showed slight delay rather than a deficit. Between 8 months 
and 3.5 years individual 16005 showed recurrent abnormal middle ear functioning affecting both 
ears and leading to otitis media with effusion (Table 6.9). Later tests performed at 7 years showed 
normal hearing sensitivity and no sign of otitis media, suggesting the earlier middle ear 
malfunctioning had cleared (Table 6.9).  
Table 6.9. Individual 518 neurodevelopmental profile and proposed genotype 







-poor communication (6mths) 
-average VIQ, PIQ and Fullscale IQ (4Y) 
-poor visual spatial reasoning on 1 WPPSI subtest (4Y) 
-high average VIQ, average PIQ and high average Total IQ (8Y) 
-some ear problems (1.5) 
-sometimes talking with the words in the wrong order (3Y) 
-impaired middle ear functioning (8mths-3.5Y) 
-recurrent middle ear infections (OME) (8m-3.5Y) 
-normal pure tone air conduction (7Y) 
-no hearing loss diagnosed (7Y) 
-no psychiatric clinical diagnosis (ADHD, oppositional/conduct 
disorder, pervasive developmental disorder, anxiety, phobia, 
depressive disorder) (7.5Y) 
-no known disorder reported by family (dyslexia, dyspraxia, 







gene for AD 
craniofacial 
abnormalities









6.3.4.2. Candidate gene in individual 518 
IFT88 codes for intraflagellar transport protein 88 (IFT88), which is a core component of IFT 
complex B and is required for the assembly and maintenance of primary cilia and flagella across 
species (from unicellular organisms to high-order mammals) (Rosenbaum and Witman, 2002). 
Ift88 is expressed in kinocilia of the organ of Corti in mouse cochlea (Jones et al., 2008). Null 
mutations result in embryonic lethality in mice due to severe left-right symmetry defects (Murcia 
et al., 2000), however, conditional inactivation of Ift88 in cochlea (ablating kinocilia in cochlea) 
causes stereocilia bundle misorientation and shortening and widening of the cochlea (Jones et al., 
2008), indicating the role of Ift88 in planar cell polarity regulation. Jones et al., also showed that 
Ift88 interacts with Vangl2, a core planar cell polarity gene (Jones et al., 2008). Furthermore, 
functional studies in zebrafish inner ear hair cells have shown the association of Ift88 with USH1 
proteins where the reported similarity in of hair cells phenotype in mutated chd23, ush1c, myo7a 
and ift88 mice (bent/splayed stereocilia and fewer hair cells forming stereocilia) suggest that the 
genes might function in same or overlapping developmental processes (Blanco-Sánchez et al., 
2014). Chekuri et al. prosed IFT88 as a candidate gene for AR inherited retinal denegation 
(resulting from two compound heterozygous mutations in two affected sisters) (Chekuri et al., 
2018). Interestingly, conditional loss of Ift88 in the cranial neural crest cells has been shown to 
lead to craniofacial abnormalities with Tian et al. proposing IFT88 as a candidate gene for AD 
craniofacial abnormalities such as cleft lip and palate with variable penetrance (in three affected 
siblings with heterozygous missense variant) (Tian et al., 2017). The AD inheritance makes the 
IFT88 frameshift variant a very plausible candidate for the presentations in individual 465: 
recurrent early OME which may be linked to cleft lip/palate symptoms, which can impact on 
hearing and language skills. There have been no reports of IFT88 pathogenic variants causing 
hearing phenotypes in humans yet, however based on expression data and mouse models, the 
role of IFT88 in hearing processes is strongly suggested. 
It needs to be noted, however, that the IFT88 variant c.2445delG reported here, is a frameshift 
variant in the last exon of the transcript and so its effect on the amount of expressed protein is 
questionable and would need further analysis. Moreover, similarly to individual 17275, there was 
no available data on CL/P symptoms or diagnosis for individual 518, so this data is very 
preliminary and only suggestive until a molecular overlap between cleft lip/palate, OME and 




 The overall goal of this chapter was to identify pathogenic coding variants with large effect that 
might be able to explain the poor performance on recognising speech in noisy environment (as a 
potential sign of suspected APD) in a small number of ALSPAC children. The results here support 
pathogenic variants in four individuals. Of note, individual 17275 and 425 had pathogenic variants 
identified in multiple genes: GRHL3, DIAPH1 and USH2A (individual 17275) and FAT4 and SLC9A3R 
(individual 425). No direct interaction between those genes detected in each individual have been 
reported, so their overall contribution to APD-related phenotypes would need to be investigated 
further. The identification of pathogenic variants in candidate genes in four individuals (30% 
detection rate) supports the conclusion that rare pathogenic variants with large effect can explain 
some APD risk (in a small number of individuals selected for a specific phenotype). This finding is 
supported by other studies in neurodevelopmental disorders, such as childhood apraxia of speech 
(CAS), which has shown FOXP2 disruptions as sufficient (monogenic) causes in some individuals 
and families (Fisher et al., 1998), while others show a heterogenous, more complex aetiology 
(Worthey et al., 2013; Eising et al., 2019).  
The genes with pathogenic variants identified here (GRHL3, DIAPH1, FAT4 and IFT88) are all 
substantiated candidates for sAPD. Two genes are cleft lip/palate genes (GRHL3 and IFT88) with 
non-syndromic cleft lip/palate disorders shown to be linked to recurrent otitis media episodes 
and worse auditory processing skills, suggesting that the three conditions might have overlapping 
molecular pathways. Two genes (FAT4 and IFT88) are involved in planar polarity, which is a crucial 
step of development especially in the inner ear, and thus might be related to auditory processing 
skills through a reduced ability to hear properly, which is a subtle deficit rather than an overt 
impairment. Three of the genes (FAT4, GRHL3 and DIAPH1) show to be expressed in the brain, 
which is consistent with the view of APD being a higher order disorder. NAV2 is a candidate 
hearing gene and has not yet been detected in human disease, so its role in auditory processing 
would require more evidence.  Furthermore, the findings here demonstrate the potential validity 
of larger-scale genetic studies in some cases of APD which makes WES/WGS a valid approach that 
could identify novel genes with high rare penetrance variants that contribute to APD. 
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7. Overall Discussion 
7.1. Summary of findings 
Previous research in a large family, affected by a severe language disorder with auditory 
processing difficulties, showed a heterozygous stop-gain USH2A variant (with very strong 
evidence of pathogenicity) which co-segregated with the disorder (Perrino et al., 2020). Given the 
role of USH2A in syndromic hearing loss (homozygous USH2A mutations causing USH2) (Eudy et 
al., 1998), the location of its protein within stereocilia links in inner ear OHCs (Adato et al., 2005a) 
and the role of OHCs in selective amplification, facilitating auditory perception (Froud et al., 2015; 
Murakoshi, Suzuki and Wada, 2015), USH2A represented a clear candidate for studying its role in 
APD. Due to the overlapping and well-studied function of typical Usher syndrome genes in 
stereocilia development, the current thesis extended the early investigations by Perrino et al., 
hypothesising that pathogenic heterozygous variants in eleven USH causing genes (MYO7A, 
CDH23, PCDH15, USH1C, USH1G, CIB2, USH2A, ADGRV1, WHRN, CLRN1 and HARS) have a subtle 
effect on developmental profiles in ALSPAC carrier individuals (H1). Hypothesis 2 proposed that 
common variants in Usher genes have an effect on hearing, auditory processing and/or language 
abilities as part of a complex genetic model (H2), while hypothesis 3 focussed on multiple rare 
variants across Usher gene regions and their complex effect on auditory processing, hearing and 
language (H3). Hypothesis 4 suggested that difficulty discriminating words in noisy environment 
(as a potential sign of sAPD) in a small number of ALSPAC children can be explained by rare coding 
pathogenic variants (H4). 
Findings from Results Chapter 1 demonstrated the association of heterozygous USH2A, MYO7A, 
CDH23 and USH1C pathogenic variants with subtle problems in hearing and delays in early 
language milestones, supporting H1. Moreover, no one individual neurodevelopmental measure 
could be taken as a “clinical marker of deficit” of Usher carriers. This suggested a more complex 
model of interaction and susceptibility, which was explored under H2 (Results Chapter 2) and H3 
(Results Chapter 3), proposing that USH common and rare variants contribute to altered hearing 
and/or language abilities. Direct and indirect associations were observed between USH2A, CLRN1 
and PCDH15 common SNPs and low-frequency hearing thresholds, early language markers and 
language outcomes (DLD) (Results Chapter 2) and between USH2A, CLRN1 and ADGRV1 rare 
variants and mid-frequency hearing thresholds or language markers (VIQ and NWR) (Results 
Chapter 3). These findings demonstrated the important role of common and rare risk variants 
within Usher genes in complex models of hearing, auditory processing and language. Moreover, 
they suggested that the combination of heterozygous USH pathogenic variants in a genomic 
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background of increased risk (through inheritance of other common and rare variants) may lead 
to increased susceptibility to APD. 
Examining the contribution of rare variants on a genome-wide level, in Results Chapter 4, H4 
proposed that pathogenic coding variants with large effect can explain poor performance on a 
surrogate measure of auditory processing difficulties in a small number of APD suspected 
children. H4 was supported by the identification of pathogenic variants in four of thirteen sAPD 
individuals highlighting GRHL3, DIAPH1, FAT4 and IFT88 as novel candidate genes for APD. Taken 
together, this research supports emerging ideas around genetic complexity and indicates a 
continuous model of complex APD genetic risk that includes multiple interacting factors. 
Moreover, it provides potential risk APD candidates that can shed light into the molecular 
pathways underlying difficulty listening in noise and advance our understanding of the 
pathophysiology of APD. This can further improve detection and diagnosis of APD, which will also 
lead to more appropriate APD- specific therapy for those affected. 
7.2. Relationship between APD and language 
The USH carriers showed delays in language milestones, as did the suspected APD (sAPD) group 
individuals, indicating that a correlate of APD is language delay (supported from both genetic 
driven and phenotype driven approach in Result Chapters 1 and 4). This adds to the literature 
which describes overlaps between language and auditory processing based on examining 
populations with APD/sAPD, speech and language disorders (SLD) or other related problems such 
as mild to moderate SNHL (Dawes and Bishop, 2009; Ferguson et al., 2011; Sharma, Purdy and 
Kelly, 2009; Halliday, Tuomainen and Rosen, 2017; Bishop, Hardiman and Barry, 2012). The 
correlation data between APD and SLD which currently exists is poor at distinguishing causal 
models (summarised in Section 1.2.1) as it based on behavioural/electrophysiological tests, but 
not molecular data. This thesis is the first study to examine correlations on a genetic basis and 
confirm that auditory perception is a building block of communication and language 
development. The overlaps observed in this work may indicate overlapping gene effects between 
hearing, auditory processing and language or from auditory processing difficulties, affected 
directly by the gene variants, having an indirect negative effect on early language development, 
supporting the risk factor model. This work therefore demonstrates that the genetic architecture 
of APD is likely to be complex and comparable to the current model of developmental disorders of 
speech and language with which it overlaps phenotypically. This further suggests that just as DLD, 
APD is influenced by the combination of many genetic and environmental risk factors (Chen et al., 
2017; Gialluisi et al., 2014; Newbury et al., 2009; Villanueva et al., 2015) and yet simplex familial 
cases of APD with private high penetrance variants are likely to exist, similar to childhood apraxia 
of speech (Fisher et al., 1998). To further unravel the relationships between APD and speech and 
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language disorders on a molecular level, further work would need to be undertaken and is 
discussed in Section 7.6. 
7.3. Relationship between APD and hearing 
Carriers of pathogenic USH gene variants (largely represented by USH2A carriers) showed subtle 
hearing difficulties that did not lead to an overt hearing impairment, suggesting a subclinical 
hearing deficit. Under this model, a subclinical impaired function in the peripheral auditory 
system (affecting the ear) can result in long-term changes that may persist even after normal 
peripheral function is restored and therefore have a negative impact on auditory processing 
(Moore and Hunter, 2013). People with normal hearing as measured on the standard audiogram, 
including those with APD, may thus have very slight, yet functionally significant hearing loss that 
goes undetected. The hypothesis that auditory processing difficulties/poor listening skills in 
background noise result from a subclinical hearing deficit has been supported by previous 
literature (Badri, Siegel and Wright, 2011; Saxena, Allan and Allen, 2015; Hoben et al., 2017). Two 
of those studies suggested that dysfunctional OHCs and abnormal acoustic reflex (both important 
auditory system feedback mechanisms) could impact upon speech perception in background 
noise in children with listening difficulties or suspected APD (Hoben et al., 2017; Saxena, Allan and 
Allen, 2015). This fits well with the present results supporting the hypothesis that USH2A may 
represent a risk factor for APD: a complete loss of Ush2a in mouse models preferentially affects 
OHCs, leading to overt hearing loss (Liu et al., 2007), while a heterozygous mutation in USH2A is 
hypothesised to preserve some of the OHC function, which may lead to subtle malfunction that 
could impact hearing in noise, but preserve hearing in quiet. Moreover, from the investigated 
eleven USH genes as candidates for APD, five (USH2A, PCDH15, CDH23, ADGRV1 and USH1C) 
showed association to low-and/or-mid-frequency hearing abilities. Such results of subtle 
differences in hearing abilities among individuals with risk variants in USH genes were expected 
because of their role in syndromic and/or or non-syndromic deafness. Moreover, they represent 
an example of allelic hierarchy where multiple variants within the same gene display different 
types of hearing phenotypes (Lenassi et al., 2015): recessive pathogenic USH2A variants are 
associated with high-frequency deafness and/or RP in USH2 while common risk variants within 
the same gene are associated with altered abilities at low-frequency hearing.  
7.4. Genetic models underlying APD and genetic contributions 
The different approaches applied in this thesis to investigate the genetic contributions to APD 
suggest that APD is a heterogeneous disorder following a complex genetic model, influenced by 
genetic variants with large effect (Result Chapter 4), and genetic variants with small effect, 
contributing to risk (Result Chapter 1- 3). This conclusion is in line with other neurodevelopmental 
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disorders with heterogeneous presentation, combining a complex interplay between genetic 
factors of different effect size (some large, some small) (Gaugler et al., 2014; Griswold et al., 2015; 
Niemi et al., 2018; Satterstrom et al., 2020). 
Furthermore, this thesis offers examples of deafness genes likely to be involved in the 
susceptibility to APD phenotypes and potential cellular pathways, with the caveat that this work 
has only captured preselected genes known to underlie deafness.  
From the eleven USH genes, investigated for association to hearing and language phenotypes 
(Result Chapters 1-3), the strongest contributor for APD susceptibility remains USH2A as first 
explored by Perrino et al. Across the three genetic models (rare Mendelian, common risk model 
and gene-based rare risk model), USH2A pathogenic heterozygous variants, common and rare risk 
variants showed consistent contribution to hearing and/or language abilities. In addition, Perrino 
et al. found that children carriers of pathogenic heterozygous USH2A variants had increased low-
frequency hearing thresholds (+1.2 dB HL at 500 Hz), which was consistent with other reports of 
obligate USH carriers from the literature (van Aarem et al., 1995; Wagenaar et al., 1995). 
Moreover, association analyses including common risk variants illustrated that USH2A has a direct 
influence upon low-frequency hearing abilities and an indirect influence upon language that is, in 
part, modulated by hearing. In support of the link between subtle hearing abilities and language, 
an association between mild/moderate SNHL and poorer phonological processing (the use of 
sounds to process spoken and written language) has been recognised in previous reports (Wake 
et al., 2006; Briscoe, Bishop and Norbury, 2001). These findings illustrate that even a very mild 
problem with hearing can lead to a reduction in a particular language skill that together with 
other risk factors can increase the susceptibility to impairment in other domains of language. The 
usherin protein functions as a lateral link providing support between stereocilia and USH2A is 
expressed transiently during development (Adato et al., 2005a), suggesting a key role in 
establishing stereocilia organisation early on. Although USH2A is found in both IHC and OHC, its 
knock-out disproportionally affects OHCs, leading to overt hearing loss specifically at high 
frequencies (Liu et al., 2007). The low-frequency hearing abilities being affected because of a 
more complex USH2A risk model therefore suggests that USH2A risk variants can increase the 
susceptibility to an APD phenotype through the subtle disruption of feedback mechanisms by 
OHCs.  
Although USH2A is primarily expressed in cochlea and retina, but not in the brain, a recent study 
by Perrino et al. provides a molecular explanation to the effects of USH2A genetic variation in CNS 
(Perrino, Newbury and Fitch, 2021). Heterozygous Ush2a mice showed an increased right superior 
olivary complex (SOC) volume compared to a decreased SOC volume in homozygous knock-out 
Ush2a mice (Perrino, Newbury and Fitch, 2021). These findings suggested that altered cochlear 
development, as a result of usherin malfunction or dysfunction, impacts higher order auditory 
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processing at both functional and structural level, but with different consequences for 
heterozygous compared to homozygous subjects. 
Findings presented in Results Chapter 4, investigating genetic variants with large effect that could 
contribute to a sAPD phenotype, offer further insight into potential novel molecular pathways. 
Two frameshift heterozygous variants, one in GRHL3 (p.Asp451fs) and another one in IFT88 
(p.Ile816fs) were detected in two individuals with very similar phenotypes of recurrent middle ear 
infections in early life, early language subtle deficits, typical audiogram and no recognised clinical 
disorder. Both genes are implicated in cleft lip/palate pathology (Basha et al., 2018; Tian et al., 
2017), which is known to be associated with higher incidence of OME (Sheahan et al., 2003), 
which is also a well-recognised risk factor to secondary APD. IFT88 is known to be expressed in the 
organ of Corti and plays a role in planar cell polarity, while the expression of GRHL3 in inner ear is 
not known, however, GRHL3 is expressed in the brain and is known to regulate cognitive function. 
How and if their pathophysiological pathways overlap with APD would need further investigations 
but is nevertheless a valuable finding. It should to be noted that no data was available for cleft/lip 
palate symptoms for these individuals, therefore these conclusions are only suggestive. 
A splicing heterozygous pathogenic variant in FAT4 (c.11899+1G>T) was found in one more sAPD 
individual presenting with some early expressive and receptive deficits and recurrent ear 
problems with very low PIQ, average VIQ, no hearing loss and no diagnosed clinical disorder. 
Homozygous mutations in FAT4 are a known cause of Van Maldergem syndrome, characterised 
with intellectual disability, craniofacial and auditory malformations, leading to hearing loss, renal 
and skeletal malformations (Cappello et al., 2013). However, cases with milder phenotypes and 
compound heterozygous mutations have been reported (van der Ven et al., 2017), suggesting a 
phenotypic variability of the syndrome. Although not explored before for FAT4, the phenotypic 
variability could be linked to heterozygous pathogenic variants (for example the FAT4 
c.11899+1G>T variant) which could result in some preservation of the protein function and 
therefore cause milder symptoms including auditory deficits. This view is similar to the subtle 
hearing effects seen in USH2A heterozygous individuals compared to homozygous USH2A 
pathogenic variants which cause hearing loss in Usher syndrome.  
7.5. Limitations 
The current work has a number of important limitations that should be considered. 
Firstly, due to the small samples size of USH carriers (N= 17) and sAPD cohort (N= 13), no firm 
conclusions can be drawn as one or two individuals with extreme phenotypes can skew the 
dataset considerably. A larger sample size from a targeted population is needed to increase the 
statistical power of the findings. This is also true for the ALSPAC genotype (N= 7,141) and ALSPAC 
UK10K (N= 1,681) core datasets used for association analyses- much bigger populations are 
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needed to detect subtle effects of risk variants, which will also improve on the statistical power 
and replicate any true associations. There are other large developmental cohorts which include 
genetic and phenotype data to potentially study longitudinal hearing/auditory processing skills in 
relation to genetic variation. Examples of such cohorts are: the Norwegian Mother, Father and 
Child Cohort Study (MoBa) ( https://www.fhi.no/en/studies/moba/) which includes over 90,000 
pregnant women, Born in Bradford cohort (https://borninbradford.nhs.uk/research/documents-
data) with over 13,500 children and their parents available, and the Millennium Cohort Study 
(MCS) (https://cls.ucl.ac.uk/cls-studies/millennium-cohort-study/), which follows the lives of 
around 19,000 young people across the UK. Although these cohorts primarily rely upon 
questionnaire-based measures and their available hearing measures are not as extensive as the 
ones within ALSPAC, they may still be suitable to study alongside ALSPAC. 
Secondly, the sAPD cohort was selected based on performance on two measures at 5 years of 
age. Although word discrimination threshold is a speech recognition test that was performed in 
quiet as well as in noisy conditions, offering selection of individuals who struggle to hear speech in 
noise (reflecting the most common complaint in individuals with APD), it is not a typical auditory 
diagnostic assessment included in the APD battery (Campbell et al., 2019). Therefore, the sAPD 
cohort of 13 children includes individuals with listening difficulties in noise that might reflect a 
more global deficit (such as cognition) or secondary auditory deficit as a result of episodes of 
middle ear infections (such as OME) rather than a specific auditory deficit. Moreover, measures 
utilised to review the broad neurodevelopmental profile for sAPD individuals were available up to 
the age of 14, with no later milestones to evaluate neurodevelopment in adult life. This further 
supports the notion that selection of sAPD individuals based on the two measures at an early age 
(at 5 years) might have in some cases led to inclusion of individuals with subtle hearing/listening 
difficulties at young age (with secondary APD perhaps), who develop a recognisable hearing loss 
with an adult onset later in life. It is assuring, however, that all sAPD individuals selected here 
show some degree of language deficit/delay and have normal hearing sensitivity with no obvious 
disorders diagnosed. Moreover, some individuals showed poorer PIQ, which fits with a possible 
auditory processing deficit (either as a developmental APD or part of a subtle language disorder) 
described in other studies (de Wit et al., 2016).  
Thirdly, the analysis of coding regions applied on sAPD individuals only shortlisted the most 
obvious candidates, which included very rare (novel in gnomAD_NFE population) and strongly 
pathogenic variants. In this way variants that have a higher allele frequency but are still 
considered rare (for example MAF ≤ 0.01) and may be relevant, have been missed, which might 
explain why no candidate variants were detected in the nine remaining sAPD individuals. This 
would also lead to any other contributing variants to the phenotypes to also remain undetected. 
Moreover, none of the detected candidate variants were confirmed on Sanger sequencing to 
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check that they were true positives (because primary DNA samples for the ALSPAC study are not 
readily available). 
Fourth, within the gene-based analyses, the frequency for selecting rare variants (MAF ≤ 0.01) 
was based on the ALSPAC UK10K cohort variant frequency, rather than a larger population (such 
as gnomAD) database frequency. The relatively small size of the UK10K cohort (N= 1,867 
individuals) compared to gnomAD (N= 76,156 individuals) may have resulted in some rare variants 
having a falsely elevated frequency and being missed, leading to missed possible gene-based rare 
variants associations across the USH genes.  
Lastly, the effect of CNVs on the ALSPAC tested phenotypes were not explored, further analysis of 
copy-number variants will be needed to account more completely for the complex genetic 
contributions to APD. 
7.6. Future work and conclusions 
7.6.1. USH2A effects on language follow-up 
Perrino et al. showed that heterozygous disruptions of USH2A in mice and humans are associated 
with altered low-frequency hearing abilities (auditory input) and altered early expressive language 
abilities (Perrino et al., 2020). In a follow-up study, Perrino et al. illustrated that altered cochlear 
development as a result of Ush2a heterozygous knock-out mutations can secondarily impact the 
development of brain regions (specifically SOC volume) and consequently affect auditory 
processing ability (Perrino, Newbury and Fitch, 2021). However, the exact relationship between 
altered input and language acquisition is still unclear. It is unclear whether worse language 
outcomes are a result of an impaired auditory input that affects central mechanisms and thus 
indirectly affects language (similar to the model of effect on auditory processing ability proposed 
by Perrino et al.) or whether background genetic language risk combines with altered auditory 
input and modifies the risk. Further large-scale characterisation of USH2A variation and 
behavioural outcomes in a homogenous cohort, such as a large cohort of USH2A carriers, will 
allow more accurate quantification of disrupted low-frequency abilities in carriers and more 
precise assessment of language and cognitive abilities across carriers. Moreover, as the mouse 
strains with Ush2a heterozygous disruption used by Perrino et al. have a homogenous background 
which lacks overt risk mutations (Perrino et al., 2020), an additional double vs single risk mouse 
model would be needed for the investigation of the double-hit model. A good candidate for a 
double risk model with heterozygous Ush2a knock-out is Cntnap2. CNTNAP2 is a well-
characterised gene with robust association to various aspects of language, communication and 
neurodevelopment in humans (Alarcón et al., 2008; Vernes et al., 2008). Moreover, auditory 
processing has been proposed as a mediator of CNTNAP2 influence upon expressive language 
(Scott et al., 2018; Truong et al., 2015). Further functional studies and imaging of the stereocilia in 
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heterozygous Ush2a mice and double risk models with Cntnap2 will allow the identification of the 
level at which the input is impaired (obvious structural stereocilia damage will indicate a crucial 
role). 
 In addition, gene expression analyses in developmental brain anatomy (for example olivary 
complex, cochlea and auditory cortex) at different time points in developing mouse models (single 
and double risk) will allow the investigation of the type of biological processes which underlie the 
auditory input changes. Such additional investigations of USH2A carriers and mouse will inform 
our understanding of auditory perception processes and the effects of genetic and 
neurodevelopmental mechanisms upon longer-term brain development and language acquisition.  
7.6.2. Association studies follow-up 
Future work would also aim to replicate findings from the association analyses (Results Chapter 2-
3), implicating common USH2A and PCDH15 variants and rare ADGRV1 variants in low-frequency 
abilities and/or language abilities. Larger GWAS or meta-GWAS (incorporating multiple 
independent GWAS) on cohorts with a range of markers of auditory processing/hearing (for 
example suprathreshold features of physiological tests like ABR) and language will have better 
association resolution to capture subtle effects. Following replication, the most promising results 
would need to be studied at the functional level to characterise molecular consequences of the 
variants (see Section 7.6.3).  
7.6.3. Candidate genes follow-up 
In addition to the larger cohorts of relevant populations, the functional effects of the identified 
predicted pathogenic variants in GRHL3, IFT88 and FAT4 would need to be investigated in cell or 
animal models. Mouse mutants would be the first step to study the effect of knocked-out or 
knocked-down Grhl3, Ift88 and Fat4 function on more specific auditory and behavioural processes 
in mice (including auditory brainstem response and prepulse inhibition tasks), similar to the 
experiments on Ush2a in Perrino et al. If these genes are confirmed to play a role in auditory 
perception, then the exact mechanisms can be further studied with the addition of histological, 
microscopy imaging and gene expression in specific brain regions. 
7.6.4. Conclusions 
The aim of this thesis was to fully examine the effect of candidate gene variation on auditory 
processing, hearing, and emergent language skills to better understand the shared mechanisms 
that underpin these processes. Overall, this research supports the idea of genetic complexity and 
suggests an overlap between auditory processing, hearing and language on a genetic level. 
Moreover, it provides an insight into the genetic architecture of APD, proposing several risk genes 
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(USH2A, GRHL3, IFT88 and FAT4) that would need to be further examined so we can gain better 
understanding into the molecular biology of APD. This will lead to a better classification of APD as 
a disorder, which will further improve the specificity of diagnostic criteria used and the 
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